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abs Absorbance 
ACN Acetonitrile 
ATPS Aqueous two-phase system 
BF4 Tetrafluoroborate 
BIB Brunel Institute for Bioengineering 
BMIM 1-butyl-3-methylimidazolium 
BSA Bovine serum albumin 
CCC Countercurrent chromatography 
CCS Centrifugal contactor-separator 
CPC Centrifugal partition chromatography 
CS Chiral selector 
CV Coefficient of variation 
D Distribution ratio 
Da Dalton 
DAAO D-amino acid oxidase 
DCM Dichloromethane 
DE Dynamic Extractions Limited 
DOM Dextrorphan 
DOMe Dextromethorphan 
E. coli Escherichia coli 
ee Enantiomeric excess 
EMIM 1-ethyl-3-methylimidazolium 
EtOAC Ethyl acetate 
F Mobile phase flow rate (ml/min) 
H Head 
HILIC Hydrophilic interaction chromatography column 
HPLC  High performance liquid chromatography 
HSCCC High speed countercurrent chromatography 
IEX Ion-exchange chromatography  
IL Ionic liquid 
KBA  Keto butyric acid 
KD Partition ratio 
Km Michaelis-Menten constant (mg) 
LC Liquid chromatography 
LP Lower phase 
MAO Mono amino acid oxidase 
MDM Multiple Dual-Mode 
MeOH Methanol 
MP Mobile phase 
mPEG-Mal Methoxy-PEG-Maleimide 
Mr Relative molecular mass (g/mol) 
N(CN)2 Dicyanamide 
NTf2 Bis(trifluoromethylsulfonyl)imide 
OD Optical density (AU) 
OPA ortho-phthalaldehyde 
PC6C6C6C14 Trihexyltetradecylphosphonium 
  7 
PEG Polyethylene glycol 
PEG-MS Polyethylene Glycol Monostearate 
PF6 Hexafluorophosphate 
PTFE Polytetrafluoroethylene 
RP Reversed phase 
rpm Revolutions per minute 
RT Retention time (min) 
SD Standard deviation 
Sf Stationary phase retention (ml) 
SP Stationary phase  
T Tail 
tBME Methyl tert-butyl ether 
TvDAAO Trigonopsis variabilis D-amino acid oxidase 
UP Upper phase 
UV Ultra violet 
v Volume (ml) 
Vmax  Maximum rate of the enzymatic reaction 
W Weight (mg) 
λ Wavelength 
  8 
Abstract 
The potential of countercurrent chromatography (CCC) as a small footprint 
bioreactor/separator for manufacture of enantiopure chiral molecules was explored, using 
as a model reaction the isolation of L-amino butyric acid (L-ABA) from a DL-ABA 
racemate and the enantioselectivity of D-amino acid oxidase (DAAO). Bioconversion of 
D-ABA to ketobutyric acid (KBA) by DAAO, immobilised by selective partitioning in 
the stationary phase of the CCC centrifuge, was accompanied by separation of unreacted 
L-ABA from KBA by the countercurrent action of the centrifuge.  
For effective bioreactor/separator action, a high partition of the biocatalyst to the 
stationary phase was required in order to retain the biocatalyst in the coil, with differing 
partitions of substrates and products between the stationary phase (SP) and mobile phase 
(MP) so that these could be separated. Aqueous two-phase systems (ATPS) were the 
major two-phase systems used to provide SP and MP, as these are well reported to be 
effective in preserving enzyme activity. The distribution ratios of DL-ABA, KBA and 
DAAO were measured in a range of phases with polyethylene glycols (PEGs) of different 
molecular weights, different salts, and different compositions of PEG and salt, using an 
automated robotic method, developed for the purpose. A system of 14% w/w PEG 1000/ 
14% w/w potassium phosphate, pH 7.6, gave the best combination of distributions ratios 
(CPEG phase/Csalt phase = CSP/CMP) for ABA, KBA and biocatalyst (DAAO) of 0.6, 2.4 and 
19.6 respectively. A limited number of aqueous-organic and ionic liquid two-phase 
systems were also reviewed, but found unsatisfactory. 
CCC operating conditions such as substrate concentration, biocatalyst concentration, 
the mobile phase flow rate (residence time in the CCC coil), temperature, rotational speed 
and operational modes (single flow and multiple-dual flow) and types of mixing (cascade 
and wave-like) were optimised to produce total conversion of D-ABA to KBA, which 
was then completely separated from unreacted, enantiomerically pure (>99% ee), L-
ABA.  
Advantages of the CCC bioreactor over conventional technology include reduced 
equipment footprint, cheaper running costs, and faster purifications. However, in its 
current format the drawbacks, such as enzyme instability and excessive optimisation 
time, reduce its commercial appeal.  Additional investigations into the use of whole cell 
preparations of biocatalyst in the CCC bioreactor showed potential to overcome the 
problem of enzyme instability and this may in the future give the CCC bioreactor a place 
in the enantioseparation field.  
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1.  INTRODUCTION AND LITERATURE REVIEW  
 
1.1. Aims and Objectives 
The aims and objectives of the research project presented in this thesis are listed 
bellow:  
 
1) Development of analytical procedures 
To allow the enzyme activity as well as partitioning of amino butyric acid (ABA), 
ketobutyric acid (KBA) and enzyme in a range of phase systems, to be determined 
analytically.  
 
2) Phase system selection 
Identification and optimisation of a two-phase system able to maintain the enzyme 
active enough to complete the conversion of injected substrate and allow unaltered L-
ABA and KBA produced within the CCC-coil to elute at a different time.  
 
3) Optimisation of the CCC-bioreactor 
To obtain a very high D-ABA degradation within the CCC coil, which was necessary 
to attain L-ABA of 99% enantiomeric purity.  
 
4) Purification of enantiomerically pure L-ABA from a racemic mixture 
To allow isolation of unaltered L-ABA, which is the target compound, from KBA 
produced within the CCC column.  
 
 
Overall, the aim of the research project presented in this thesis was creating a 
bioreactor based on a CCC centrifuge, to enable the enantioseparation of L-amino 
acid of at least 99% enantiomeric purity from the racemic mixture of DL-
aminobutyric acid. 
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1.2.  Introduction to chromatography 
 
Chromatography is a separation technique thought to be invented in 1906 by the 
Russian scientist Mikhail Semyonovich Tsvet, who applied it to the separation of 
plant pigments during his research on chlorophyll using columns of calcium 
carbonate. The term chromatography comes from Greek χρώµα: chroma, colour and 
γραφειν: graphein, to write. However, a number of commentators have pointed that 
Tsvet named the technique after himself, literally “Tsvet’s writing”, as the word tsvet 
in the Russian language means colour.1 
 
1.2.1. Chromatographic theory 
Chromatography is the collective term for a set of techniques used for the 
separation of mixtures. The technique, which involves passing a mixture of different 
molecules, dissolved in the mobile phase, through a stationary phase is based on the 
differential partitioning between these two phases. Molecules which interact with the 
stationary phase need more time to pass through, therefore they elute at different 
times.  
The aim of all chromatography is the separation, or resolution, of compounds in 
the mixture. The quality of resolution is defined by the resolution factor (RS) 
determined according to equation 1. RS is expressed as the ratio of the distance 
between the two peak maxima (d) to the mean peak width (W) at the baseline.2 
 
RS higher than 1.5 means that the two peaks are separated with the baseline return, 
whereas a resolution factor lower than 1.5 means that there is some peak overlap.2 
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W1 W2
d
 
Figure 1 Resolution between a two peaks. d – the distance between the two peak maxima; W1 and W2 
– width of the two peaks at the baseline 
 
2/)( 21 WW
dRs
+
=  Equation 1 
 
1.2.2. Review of chromatographic techniques 
The various chromatographic techniques are named according to the state of the 
mobile phase. Liquid chromatography (LC) is a technique where the mobile phase is a 
liquid, whereas gas chromatography (GC) uses a gas as the mobile phase. A further 
subclassification was made according to the state of the stationary phase e.g. column 
or planar chromatography.  
Planar chromatography is a separation technique where the stationary phase is 
present on a plane, such as paper or a glass plate covered by a layer of the stationary 
phase. An example of planar chromatography is thin layer chromatography (TLC).  
In the case of column chromatography the stationary bed is located within a tube 
(column). Since the mobile phase can be either a liquid or a gas, column 
chromatography can be divided into LC and GC.  
 
1.2.2.1. Gas chromatography (GC) 
Gas chromatography (GC) is that form of chromatography in which a gas is the 
mobile phase. The sample is vaporized and carried by the gaseous, mobile phase (the 
carrier gas). Samples partition into the stationary phase, which usually is a liquid, 
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based on their solubilities at a given temperature. The components of the sample 
separate from one another based on their relative vapour pressure and affinities to the 
stationary phase.3 
Although GC is a fast, efficient and sensitive technique, the method has some 
disadvantages such as limitation to volatile samples. Samples containing high 
concentrations of nonvolatile molecules, such as salts or PEG, cannot be analysed 
directly as those molecules, unless removed before an injection, would build up in the 
coil. For that reason GC is not convenient for analysing samples of an aqueous two 
phase system (ATPS).  
 
1.2.2.2. Liquid Chromatography (LC) 
Liquid chromatography (LC) is a separation technique which uses a liquid mobile 
phase and can be carried out either in a column or on a plane. The stationary phase 
applied for that technique can be either a solid or a liquid.  
 
The most common LC technique is high-performance liquid chromatography (or 
high pressure liquid chromatography, HPLC). It is a very efficient method to separate, 
identify and quantify different molecules. The stationary phase might contain various 
functional groups such as C18H37 attached to a solid support which usually is silica 
beads, packed in a column. The size of beads is in the order of 5µm, which creates a 
very high pressure inside the column, up to 6000psi. The smaller the beads the higher 
the resolution therefore, for modern HPLC, columns are filled with particles that are 
smaller than 2µm. This generates a pressure reaching 15,000psi, which requires 
special pumps. This type of HPLC system is called Ultra High Pressure Liquid 
Chromatography (UHPLC).  
Depending on the functional groups attached to the silica beads, different types of 
columns are available for use in HPLC:  
 Normal Phase HPLC (NP-HPLC) was one of the first types of HPLC used for 
separation of polar compounds. The column is typically filled with silica beads 
which intrinsically are very polar. The mobile phase consists of a very nonpolar 
solvent, like hexane or heptane, mixed with a slightly more polar solvent like 
isopropanol, ethyl acetate or chloroform. Recently its modification, HILIC bonded 
phases are becoming popular.  
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 Hydrophilic Interaction Chromatography (HILIC) is a version of normal 
phase liquid chromatography. The polar stationary phase is usually made of silica 
beads modified by attaching polar groups such as amino, amide, cationic or 
zwitterionic groups. The separation is achieved by hydrophilic partitioning 
mechanisms between the mobile phase and the water-enriched layer in the 
hydrophilic stationary phase, superimposed on weak electrostatic interactions 
between charged analytes and the neutral zwitterionic stationary phase (Figure 2). 
That results in a unique selectivity, which is especially suitable for analytes that 
are poorly retained on reversed phase columns. 
 
 
 
Figure 2 Separation process for the ZIC-HILIC column made by SeQuant. Taken from 
www.sequant.com 
 
 Reversed Phase HPLC (RP-HPLC) uses moderately polar mobile phase and a 
non-polar stationary phase, which is a straight chain alkyl group such as C18H37 or 
C8H17 attached to silica beads. The method is used for separation of moderately 
nonpolar molecules, which are very common compounds in nature. Reversed 
phase chromatography operates on the principle of hydrophobic forces, therefore 
the less polar the compound, the higher the retention on the column. To decrease 
retention a less polar mobile phase is used, usually by adding methanol or 
acetonitrile. Frequently a gradient elution is applied by gradually increasing the 
concentration of less polar solvent in the mobile phase. This accelerates the 
elution of highly nonpolar compounds from the column.  
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 Ion-exchange chromatography (IEX) allows separation of ions and charged 
molecules, such as amino acids, based on their charge. The stationary phase 
surface displays ionic functional groups, which interact with an analyte of 
opposite charge. This type of chromatography is further subdivided into cation 
exchange chromatography and anion exchange chromatography.  
 Size exclusion chromatography is a technique which separates molecules based 
on their size. Small molecules, trapped in pores of the stationary phase particles, 
need more time to elute than big molecules. Those which are too big to enter the 
pores simply pass through the column. Because of very low resolution, the 
technique is often used as a final step of purification of macromolecules, such as 
proteins and polymers.  
 Affinity chromatography is a method of separating biochemical mixtures based 
on highly specific biological interactions, such as that between a protein and an 
antibody, enzyme–substrate or receptor-ligand. The separation procedure usually 
consists of two steps. First a mixture is loaded onto the equilibrated column. The 
compound of interest is temporarily bound to the column, whereas the flow-
through containing impurities is discarded. The next step involves flushing the 
column with a wash solvent, which washes out the previously bound compound of 
interest.  
 
1.2.3. Analytical and preparative chromatography 
Analytical chromatography, which usually requires a small amount of a sample, is 
used for the identification and quantification of molecules. However, chromatography 
can only be used for the identification of already defined molecules by comparison of 
elution time for eluted compounds and their standards.  
The most widely used chromatography techniques for analytical purposes are 
HPLC and GC. In both cases the mobile phase coming out from a column passes 
through a detector, which emits a signal proportional to the concentration of eluent 
passing at any time through the detector. The signal, which is recorded by a computer, 
is plotted against the elution time. The area under a peak is proportional to the 
concentration of the eluted compound.  
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Preparative chromatography is used for isolating compounds from a mixture of 
chemicals. Fractions of mobile phase eluted from a column are collected such that 
each compound of interest is present in a different set of fractions. Examples of 
preparative chromatography are IEX, affinity chromatography, HPLC and CCC.  
 
1.3. Countercurrent chromatography (CCC) 
 
Countercurrent chromatography is a liquid-liquid separation technique without 
any solid support invented by Ito in late 1960s4. In CCC both the mobile phase as well 
as the stationary phase are liquid. To retain the liquid-stationary phase in a column, a 
centrifugal force is used, while the second immiscible phase is passed through as a 
stream making contact with the stationary phase. The separation is based upon the 
partitioning of an analyte between the stationary and the mobile phase.  
The technique has several advantages over commonly used techniques such as 
preparative HPLC. Since both phases are liquid, a sample can always be recovered, 
either from blowing out the coil contents or applying elution-extrusion5. Therefore, 
unlike in HPLC, the irreversible adsorption or loss of a sample in the column cannot 
occur. A very high percent of the column (up to 70-90%) is a liquid stationary phase. 
That allows for injecting as much sample as 10-30% of the column volume. Since 
both phases are liquid, either can be used as mobile or they can even be switched over 
during a run.  
The technique has been used to separate natural products6, synthetic molecules7, 
proteins8, organelles9, cells10, 11 and bacteria12.  
 
1.3.1. Types of phase-mixing in CCC 
In order to improve the mixing and separation of the two phases, a number of 
different mixing modes have been developed. The two main mixing modes are 
hydrodynamic and hydrostatic mixing.13 
 In hydrodynamic CCC a wave of mixing and settling of the two phases passes 
through the column. Therefore, if the flow stops, the phases will redistributed 
according to the rule described in section 1.3.2, i.e. the heavy phase gathers in the 
tail end, whereas the light phase tends to the head end of a coil. Since the coil of a 
hydrodynamic CCC consists of a tube wound around a bobbin rotating in the 
planetary motion, no sealing system is required and the process is not pressure 
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limited. A coil made of PTFE tube is also easy to clean. Moreover, the process can 
be easily scaled up14,15 by applying a large bore coil such as 17.5mm, allowing 
throughput in excess of 25kg/day16. The disadvantage of this type of column 
comes from its sensitivity to changes in interfacial tension between the phases, so 
it does not retain an aqueous two-phase system (ATPS) well. 
 In hydrostatic CCC the stationary phase is trapped in a series of chambers, thus if 
the flow stops it will remain there. In spite of some advantages, such as retaining 
“difficult” phase systems for instance, ATPS provides much more efficiency in 
comparison to hydrodynamic CCC, and better mixing between the phases, this 
type of column also has some limitations. The main disadvantage is related to the 
limited length of a column due to the increasing pressure. Moreover, a system of 
chambers is more difficult to clean compared with the tube used in hydrodynamic 
CCC. Hydrostatic CCC, in comparison to hydrodynamic CCC, is also more 
difficult to scale-up or scale-down.  
 
1.3.2. Principle of hydrodynamic countercurrent chromatography 
The liquid stationary phase is retained in the coil by the Archimedean screw force, 
which is generated by rotating the coil. Figure 3 shows that, in a slowly rotating coil 
filled with water, both air bubbles and metal beads migrate to the same end of the coil, 
called the head of a coil. The opposite end of the coil is called the tail.17 
 
Figure 3 Motion of various objects in a slowly rotating coil. Inside the helically wound coil filled with 
water there are air bubbles and beads. If the coil is slowly rotated around its helical axis, air bubbles as 
well as beads tend to move towards one end of the coil, contractually named the head of the coil. The 
other end is called the tail. (Taken from Ito and Conway (1996)17). 
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If the coil filled with two immiscible phases is rotated, both phases tend to move 
towards the head of the coil. Since they cannot occupy the same place, the lighter-
upper phase occupies the head of the coil whereas the lower phase is displaced 
towards the tail. Therefore, to maintain the stationary phase in a coil, if the lower 
phase is the mobile phase it should be pumped from head to tail, and the upper phase 
in the opposite direction (tail to head) if it is used as the mobile phase.  
 
If a spinning coil is entirely filled with one phase (i.e. the stationary phase, SP) 
and the other phase flowed over it (i.e. the mobile phase, MP), some of the SP is 
going to be displaced till the hydrodynamic equilibrium is obtained. When a mixture 
of different compounds, having different partition coefficients between the stationary 
and the mobile phase, is injected onto the coil, they will elute from the other end of 
the coil at a time governed by their partitioning (KD) between the phases. If the 
analyte is only soluble in the mobile phase (KD = 0), it will elute with the solvent front 
of the mobile phase. Alternatively it will stay in the column if it is soluble only in the 
stationary phase (KD = ∞). However, since the stationary phase can be pumped out 
from the column, a totally retained analyte can easily be recovered.  
 
1.3.3. Distribution ratio (D) 
The retention time of an injected analyte in CCC depends on its affinity for the 
stationary and the mobile phase. Since both the mobile as well as the stationary phase 
are liquid, partitioning of an analyte can easy be determined by analysing its 
concentration in those phases. 
 
The distribution ratio (D) is the total analytical concentration of an analyte in each 
liquid phase of the two phase system, regardless of a chemical form of the analyte. 
 
The distribution constant or partition ratio (KD) is the ratio of the concentration of 
an analyte in a single form between the two phases. In countercurrent chromatography 
it is the ratio of a concentration of an analyte in the stationary phase [A]stat. and the 
mobile phase [A]mobile at equilibrium: 
 
[ ]
[ ]mobile
stat
D A
A
K .=  Equation 2 
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Often there is no chemical reaction, ionisation or complexation in the two liquid 
phases, in which case D = KD.  
 
KD values of many solutes are directly analysed by the so-called shake-flask 
method. The solute is partitioned between the two liquid phases of a proposed solvent 
system in a tube. After equilibrium is achieved the concentration of the analyte in 
each phase is determined using a variety of techniques such as HPLC, GC or 
biological assays.18 
 
These values show the affinity of an analyte to both phases, thus they determine 
the time an injected analyte elutes from a CCC coil (retention time, RT). In 
countercurrent chromatography the retention time of an analyte can be predicted 
according to equation 3: 
 
F
VVVK
R extraMSDT
++⋅
= ; [min] Equation 3 
 
KD - distribution constant, VS – stationary phase volume [ml], VM – mobile phase 
volume [ml], Vextra - extra coil volume [ml], F – mobile phase flow rate [ml/min] 
 
Values VS and VM can be calculated based on the volume of the stationary phase 
displaced (Vdisp) to equilibrate the coil of the volume VC [ml].  
 
VC = VS + VM Equation 4 
VC = Vdisp + VS - Vextra Equation 5 
 
1.3.4. CCC setup 
Figure 4 shows a typical CCC setup used for the separation of compounds. Two 
pumps supply the CCC centrifuge with the mobile and the stationary phase. Before 
the CCC, there is an injection port used for injecting a sample.  
The injection port is based on a 6-way selection valve operated in the two modes: 
load or injection. In the load position the sample loop, which is made of a certain 
length of a PTFE or stainless steel tube, is filled with a sample. When the valve is set 
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in the inject position, the stream of mobile phase passing through the sample loop 
injects its content onto the coil. 
The mobile phase coming out from a CCC-centrifuge can pass into a detector, 
connected to a computer, which records signals as chromatograms. Since CCC is a 
preparative technique, almost always fractions of the eluted mobile phase are 
collected using a fraction collector. For blowing out phases from the CCC-centrifuge, 
to extrude compounds which do not elute during a CCC run, compressed nitrogen is 
often used. 
 
 
Figure 4. Schematic diagram of a typical CCC set up taken from Garrard et al (2008)19 
 
1.3.4.1. Hydrodynamic CCC 
The tubing is wound on a bobbin which rotates on a planetary axis (Figure 5) in 
such way that at the proximal (nearest) side of the planetary coil there is mixing 
between two immiscible liquid phases in the tube, whereas at the distal (furthest) side 
there is settling between the two phases. Rotating the coil creates a wave of 
simultaneous mixing and settling zones which travel synchronously towards the head 
end of the tubing. A sample injected on a coil would experience 1000 mixing and 
settling zones a minute when the main rotor speed is 1000rpm.20 
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Figure 5 Planetary motion of CCC column. The red line indicates the path traced by a point of the coil.  
 
The planetary motion is created by mounting the planetary gear on the coil holder 
axis to an identical sun gear rigidly fixed to the centrifuge framework.21 The column 
rotates around its own axis while revolving around the centrifuge axis, like the 
rotating earth revolves around the sun. Both the rotation and the revolution are at the 
same angular velocity (ω) and in the same direction (synchronous). 
 
 
Figure 6 Design principle of the J-Type CCC. The bobbin rotates around its own axis and revolves 
around the centrifuge axis at the same angular velocity (ω) in the same direction (synchronous motion). 
That rotation prevents twisting of the flow leads, which eliminates the need for seals. Taken from Ito 
and Conway (1996)17 
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In planetary coil rotation there are two zones where different forces and processes 
take place. In the peripheral part of the coil from the axis of revolution, there are 
centrifugal forces which cause separation of the two phases, whereas, the proximal 
part of the rotating coil makes a loop which causes mixing of the two phases as shown 
in Figure 7 based on a spiral coil. When the molecules migrate with the mobile phase 
through the rotating coil, they pass alternately zones of mixing and zones of 
separation.  
The other consequence of synchronous moving is that the flying leads do not 
twist. Therefore no rotating seals are required, which eliminates the risk of a phase 
leaking or contamination.  
 
Figure 7 Solvent distribution in a multilayer coil. Taken from Ito and Conway (1996)17 
 
Many coils are made by winding a tube in several layers. In a multilayer coil there are 
at least two forces that influence the two immiscible phases: 
1. The Archimedean screw action forces the heavy phase to the tail 
2. Hydrostatic pressure forces the heavy phase to the periphery of a multilayer 
coil 
The best stationary phase retention is obtained when the two forces are coupled rather 
then competing. Therefore, it is desirable to have the tail of the coil at the periphery 
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and the head at the centre. Table 1 shows the orientation of the head and the tail of a 
coil according to winding and spinning direction. For the best retention, a clockwise 
wound coil ought to be rotated in the clockwise direction, whereas a counter 
clockwise wound coil in counter clockwise direction.  
 
 
  
Counterclockwise Coil Clockwise coil 
Periphery Head Periphery Tail 
Spun Clockwise 
Centre Tail Centre Head 
Periphery Tail Periphery Head Spun 
Counterclockwise Centre Head Centre Tail 
 
Table 1 Orientation of the Head and the Tail for a coil wound clockwise and counter clockwise, spun 
clockwise or counter clockwise. 
 
The mobile phase can be pumped in two directions: from the head to the tail and from 
the tail to the head. The heavier phase tends to occupy the tail of a coil. If that phase is 
chosen as the stationary phase, the solvent inlet must be at the tail of the column. 
Therefore, the mobile, upper phase should be pumped from the tail (periphery) of the 
coil to its head (centre). Table 2 shows the pumping direction of the mobile phase, 
depending on whether the upper or the lower phase is used.  
 
Mobile phase Direction of the mobile phase pumping
Upper phase from the tail (periphery) to the head (centre)
Lower phase from the head (centre) to the tail (periphery)
 
Table 2 Direction of the mobile phase pumping.  
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Different CCC operating modes 
 Isocratic Mode. The composition of the mobile phase is the same through the 
whole separation process. 
o Normal Phase Mode is when the stationary phase is the polar one and the 
mobile phase is nonpolar one. For most aqueous-organic phase systems the 
polar phase is the lower, aqueous one. It is recommended to pump the 
upper, mobile phase from Tail (Periphery) to Head (Centre).  
o Reverse Phase Mode is when the stationary phase is the nonpolar one and 
the mobile the polar one. It is recommended to pump the upper mobile 
phase from Head (Centre) to Tail (Periphery).  
 Gradient elution. The composition of the mobile phase changes during a 
separation.  
 Co-current chromatography. Both phases are pumped in the same direction 
at different flow rates. This operating mode allows an analyte having a very 
high affinity to the stationary phase to elute.22 
 Dual Mode. The mobile phase is initially pumped in the recommended 
direction e.g. from tail to head if it is the lower phase. Then both the mobile 
phase and the flow direction are altered. Thus, the stationary phase becomes 
the mobile phase and would be pumped from head to tail.  
 Continuous counter-current extraction. Both phases are mobile and are 
pumped at the same time in opposite directions to each other. The sample is 
supplied continuously to the centre of the column. This mode requires a 
special design of CCC column.23, 24 
 Intermittent counter-current extraction. This uses a series of alternating 
flow, between normal phase operation and reversed phase operation with the 
sample continuously injected in the middle.25  
 
1.3.4.2. Hydrostatic CCC (CPC) 
In hydrostatic CCC, when the flow rate stops the distribution of the stationary phase 
does not change when the centrifugal field is maintained. An example of hydrostatic 
CCC is centrifugal partition chromatography (CPC), where the stationary phase is 
held in cells or compartments under the action of a uniform field and the mobile phase 
flows through these compartments serially.  
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A CPC column consists of a number of chambers serially connected by ducts, placed 
on the rotor of a centrifuge (Figure 8). The stationary phase is maintained in chambers 
by a constant centrifugal force field produced by rotation around a single axis. 
The mobile phase can be delivered to the ducts in two ways: 
 descending (i.e. with the centrifugal force)  
 ascending (i.e. against the centrifugal force)  
When the mobile phase is the lighter of the two phases, (the upper-phase) it is pumped 
in ascending mode, whereas the heavier, lower phase is pumped in descending mode.  
 
Figure 8. A schematic visualisation of chambers and ducts that make a CPC column. 
 
It has been found that hydrostatic CCC is more efficient in retaining ATPS for 
example PEG1000/ potassium phosphate26. 
 
1.3.4.3. Toroidal CCC (TCCC) 
A toroidal coil is a helically wound tube, either mounted circumferentially around a 
rotating disc27 or wound on a rotating, planetary motion, large diameter, cylindrical 
coil holder28 (Figure 9).  
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Figure 9 Toroidal coil wound around a rotating bobbin 
 
A toroidally-wound coil, which is a pseudo-hydrostatic CCC, matches features of 
both hydrostatic and hydrodynamic CCC. In a similar manner to hydrostatic CCC, a 
toroidal coil provides vigorous, cascade mixing between the stationary and the mobile 
phase, enabling effective mass transfer which results in a good resolution the between 
separated compounds. That is especially beneficial if phases of high viscosity, like 
ATPS, are used. Analogously to a hydrodynamic CCC, a toroidal coil is wound of 
either PTFE or a stainless steel tube and therefore much easier to clean compared to a 
hydrostatic CCC coil made of inter-connected chambers. Moreover a toroidal type 
coil can be easily scaled-up by increasing an internal diameter of a tube. 
Rotating a toroidal coil in synchronous planetary motion (Figure 10) like J-type 
CCC, allows continuous elution without using rotating seals28. 
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Figure 10 Overall view on the toroidal coil planet centrifuge. (From Ref. 28) 
 
Using two model proteins, myoglobin and lysozyme, and ATPS composed of 
PEG1000 and K2HPO4 as a phase system, Guan et al29 made a direct comparison 
between a toroidal coil and hydrodynamic J-type centrifuge. Due to inefficient mass 
transfer between the two phases, the J-type centrifuge of 45.1ml coil volume did not 
provide any separation of the two proteins. By contrast, the proteins were partly 
separated when a toroidal coil of volume 51.7ml was used and totally resolved when 
the coil volume was doubled (107.1ml) by doubling the coil length. Moreover when 
the toroidal coil was used, no stripping of the stationary phase (i.e. elution of the 
stationary phase from the column) was noticed as has often been observed in the 
hydrostatic CCC (CPC)30.  
Shinomiya et al31 have also demonstrated a complete separation of the two model 
proteins, myoglobin and lysozyme, on a toroidal coil using ATPS composed of 
PEG1000 and K2HPO4 as a phase system. 
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1.3.5. Types of Two-Phase System for CCC 
Phase system selection32 plays the key role in the CCC separation as the technique 
is based on the differential partitioning between two immiscible phases (section 
1.3.3).  
There is a whole range of available phase systems that can be applied to CCC and 
searching for the most suitable two-phase system may be estimated as 90% of the 
entire work in CCC. Selecting the most appropriate solvent system frequently starts 
with a literature review of the separation of similar compounds in CCC. 
The choice of solvent system is determined by the nature of separated molecules 
and criteria such as the polarity of the analyte and its solubility. Net charge as well as 
stability and ability to create complexes should also be taken into consideration. 
In the next sections two-phase systems based on organic solvents, polyethylene 
glycol and ionic liquids are described.  
 
1.3.5.1. Aqueous-organic phase systems 
A wide spectrum of available organic solvents enables a wide range of different 
combinations and proportions. This results in a whole range of potentially useful 
phase systems for countercurrent chromatography, which might make the selection of 
a suitable phase system a very complicated and laborious procedure. Therefore, some 
efforts were put into classifying organic solvent systems according to their polarity. 
Abbott and Kleiman33 (1991) classified solvent systems into three groups: lipophilic, 
polar and intermediate, based on a polarity determined using Reichardt’s dye, which 
absorbs light in solution between 400 and 900nm depending on the polarity of the 
solvent. 
Aqueous organic two-phase systems are the most commonly used solvent systems 
in countercurrent chromatography. Since they are mixtures of water and various 
organic solvents, their low viscosity and relatively low density makes these phase 
systems convenient in operating CCC. Moreover the high volatility of most organic 
solvents enables an easy isolation of a fractionated analyte from the phase system by 
evaporation.  
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1.3.5.2. Aqueous two-phase system (ATPS) 
Aqueous two-phase systems are composed of water and either two immiscible 
polymers or a polymer and a salt, which above a critical concentration makes two 
immiscible phases. 
In 1896 a Dutch microbiologist, Martinus Beijerinck, noticed the immiscibility of 
aqueous solutions of gelatine and an agar or starch, which mixed together were 
creating biphasic systems34. In 1955 Albertsson35 mixed polyethylene glycol (PEG) 
with an hydroxylapatite sediment containing firmly-adsorbed chloroplast particles in 
1M potassium phosphate buffer. A two-phase system was created and the intense 
green colour of chloroplasts was present in the top PEG rich phase. That was the first 
example of using a two-phase system for the partitioning of cell particles.36  
Nowadays aqueous two-phase systems are commonly used both for single batch 
extraction37 as well as a phase systems in countercurrent chromatography38. The high 
water content (70-90%) and very low interfacial tension (0.0001-0.1dyne/cm 
compared to 1-20dyne/cm for water-organic solvents)39 makes those systems a 
comparatively gentle environment for biological materials and thus appropriate for the 
separation of biomolecules, cellular organelles and whole cells.  
 
a) Partitioning behaviour of amino acids in ATPS 
Shang et al40 (2004) made a complex study of the partitioning behaviour of four 
different amino acids (cysteine, phenylalanine, methionine and lysine) in 15 aqueous 
two-phase systems made of different PEG molecular weight and potassium phosphate 
at various pH. Hydrophobicity, electrostatic interaction and pH of a phase system 
were found to be the main factors affecting the partitioning of amino acids in ATPS. 
The more hydrophobic PEG-phase was favoured by the non-polar phenylalanine, 
whose distribution ratio was the highest of the tested amino acids. The important 
parameter was the charge of the amino acid. Lysine, which at the tested pH was 
positively charged, preferred the more polar, salt-rich phase. This was explained by 
the biggest electrostatic interaction being between the lysine cation and the salt anion. 
The remaining three amino acids, which were negatively charged at the tested pH, 
preferred the polymer rich phase, because of the repulsion caused by the salt anions. 
pH positively influenced the partitioning of all amino acids. In most experimental 
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conditions, especially at high pH, the four amino acids partitioned more into the PEG 
phase as the molecular weight of PEG increased.  
Cohen et al41 (1995) observed a positive correlation between the number of 
methylene groups in the aliphatic chain of an amino acid and its partitioning in ATPS 
made of PEG8000 and potassium phosphate. The longer the aliphatic chain of an 
amino acid, the less polar was the molecule and so the amino acid prefered the less 
polar, PEG-rich, upper phase.  
 
b) Partitioning behaviour of proteins in ATPS 
Partitioning of a protein in ATPS depends on its own properties, such as size, net 
charge and hydrophobicity, as well as the type of the phase system, such as the 
polymer and salt type, their concentration, polymer molecular weight and pH.42 
An aqueous two-phase system, used for partitioning of biomolecules, is usually 
made of polyethylene glycol (PEG) and dextran or a salt, which usually is a phosphate 
or a sulphate. In the literature there are other systems based on polyethylene glycol. 
Other examples of the second polymer include a guar gum derivative43, starch44,45, 
maltodextrin46 or cellulose47.  
Another type of ATPS consists of systems made of thermoseparating polymers, 
i.e. polymers which above a certain temperature precipitate out of the solution. This 
makes the recovery of a sample easier which, staying in aqueous phase is separated 
from the polymer.  
Partitioning of proteins in ATPS made of a thermo separating polymers has been 
intensively studied by Tjerneld and co-workers48,49,50. The publication50, published in 
1995, presents the effect of salts and the surface hydrophobicity of five model 
proteins, bovine serum albumin (BSA), lysozyme, β-lactoglobulin, myoglobin and 
cytochrome C, on the partitioning in aqueous two-phase systems. The top phase of 
two-phase systems consisted of either a relatively polar polyethylene glycol (PEG, 
100% EO) or copolymers of ethylene oxide (EO) and propylene oxide (PO) in 
proportions 50%EO/50% PO and 30%EO/70% PO. The more PO in a polymer, the 
more hydrophobic was the phase system. Reppal PES 200 (hydroxypropyl starch) was 
used as the bottom phase polymer. Hydrophobicity and the presence of a hydrophilic 
salt affected most the partitioning of lysozyme, a protein with the highest surface 
hydrophobicity. It could be easily driven to the top phase by increasing the proportion 
of PO and the presence of the relatively hydrophobic anion, ClO4-. In the publication49 
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published in 2002 the effect of surface exposed amino acids on partitioning of 
monomeric proteins was demonstrated. Aromatic residues had the strongest effect on 
the partition coefficient, showing preference to the less polar upper, EO30PO70, 
phase. On the other hand the presence of charged amino acids on the protein surface 
enhanced the partitioning of the protein in the lower dextran-rich phase.  
Pereira at al51 tested an aqueous two-phase system made of Ucon 50-HB-5100 (a 
mixture of ethylene oxide and propylene oxide) and a salt for the separation of endo-
polygalacturonase, which partitioned to the salt phase. Then by increasing the 
temperature of the polymer phase, the polymer was extracted with a recovery of 95%. 
 
1.3.5.3. Aqueous Ionic Liquids two-phase systems 
Ionic liquid biphasic systems consist of room temperature ionic liquids (RTILs) 
and one or more other solvents such as water, a buffer or an organic solvent.  
Room temperature ionic liquid is a collective term for salts with a melting point 
below room temperature. Although they look like viscous organic solvents, they are 
molten salts made of ions free to move within the liquid volume. The most common 
cations are dialkylimidazolium, alkylpyridinium, tetraalkylammonium and tetraalkyl-
phosphonium. For the anionic component, most researchers are using 
tetrafluoroborate, hexafluorophosphate, bis(trifluoromethanesulfonyl) inide 
dicyanimide52. By modification of either the cation or anion or both, the physical and 
chemical properties of a solvent can be changed, thus it is possible to design a tailor-
made solvent53. 
Ionic liquids have been widely researched as possible “green” replacements for 
organic solvents as they have no vapour pressure and extremely low volatility. For 
that reason, it may be easier to efficiently reuse solvents based on RTIL compared to 
those based on organic solvents53. Moreover the ability to dissolve many compounds 
and form two-phase systems with many solvents make RTILs ideal solvents for 
engineering media for biocatalytic reactors54.  
Ionic liquids can be used as a polar environment for enzymatic reactions, 
replacing conventional polar organic solvents which usually inactivate enzymes. 
However not all ionic liquids are suitable for biocatalysis. Enzymes usually stay 
active in RTILs containing BF4, PF6 and NTf2 anions, but not in those containing Cl, 
NO3, CF3SO3, trifluoroacetate or acetate anions. The most common ionic liquids used 
in biocatalysis are imidazolium based ionic liquids such as BMIM·BF4 (1-butyryl-3-
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methyl-imidazolium tetrafluoroborate)53. Van Rantwijk et al55 have reviewed the 
effect of different ionic liquids on enzyme activity and the thermal and operational 
stability of biocatalysis. 
Luts-Wahl et al56 tested the activity and stability of free and immobilised D-amino 
acid oxidase from Trigonopsis variabilis in the presence of five different ionic liquids. 
The most promising RTILs were BMIM·BF4 and BMIM·MMPO4. However the 
DAAO activity depended on the water content and the enzyme was the most active in 
the highest tested water content (80%). 
 
In the literature are reports that some aqueous two-phase systems based on ionic 
liquids are able to retain proteins in the IL-rich phase57,58,59.  
 
Since many RTILs make biphasic liquid systems with numbers of solvents, 
including water, they can be used as part of a phase system in countercurrent 
chromatography60. The biggest challenge is the high viscosity of pure RTILs which 
can be reduced by adding some organic solvent, such as acetonitrile or a short chain 
alcohol61. The ionic liquid-based ATPS is better retained in a CCC coil compared to 
the similar PEG-based ATPS, due to the larger phase density difference for the IL-
based ATPS 60. 
There are already examples in the literature of applying RTILs as solvent systems 
in CCC.  
An ionic liquid, 1-butyl-3-methylimidazolium hexafluorophosphate (BMIM·BF6), 
was successfully employed for the first time as a stationary phase in CCC for 
retaining different aromatic solutes, including bases, acids and neutral compounds62. 
Acetonitrile was added to the phase system in order to reduce the viscosity of the IL.  
Ruiz – Angel et al60 ( 2006) investigated the ATPS based on an IL, BMIM·Cl and 
K2HPO4 as the phase system in CCC for the separation of four model proteins 
(cytochrome C, haemoglobin, myoglobin and ovalbumin). However, the separation 
was found to be not possible, as all four tested proteins were totally partitioned into 
the BMIM·Cl rich phase. 
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1.4. Chemistry of chiral compounds 
 
Isomers are different compounds that have the same molecular formula but 
different structural formula. Isomers that have the same connectivity but differ in the 
arrangement of their atoms in space are stereoisomers. If a molecule lacks an internal 
plane of symmetry and has a non-superimposable mirror image like a left and a right 
hand, it is called a chiral compound (from the Greek χειρ, hand). Two mirror images 
of a chiral molecule are called enantiomers (from the Greek ἐνάντιος, opposite, and 
µέρος, part or portion). Stereoisomers that are not mirror images of each other are 
called diaseteroisomers. When two diastereoisomers differ from each other at only 
one stereocenter, they are epimers. 
The existence of a compound in two different chiral forms is often caused by the 
presence of a chiral carbon atom which is attached to four different atoms or four 
different groups of atoms. For instance in an amino acid, the amino and the carboxyl 
group as well as hydrogen and a substituent are attached to the same carbon atom 
which makes it chiral (Figure 11). Therefore, most amino acids, including amino 
butyric acid, exist as two chiral forms. An equimolar mixture of two enantiomers is 
called a racemic form (either a racemate or a racemic mixture).  
 
 
 
Figure 11 Chiral D- and L-amino acids image [from http://www.nai.arc.nasa.gov/] 
 
Most physical properties of a pair of enantiomers, such as boiling point, melting 
point, solubility, refraction index, infrared spectra and solubility in common solvents, 
are identical. The physical property that differentiates a pair of enantiomers is an 
interaction with plane-polarised light. The plane of plane-polarised light is rotated 
when the light passes through a solution of an enantiomer. Two enantiomers always 
CHAPTER 1 – Introduction and Literature Review 
 
 34 
show opposite optical activity; that is, the plane of plane-polarised light passing 
through an equimolar solution of an enantiomer is rotated at the same angle but in the 
opposite direction for the two enantiomers. Dextrorotatory enantiomers, also labeled 
(+), rotate the plane of the polarized light in the clockwise direction, whereas their 
mirror-images, levorotatory enantiomers, labeled (−) rotate the plane of the polarized 
light in the counter clockwise direction.  
The important system of nomenclature for denoting enantiomers is the R / S 
system, which labels each chiral center R or S according to a system in which its 
substituents are each assigned a priority, according to the Cahn-Ingold-Prelog priority 
rules. The chiral centre of a molecule needs to be oriented so that the lowest-priority 
of the four is pointed away from a viewer. If the priority of the remaining three 
substituents decreases in clockwise direction, it is labeled R (for Rectus), if it 
decreases in counterclockwise direction, it is S (for Sinister).  
In certain areas of biochemistry, such as amino acid and carbohydrate chemistry, 
the D/L system is used by relating a molecule to either D- or L-glyceraldehyde.  
 
A wide range of biological and physical functions are generated through precise 
molecular recognition because enzymes, receptors and other natural binding sides 
interact with different enantiomers in decisively different ways63. For that reason 
molecular chirality plays a fundamental role in many biological processes. For 
example, the dextrorotatory enantiomer of limonene has the odour of orange, but the 
levorotatory enantiomer smells of lemons. One enantiomer of a compound called 
carvone is the essence of caraway, the other, the essence of spearmint. This shows that 
the two enantiomers of the same compound can stimulate different receptors.  
Chirality is especially important in pharmacology, for many drugs used in 
pharmacology both enantiomers are active. However it often happens that only one 
form (eutomer) shows a pharmacological effect, whereas the other enantiomer 
(distomer) might cause several effects such as toxicity, inactivity or an antagonistic 
effect. Thus, especially if one of the enantiomers shows toxicity, only the desired 
form can be applied.  
For instance ibuprofen contains one chirality centre, and only the S-enantiomer is 
active as an analgesic and anti-inflammatory agent. The R-enantiomer of ibuprofen is 
inactive, although slowly converted in the body to the active S form. A medicine 
based on the S-form alone takes effect more quickly than a racemate.  
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Thalidomide, a drug which was used in early 1960’s to alleviate the symptoms of 
morning sickness in pregnant women, exists in two enantiomeric forms. One of them 
had the desired therapeutic effect, but the other was the cause of birth defects in many 
children.  
This shows the significance of using the correct enantiomer, especially in medical 
applications. In many cases the synthesis of a chiral compound leads to an equimolar 
mixture of two forms that later need to be resolved. 
 
1.4.1. Enantioseparation (chiral resolution) 
Enantioseparation, called also chiral resolution, is a collective term for the 
techniques used to obtain a pure enantiomer. A sample of an optically active 
compound that consists of a single enantiomer is said to be enantiomerically pure or 
to have an enantiomeric excess of 100%. The enantiomeric excess (ee) is defined as:  
 
ee =
moles of one enantiomer – moles of another enantiomer
total moles of both enantiomers
x 100 Equation 6 
 
Usually, there are three possibilities to obtain pure enantiomers:  
• natural source 
• asymmetric synthesis  
• separation from a racemic mixture 
The limitation of the first method is due to the limited numbers of chiral 
compounds that can be found in natural sources. Asymmetric synthesis is both 
expensive and time consuming.64 Therefore, the most popular method of obtaining 
pure enantiomers is based on the separation of a racemates.  
 
1.4.2. Characterisation of chiral separation techniques 
There are several methods available for separation of chiral compounds: 
o Crystallization 
o Membrane separation 
o Kinetic resolution 
o Chromatography 
 Simulated moving bed 
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 Liquid – liquid extraction 
 Liquid-liquid chromatography (CCC) 
 Gas chromatography  
 Capillary electrophoresis  
 Liquid chromatography (HPLC) 
 
1.4.2.1. Resolution of the racemate through crystallisation 
Two enantiomers can interact with a reagent to form a new complex compound of 
diastereomers. Diastereomers are stereoisomers that are not enantiomers, therefore 
having different physiochemical properties, one can be selectively crystallised 
through traditional techniques. That is called diastereomeric crystallisation.  
In 1849 Louis Pasteur, a French chemist and biologist, separated the two 
enantiomers of tartaric acid by the crystallisation of salts of tartaric acid derived from 
wine. That led to the discovery of enantiomerism. Salts of tartaric acid form two 
distinctive kinds of crystals which could be separated using tweezers and a 
magnifying glass.  
Unfortunately, few organic compounds give chiral crystals as do the (+) and (-) 
tartaric acid salts. Therefore, Pasteur’s method is not one that is generally applicable. 
The selection of an appropriate resolving agent remains a serious challenge. There 
are, however, a few examples in the literature of using diastereomeric crystallisation. 
For instance a racemate of mandellic acid was enriched up to 85% by the use of L-
phenylalanine as the resolving agent65.  
 
1.4.2.2. Membrane technology in enantioseparation 
Very promising new processes are enantioseparations using the membrane 
separation methods66. A chiral selector membrane binds one of the enantiomers, while 
allowing the other enantiomer to pass through the membrane. In principle, the 
membrane separates one enantiomer from the chiral solution to a pure solvent. The 
technique can be divided into two main classes: the chiral selector molecules are 
located in retentate phase or inside the of porous, solid membrane layer. The 
membrane itself can be enantioselective, or an enantioselective carrier is bound to a 
nonselective membrane.67 Hadik et al68 (2005) used N-3,5-dinitrobenzoyl-L-alanine-
octylester as a chiral selector and a polypropylene hollow fiber membrane for the 
resolution of DL-lactic acid. Jiao et al69 (2006) presented enantioseparation of 
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salbutamolsulfate on polyvinylidene fluoride hollow fiber membrane using tartaric 
acid ramifications D-dibenzoyltartaric acid and di-p-toluoyl-D-tartaric acid as 
combinatorial chiral selectors. Ul-Haq et al70 (2008) used an enantioselective 
membrane made of poly[acrylonitrile-co-acrylic acid] for enantioseparation of 
phenylalanine. Gumi et al71 proposed a membrane-based system for enantioseparation 
of β-blocking drug, SR-propanolol, using N-hexadecyl-L-hydroxyproline as a chiral 
selector.  
 
1.4.2.3. Kinetic resolution in enantioseparation 
Kinetic resolution is applied to two enantiomers which show different reaction 
rates in a chemical reaction, thereby creating an excess of the less reactive 
enantiomer.  
An important part of enantioseparation is a dynamic kinetic resolution using 
various enantioselective enzymes which, by converting only one of the two 
enantiomers, leaves the other unaltered. Then the unaltered form, which is usually a 
target compound, is isolated using a chromatographic or separation technique. The 
theoretical maximum yield of the desired form of an enantiomer is 50%. The yield can 
be increased even up to 100% in the case of applying a racemase72, an enzyme which 
catalyses stereochemical inversion around an asymmetric carbon atom.  
 
There are examples of performing an enzymatic kinetic resolution in a membrane 
bioreactor for enantioseparations. In 2009 Ahmad et al73 proposed a membrane 
bioreactor for the production of L-homophenylalanine. Ong et al74 in 2008 studied the 
enantioseparation of (R,S)-ketoprofen using Candida antarctica lipase B, which 
catalysed the esterification of (R)-ketoprofen, leaving the target compound (S)-
ketoprofen in unreacted form. At the optimum reaction conditions, the conversion of 
(R)-ketoprofen was 73%, with an enantiomeric excess of the product (ee) of 87.8%. 
Unlike the techniques described in section 1.4.2.2, when enantioselective membranes 
were used, membranes used in the membrane bioreactor provided only an essential 
barrier to enzymes, keeping them in soluble form, while allowing the transport of 
substrates and products to and from the homogenous solution. 
Koter and Ceynowa75 in 2003 described the kinetic resolution of chiral alcohols in 
a bioreactor based on a bifunctional membrane made of asymmetric polyamide film. 
The membrane exhibited both enantioselective permeabilities and catalytic properties 
CHAPTER 1 – Introduction and Literature Review 
 
 38 
induced by the immobilised lipase. Applying a bifunctional membrane produced an 
increase of the enantiomeric excess (ee) of the product from 80%, when a 
nonselective membrane with an immobilised enzyme was used, to 98.5%. 
 
1.4.2.4. Chromatography in enantioseparation 
Two enantiomers can be separated from each other using chromatographic 
techniques. As described in section 1.2.1, chromatography is a separation technique 
which is based on the different partitioning of compounds between the stationary and 
the mobile phase. Since two enantiomers share the same physical properties, they both 
partition between the two phases to the same extent. Therefore, to make a separation 
possible, one of the two following methods is applied. A direct method requires a 
chiral stationary phase (CSP) or a chiral selector if an achiral stationary is used. 
Indirect methods involve a chiral derivatising agent (CDA) which, upon reacting with 
the enantiomers, gives diastereomeric derivatives which can be separated on an 
achiral stationary phase76.  
 
1.4.2.5. Simulated moving bed in enantioseparation 
A common technique used for enantioseparations is simulated moving bed 
(SMB). The system consists of several columns (usually 6-12) connected in series. 
Due to the movement of the external streams and internal flow-rates of sections the 
counter-current flow of the absorbent is simulated.  
Schulte and Strube77, in their review of 2001, quote a number of chiral compounds 
with enantiomers which were separated using SMB. Among them are DL-threonine, 
cis/trans-phytol, 1-phenylethanol, cyclosporine A, aminoglutethimide.  
Swarup et al78 used tris cellulose 3,5 dimethylphenyl carbamate bonded on silica 
gel, the chiral selector, to resolve oxprenolol.  
 
 
1.4.2.6. Enantioselective liquid-liquid extraction 
Enantioseparations based on centrifugal contactor separators (CCS) have been 
proposed by Schuur et al79, 80 in 2009. Since a single centrifuge can provide only one 
mixing and separating step, several stages are required to obtain 99% ee, the generally 
accepted measure of “pure” enantiomer. For the enantioseparation of phenylglycinol 
with an azophenolic crown ether as a chiral selector, 4 stages were sufficient, whereas 
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12 stages were required for the separation of 3,5-dinitrobenzoyl-leucine using a 
cinchona alkaloid derivative. In both cases racemates dissolved in the aqueous mobile 
phase entered the extraction cascade made of a number of CCS connected in series. 
The enantiomers were countercurrently flowed with the organic stream containing the 
extractant. The organic phase was enriched with the (S)-enantiomer due to a 
preferential extraction of this enantiomer. Then the organic stream containing (S)-
enantiomer was back-extracted to recover the extracted enantiomer and to recycle the 
organic phase with an extractant.  
 
1.4.2.7. CCC in enantioseparation 
The main advantage of countercurrent chromatography over solid-liquid 
chromatography comes from the lack of a solid support. One consequence of this is 
the availability of a considerable proportion of the stationary phase volume, up to 
80% or even 90%, compared to a maximum of 20% for reversed phase high 
performance liquid chromatography (HPLC). Since the stationary phase in CCC is 
also liquid, a separated analyte has access to the whole volume of the stationary 
phase, unlike in HPLC where it is limited to the interface with the mobile phase. This 
leads to a higher loading capacity and a lower solvent consumption.81 Moreover, the 
chiral selector (CS) can be re-extracted from the liquid stationary phase by common 
separation techniques such as evaporation of the liquid phase.82 
However, in spite of the mentioned advantages, this technique also has some 
limitations, especially if applied to enantioseparations. The major difficulty is to find 
a chiral selector that is highly selective in a liquid phase as well as a combination of 
solvents that do not destroy this selectivity yet retain the capacity to elute the chiral 
isomers of interest.83 Moreover, the CS must totally partition into one of the two 
phases, used as the stationary phase. Otherwise, the continual stripping of the CS with 
the mobile phase would contaminate the eluting enantiomer. Due to these difficulties, 
examples of enantioseparations using countercurrent chromatography are not 
numerous84.  
In 1980’s pioneering work on applying counter-current chromatography for 
enantioseparations was performed on low efficiency locular counter-current 
chromatography (RLCC) and droplet counter-current chromatography (DCCC) 85. It 
was often taking a few days to complete a separation of a pair of enantiomers. The 
technique was applied by Domon and co-workers86 (1982) for the separation of 
CHAPTER 1 – Introduction and Literature Review 
 
 40 
enantiomers of (±)-norephedrine using RLCC consisting of 16 columns, divided into 
37 loculi each. (R,R)-di-5-nonyl tartarate was used as a chiral selector. The complete 
separation was achieved after four days. Although the separation technique was very 
slow, the potential of CCC as a tool for chiral separations was demonstrated. Oya and 
Snyder87 (1986), used DCCC for the chiral resolution of carboxylic acid with (-)-R-2-
aminobutanol as CS. The resolution was achieved after 56 hours. In another 
application of DCCC, resolution of DL-isoleucine using N-n-dodecyl-L-proline as a 
chiral selector took 2.5 days.88 
The introduction of high speed counter-current chromatography (HSCCC) enabled 
the separation time of enantiomers to be shortened to 1-2 hours which has made the 
technique more popular89. One of the earliest chiral separations using HSCCC90 was 
performed in 1995 to resolve (±)-dinitrobenzoyl amino acids (DNB-phenylglycine, 
DNB-phenylalanine, DNB-valine, DNB-leucine). N-dodecanoyl-L-proline-3,5-
dimethylanilide was used as a chiral selector. In this study, standard CCC and pH-
zone refining techniques were compared. By using a standard CCC method, from 
10mg to a maximum of 1g of samples were resolved in 2-9 hours, using a solvent 
system consisting of hexane-ethyl acetate-methanol-10mM hydrochloric acid. To 
achieve higher loading, a more concentrated CS was used. By using pH-zone-refining, 
more sample (2g) was efficiently separated in less time (3h), using a phase system 
based on tert-butyl ether-water. It was also demonstrated89 that increasing the 
concentration or net amount of CS in the stationary phase improved both the 
separation factor and peak resolution. 
Since then various chiral selectors and operational modes have been proposed for 
operating CCC. The most used group of CS has been L-proline and its derivatives. As 
mentioned above, N-dodecanoyl-L-proline-3,5-dimethylanilide was also used to 
resolve of N-(3,5-dinitrobenzoyl)-tert-butylleucinamide and N-(3,5-dinitrobenzoyl)-
tert-butylvalinamide91 as well as N-(3,5-dinitrobenzoyl)-(±)-leucine92, whereas L-
proline and (4R)-hydroxy-L-proline were used for the chiral separation of N-(3,5-
dinitrobenzoyl)-(±)-leucine and (±)-ketoprofen93.  
Cinchona-derived anion-exchange has been adopted in CCC for the separation of 
enantiomers of N-derivatised amino acids and 2-aryloxypropionic acid94.  
β-cyclodextrin was applied for the separation of 7-des-methyl-ormeloxifene95, 
whereas its derivative, carboxymethly-β-cyclodextrin was applied for the chiral 
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resolution of aminglutethimide96 and chlorpheniramine97. Cellulose tris(3,5-
dimethylphenylcarbamate) was used for the separation of pindolol and warfarin98,99.  
The racemate of gemifloxacin was resolved using crown ether, (+)-(18-crown-6)-
tetracarboxylic acid100,101 as the CS. 
There are also examples of using proteins as a chiral selector for 
enantioseparations in counter-current chromatography. Bovine serum albumin was 
used to resolve racemates of DL-kynuremine102 and DL-tryptophan103.  
Rubio et al104 applied (S)-naproxen N,N-diethylamide as a chiral selector for the 
resolution of (±)-N- (3,4 –cis -3 -decyl -1,2,3,4 -tetrahydrophenanthren -4-yl) -3,5 -
dinitrobenzamide in multiple dual-mode (MDM) using CCC. The CCC coil was 
initially filled with the lower phase of the solvent system consisting of n-hexane-ethyl 
acetate-methanol-water (9:1:9:1, v/v/v/v), containing the CS. This phase was the 
initial stationary phase. The sample was injected onto the equilibrated column. The 
mobile phase was the upper phase pumped from head to tail direction. When one of 
the enantiomers was about to elute, the mobile phase as well as the flow direction 
were altered, thus the lower phase with the CS become the mobile phase, pumped 
through the column from tail to head direction. To avoid elution of analytes with the 
lower phase where the CS was partitioned, the system was then returned to the initial 
conditions, thus the mobile phase once again become the upper phase pumped from 
head to tail of the coil. Both enantiomers eluted separated from each other and free of 
the chiral selector. Applying MDM allowed the resolution between the two peaks to 
be improved from 0.85, when a classic elution mode was applied, to 1.51. 
 
1.4.3. Production of 2-L-aminobutyric acid (L-ABA) 
L-(+)-2-aminobutyric acid (L-ABA) and D-(-)-2-aminobutyric (D-ABA) are the 
racemic forms of 2-aminobutyric acid (DL-ABA). L-ABA (Figure 12) like many 
other unnatural amino acids105 is obtained as a result of synthesis.  
 
 
Figure 12. L-(+)-2-aminobutyric acid chemical structure 
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In 1988, Tokarski et al106 obtained 2-L-aminobutyric acid in a reaction catalysed 
by a transaminating enzyme with 2-ketobutyrate and alanine.  
2-L-aminobutyric acid has also been synthesised from 2-ketobutyric acid and 
benzylamine in the enzymatic reaction catalysed by ω-transaminase. The reaction was 
performed in an aqueous-organic biphasic system as benzaldehyde, the co-product of 
the reaction, inhibited the enzyme. Over 99% of enantiomeric excess of 2-L-
aminobutyric was achieved.107  
Ingenza Ltd (Wallace Building, Roslin BioCentre, Midlothian, EH25 9PP, UK) 
used the reduction of ketobutyric acid (KBA) for the production of 2-L-aminobutyric 
acid. This process is nonselective, leading to a racemate of 2- aminobutyric acid. To 
separate the two forms, the unwanted D-form was oxidised by the enantioselective 
enzyme D-amino acid oxidase (section 1.5.3) to KBA, whereas L-ABA stayed 
unaltered. Then L-ABA was separated from KBA in a two-phase batch extraction. 
The enantiomeric excess (ee) of 2-L-aminobutyric acid obtained was over 99.5%.  
 
1.5. Biocatalysis 
 
Biocatalysis is the use of natural catalysts, such as protein enzymes or RNA 
enzyme also called ribozyme, to perform a chemical transformation on organic 
compounds. In this project CCC was used as a bioreactor with the biocatalyst 
immobilised in the liquid stationary phase. The biocatalyst used was a protein 
enzyme, D-amino acid oxidase.  
 
1.5.1. Structure of enzymes 
Enzymes108 are biological catalysts which increase the rate of chemical reactions 
without themselves suffering any overall change. The reactants of enzyme-catalysed 
reactions are termed substrates and each enzyme is quite specific in character, acting 
on a particular substrate or type of substrates.  
Although nearly all enzymes are proteins, many of them contain a non-protein 
component called a cofactor. The protein part of the enzyme is termed apoenzyme, 
whereas the whole structure is called a holoenzyme. A further subclassification of 
cofactors has been introduced according to how tightly they are bound to an enzyme. 
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Coenzymes are loosely-bound cofactors whereas a prosthetic group is bound so 
tightly that it is difficult to remove without damaging the enzyme.  
 
1.5.2. Enzyme protein structure 
Since enzymes are proteins, four levels in their structure can be determined. The 
primary structure of the protein is the sequence of amino acids, which determines its 
unique properties. Secondary structure refers to regularly repeating local structures 
stabilized by hydrogen bonds. The tertiary structure is the overall shape of a single 
protein, often stabilised by covalent bonds between two thiol groups of cysteine 
amino acids. The term quaternary structure refers to the arrangement of the subunits 
in oligomeric enzymes, as most large proteins consist of a number of subunits held 
together by non-covalent forces.  
α-Amino acids are classified on the properties of the side chain into four groups: 
polar, nonpolar, basic and acidic. Prevalence of one type of -amino acid in a protein 
molecule determines the protein’s polarity and net charge at a certain pH.  
 
1.5.3. D-amino acid oxidase (DAAO) 
D-amino acid oxidase (DAAO, EC 1.4.3.3.) is a peroxisomal enzyme belonging to 
the class of flavin dehydrogenase as it contains non-covalently bound flavin adenine 
dinucleotide (FAD) as the prosthetic group. The enzyme is expressed in a wide range 
of species from yeasts to human. It is not present in bacteria or in plants. DAAO 
catalyses an O2-dependent transformation of D-amino acids to the corresponding α-
imino acids, which spontaneously hydrolyze to α-keto acids, ammonium ions and 
hydrogen peroxide (Figure 13). 
 
 
Figure 13 A reaction catalysed by D-amino acid oxidase.  
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DAAO from pig kidney and from yeast possess a broad substrate specificity. 
However it is not active against acidic amino acids such as D-glutamate and D-
aspartate 109.  
The pH optimum of DAAO isolated from the yeast Trigonopsis variabilis is 
between 7 and 9. The enzyme shows the highest activity in the temperature range 
between 50 and 55°C. However, although the enzyme is stable at temperatures up to 
40°C it loses activity when incubated above that temperature and is completely 
inactivated at 65°C within 30 min110. According to Schrader and Andersen111 (1996) 
the apparent Vmax and Km values for different substrates vary from 3.7 to 185 U/mg 
and 0.2 to 17.3 mM, respectively. 
 
D-amino acid oxidase is one of the few flavoproteins that have been exploited in 
enzyme technology. Currently the most important use of DAAO is the conversion of 
cephalosporin C into 7-(5oxoadipoamido) cephalosporanic acid that is further 
transformed chemo-enzymatically into 7-ACA (7-aminocephalosporic acid), the 
precursor of numerous cephem antibiotics112. 
Sacchi et al113 (1998) proposed a biosensor based on DAAO from Rhodotorula 
gracilis for quantifying the presence of bacteria in food. Since D-amino acids are 
formed mainly by bacteria, the current produced by oxidising D-amino acids is 
proportional to the bacterial contamination in food.  
 
1.5.4. Monoamine oxidase (MAO) 
Monoamine oxidase (MAO) is a flavoprotein that catalyses the oxidative 
deamination of primary amines into imines, which are then hydrolysed to give 
aldehydes114. Since the enzyme was originally discovered in the liver, it has been 
found bound to the outer membrane of mitochondria in most cell types in the body. 
 
1.5.5. Bioconversion in two-phase systems 
An aqueous two-phase system seems to be an ideal phase system for the CCC-
bioreactor because it creates a gentle environment which is known to maintain 
enzymatic activity. In the literature, there are a number of examples using ATPS as a 
reaction media. The advantages of performing a bioconversion on such media result 
from the possibility of enzyme recovery and product extraction (extractive 
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bioconversion), which plays a key role in case of a bioconversion inhibited by a 
product of the reaction.  
There are a number of publications demonstrating the conversion of 
benzylpenicillin (penicillin G) to 6-aminopenicillanic acid (6-APA) in various ATPS, 
when the enzyme, penicillin acylase, was used in both free form and in whole cells of 
E. coli in which form the enzyme turned out to be more stable, allowing ten times 
repeated batch conversion. To perform the reaction, Liao et al115 (2009) used the 
phase system made of PEG6000 and potassium phosphate. Xue-jun116 and co-workers 
(2004) performed the same reaction in five repeated batches using PEG 20,000 and 
Dextran T 70 as the phase system. In both experiments, the enzyme was partitioned in 
the bottom phase, whereas the product was extracted to the top phase. Anderson et 
al117 (1984) performed the reaction with free penicillin acylase, using ATPS made of 
8.9% (w/w) PEG2000/7.6% (w/w) potassium phosphate. The enzyme partitioned into 
the bottom phase, allowing repeated batch conversion. Applying the enzyme in 
discrete countercurrent mode allowed Wang et al118 (2007) to achive an increase of 
the conversion ratio of the reaction from 50 to 65%. Dong-Zhi et al119 (2002) used the 
enzyme immobilised in 20% (w/w) PEG400/ 15%(w/w) magnesium sulphate for the 
synthesis of cephalexin from 7-aminodeacetoxicephalosporanic acid (7-ADCA) and 
phenylglycine methyl ester (PGME). 
There are a few more examples of performing an extractive bioconversion on 
ATPS made of PEG and dextran. Ilic et al120 (2005) performed the bioconversion of 
apigenin-7-O-β-glucoside into apigenin in polyethylene glycol 6000 / dextran 20,000 
by β-glucosidase. PEG40,000/Dextran 40 aqueous two-phase system was used for 
enzymatic hydrolysis of cellulose121. 
Jyh-Ping and Cheng-Hsin 122 tested various aqueous two-phase systems for lactose 
hydrolysis with bacterial, yeast and fungal β-galactosidase. The distribution ratio of 
lactose in ATPS made of 30% (w/w) PEG4000 and 7.5% (w/w) sodium citrate was 
found to be 0.0042 which allowed for an extractive hydrolysis of lactose. After 84h of 
hydrolysis in the phase system, the enzyme had lost only 10% of its activity.  
Mian and co-workers123 (2002) tested four varied two-phase systems, PEO-
PPO/(NH4)2SO4, PEO-PPO/MgSO4, PEG/(NH4)2SO4  and PEG/MgSO4 for the 
bioconversion of starch with α-amylase and amyloglucosidase. The higher production 
of maltose and glucose was when PEO-PPO/MgSO4 was used. 
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The extractive bioconversion with the bacterium, Arthrobacter simplex was 
studied by Kaul and Mattiasson124 (1986) for the transformation of hydrocortisone to 
prednisolone in aqueous two-phase systems. In order to reduce the cost of dextran, a 
cheaper starch-based polymer (Reppal-PES) was successfully used. 
 
1.6. Simultaneous conversion and separation 
 
The concept of reactions in chromatographic columns comes from early 1960s125, 
when it was applied to reversible chemical reactions, which could be pushed to 
completion despite an unfavourable equilibrium constant, by constantly removing the 
products of a reaction.  
Chromatographic reactors126 are made to perform a simultaneous conversion of a 
compound and removal and separation of formed products during a reaction. This has 
a great advantage in the case of reversible reactions, where the conversion can be 
pushed to completion by removal of product, as well as the removal of putative 
inhibitors. The last case refers to those catalysts which are inhibited or inactivated by 
a product of a reaction.  
Figure 14 shows a schematic batch chromatographic reactor. In a reaction, which 
takes place in the column, substrate A, injected into a column, is converted onto the 
products B and C. Because of their different retention times, products B and C are 
separated from each other as well as from any unconverted compound A.  
 
 
B C
A
 
Figure 14 Schematic presentation of the batch chromatographic reactor. A is injected onto a column 
with the mobile phase. As it travels through the column it is converted into B and C which are 
separated by the chromatographic action of the column. 
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1.6.1. Chromatographic bioreactor 
Chromatographic bioreactors are chromatographic reactors where an enzyme or an 
enzyme system, present either in pure form or in a cell preparation, catalyses the 
reaction. Few chromatographic bioreactor systems have been reported in the literature 
and the majority of those were performed with an enzyme immobilised on a solid 
matrix of the stationary phase.  
Akintoye et al127 (1991) performed inversion of sucrose to glucose and fructose in 
the presence of the enzyme invertase in a semi-continuous counter-current 
chromatographic reactor-separator (SCCR-S) consisting of twelve columns packed 
with calcium-charged, crossed-linked, polystyrene resin. The enzyme was not 
immobilised on the column, therefore the reaction occurred in the liquid mobile 
phase. Purities of fructose and glucose were over 90% and complete conversion was 
achieved, even at 55% sucrose feed concentration. Subsequently, the process was 
conducted at a preparative scale with throughput in excess to 16kg of dry sugar per 
cubic metre of resin per hour, achieving 100% sucrose conversion, and product 
purities up to 95% w/v. SCCR-S allowed increasing the formation of high molecular 
weight dextran, at 80% in comparison to conventional process. Dextran can be 
synthesised as a result of an enzymatic conversion of sucrose. Fructose, which is a 
side-product of the reaction, inhibits the enzyme dextransucrase. As the bioconversion 
was performed in SCCR-S, fructose was continuously removed from the reaction 
media. That resulted in the yield of over 77% of synthesised dextran with a molecular 
mass of more than 150,000Da. 128 
SCCR-S  has also been used for the saccharification of modified starch to maltose 
and dextrin129 and hydrolysis of lactose130.  
All these separations were catalysed by a non-immobilised enzyme which was 
continuously added to the mobile phase.  
An HPLC column has also been used as a chromatographic bioreactor for 
enantioseparations. Calleri et al131 in 2004 presented an enzyme reactor based on β-
glucuronidase for on-line determination of the urinary molar ratio of 
dextromethorphan (DOMe) and dextrorphan (DOH). The enzyme was immobilised in 
an HPLC analytical column, to perform both bioconversion and separation as well as 
quantification of DOMe and DOH.  
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Various esterolytic reactions were successfully performed by Candida rugosa 
lipase immobilised on the silica stationary phase in HPLC with a simultaneous 
separation of products form the unconverted enantiomers132. Zeying et al133 (2011) 
used HPLC to perform asymmetrical enantioseparation of chiral esters hydrolised by 
Candida antarctica lipase B immobilised on silica gel.  
 
1.6.2. CCC-reactor 
CCC can potentially perform both a conversion and a separation at the same time 
if a catalyst is immobilised by partitioning to the liquid stationary phase, with the 
substrate passing through the column dissolved in the mobile phase. The reaction 
occurs in the zones of mixing, together with separation of product from substrate, by 
the chromatographic action of the CCC. 
In a series of experiments conducted first on CPC then on CCC by Bellefon et 
al134 (1998), benzaldehyde was reduced to benzylic alcohol by a water-soluble 
ruthenian complex immobilised in the aqueous stationary phase. The experiment, 
performed on CPC, used as a liquid-liquid catalytical reactor, was operated in two 
ways, in continuous mode and in a plug-flow mode. In continuous reaction mode, 
where the substrate was constantly pumped on dissolved in the mobile phase, the 
amount of benzylic alcohol produced in the coil depended inversely on the mobile 
phase flow rate. In a plug injection mode, the substrate travelled through the column, 
where it was converted into benzylic alcohol as a result of a contact with the catalyst. 
Since the substrate and the product of the reaction had different partition ratios 
between the mobile and the stationary phase, the separation between unconverted 
substrate and the product created in the coil occurred. Although, over 85% of injected 
benzaldehyde was converted, the process was found to be limited by the chemistry of 
the reaction135. Moreover, the disadvantage of the process was a large quantity of the 
catalyst was required for the reaction. Therefore, for further studying the CCC 
bioreactor a faster reaction was tested136.  
CPC has been used by the same research group137 as a liquid-liquid chemical 
reactor for the isomerisation of hexen-3-ol into ethylpropylketone with a water-
soluble rhodium catalyst. The plug of substrate was injected with the organic mobile 
phase into the CPC column. The research revealed inefficient mass transfer between 
the liquid-liquid phases. Despite this, the CPC-bioreactor seemed to have some 
advantages over other techniques. Due to a weak axial dispersion in the coil an ideal 
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plug flow could be assumed. Moreover, due to the chromatographic properties of the 
CPC, product and substrate can be separated along the reacting volume. Finally, 
working with pulse injections and sampling, the process can be easily automated. 
 
1.6.3. CCC-bioreactor 
Although, in the literature there are few examples of using countercurrent 
chromatography as a simultaneous bioreactor and a separator, there is no evidence of 
a successfully created CCC-bioreactor which would provide both a total conversion of 
a substrate and a complete separation of reaction products.  
Bousquet et al138 (1995) employed CCC as a bioreactor, using a biphasic system, 
1,1,1 trichloro ethane–aqueous phosphate buffer with a bacterial esterase present in 
the aqueous stationary phase, for an enantioselective hydrolysis of 2-cyano 
cyclopropyl-1,1 dicarboxylic acid dimethylester. 500mg of the substrate was injected 
onto the column filled with the enzyme solution of concentration 7g/L. Hydrolysis of 
one isomer made it go to the aqueous stationary phase, whereas the unreacted isomer 
remained in the mobile, organic phase. After 8 hours 80% of enantiomeric purity was 
achieved. In the publication, there were no details of the CCC centrifuge provided, 
such as the coil volume or type of machine.  
Yamada et al139 (1995) used CPC as a bioreactor with the enzyme β-galactosidase 
immobilised on the coil by encapsulating it in reverse micelles. Substrates of the 
bioconversion, o-nitrophenol β-D-galactopyranoside and 4-methylumbelliferyl β-D-
galactopyranoside, were continuously pumped onto the column with the mobile 
aqueous phase. The recovery of galactose, the product of the enzymatic reaction, was 
more than 85% over a period of 5 hours. In this research, no chromatographic action 
of CPC was used as the centrifuge was only employed to provide an effective mixing 
between an aqueous and an organic phase, which resulted in a very good mass transfer 
between the two phases. 
Armstrong et al140 (1990) used CPC as a bioreactor and separator with the enzyme 
α-chymotrypsin to perform the enantioseparation of DL-tryptophan methyl ester. A 
plug of the substrate was injected with the organic mobile phase into the CPC column. 
L-tryptophan methyl ester was hydrolised by α-chymotrypsin immobilised in the 
aqueous stationary phase. Since the column acted as both a reaction bed and a 
separating media, formed L-tryptophan was separated from unreacted D-tryptophan 
methyl ester. An unexpected limitation of the process arose from the instability of the 
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enzyme in the aqueous - organic phase system. Although the enzyme was dissolved in 
the aqueous stationary phase, constant contact with the organic mobile phase caused 
its deactivation by denaturation. Therefore, no total conversion of the substrate was 
achieved. To overcome the enzyme instability in the aqueous – organic phase system 
and utilise the catalytic activity of α-chymotrypsin, an external incubation step, 
preceding the separation, was added. In the external enzyme reactor, the initial 
racemate of tryptophan methanol ester was hydrolyzed for 5 hours by the enzyme. 
The reaction mixture was then injected onto the CPC, which in this case acted only as 
a separator. This not only avoided the enzyme deactivation but also reduced its 
consumption. A considerably smaller amount of enzyme was required when the 
reaction was performed in an external chamber than in the CPC unit, where it was 
dissolved in a larger volume of the stationary phase. Moreover, when the enzyme was 
present in the stationary phase, the first part of the CPC acted as a bioreactor after 
which the separation of L-tryptophan created from the unreacted D-form occurred on 
the remaining plates. Therefore, the separation process was more efficient with a 
preincubation step, as all of the plates of the CPC were used for the separation. 
Although there was an excellent separation between L-tryptophan and D-tryptophan 
methyl ester, there was a small overlap area between the two peaks showing 
incomplete separation. The authors proposed an automated system for the separation 
of amino acids based on a reaction column with immobilised α-chymotrypsin 
followed by the stream of the mobile phase led through a detector to a CPC column to 
separate compounds. 
Hollander and co-workers141,142 (1998, 1999) investigated a bioreactor based on 
CPC for the enantioseparation of amino acids. The model reaction was deracemisation 
of N-acetyl-DL-methionine by acylase I. The performed reaction was reversible, 
therefore simultaneous separation of the two hydrolysis products, acetic acid and L-
amino acid, improved the yield of the conversion by shifting the equilibrium of the 
reaction. The substrate, a racemic mixture of N-acetyl-methionine, was injected onto 
the CPC column with the mobile phase. As a result of the selective catalytic activity 
of acylase I present in the upper, stationary phase of the ATPS (16/16% (w/w) 
PEG600 and potassium phosphate, pH 7.39), only the L-enantiomer of racemic 
acylated amino acid was hydrolysed to the L-amino acid and acetic acid. Then, in a 
chromatographic action of CPC, L-methionine produced in the column and acetic acid 
and unreacted N-acetyl-D- methionine, were separated, eluting individually. Although 
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there was an overlap between peaks, N-acetyl-D-methionine eluted mainly as a pure 
compound. However, the authors reported a small amount of unconverted substrate 
eluted from the column which would indicate incomplete deracemisation of the 
injected amino acid. Therefore, not only there was no total bioconversion achieved 
but also the separation was incomplete.  
Hollander and co-workers used CPC as a bioreactor which is not as directly 
scalable as CCC. Moreover, a CPC unit requires the use of two rotary seals which 
presents the risk of leakage or cross contamination.  
 
1.7. CCC-bioreactor for isolation of L-2-aminobutyric acid 
 
The aim of this current PhD project was the creation of a simultaneous CCC-
bioreactor and separator (Figure 15) for the isolation of a high value, enantiomerically 
pure form of amino butyric acid (ABA) from the relatively cheap racemate. The 
enzyme was immobilised by partitioning into the liquid stationary phase and the 
substrate dissolved in the mobile phase passed through the column. The reaction 
(Figure 16) occurred in the zones of mixing, together with separation of product from 
substrate by the chromatographic action of the CCC. Since the KBA produced by 
enzymatic action and the unreacted L-ABA, which was the target compound, had 
different partition ratios between the two phases, they eluted at different times.  
CHAPTER 1 – Introduction and Literature Review 
 
 52 
 
ENZYME   ENZYME ENZYME
CCC coil
L-2-Amino butyric acid
(L-ABA)
Keto-butyric acd 
(KBA)
D-2-Amino butyric acid
(D-ABA)
L-2-Amino butyric acid
(L-ABA)
Stationary phase
Mobile phase
 
Figure 15 CCC-bioreactor with D-amino acid oxidase in the stationary phase. Only D-form of the 
aminobutyric acid racemate is oxidised to its keto analog (KBA). Since the L-ABA and KBA have 
different partition ratios between the two phases in CCC, they elute at different times.  
 
 
 
Figure 16. Catalytic action of D-amino acid oxidase (DAAO). D-amino butyric acid (D-ABA) is 
oxidised to ketobutyric acid (KBA), whereas the other enantiomer L-amino butyric acid (L-ABA) stays 
unaltered.  
 
H2N CO 2H
H2N CO 2H
H 2N CO 2H
O CO 2H
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L-ABA
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2. EXPERIMENTAL SET UP AND DEVELOPMENT OF 
THE ANALYTICAL PROCEDURES 
 
2.1. Introduction 
In this chapter general experimental methods related to this thesis are described. 
 
2.2. Countercurrent chromatography (CCC) experimental set up 
Typically, the experimental set up consisted of a CCC Milli centrifuge, an 
analytical pump, a sample port and a fraction collector. For same experiments a UV-
detector was also used. All instruments were connected using 0.8mm bore PTFE 
tubing. 
 
2.2.1. CCC centrifuge 
The J-type CCC centrifuge, called Milli-CCC®, was a prototype machine designed 
and made by the Brunel Institute for Bioengineering, Brunel University (Uxbridge, 
UK). The rotor (R) and the planet (r) radii were 50mm and 28-39.5mm respectively, 
which gives the β-value 0.56-0.75. The centrifuge allowed the column to be rotated at 
a rotational speed within the range of 500-1800rpm in two modes: clockwise (run) 
and counter clockwise (empty). In all performed experiments, apart from when the 
Multiple Dual-Mode (5.3.3.) was applied, the CCC was operated in the run mode 
during separation and in the empty mode when the coil was being filled with a 
stationary phase. Filling the coil in the empty mode helps in removing potentially 
trapped air bubbles. 
 
The CCC column, made at the Brunel Institute for Bioengineering, was made of a 
PTFE tube, wound around a bobbin in the counter clockwise direction. Table 3 shows 
the position of the head and the tail of the coil when the coil is rotated clockwise or 
counter clockwise.  
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Periphery Centre
Spun 
clockwise Head Tail
Spun counter 
clockwise Tail Head
 
Table 3 Positions of Tail and Head at centre or periphery for a counter clockwise wound coil spun 
clockwise or counter clockwise. 
 
The bore of a tube is relatively large (2.7mm compared to the standard Milli CCC 
coil bore 0.8mm) to help retain the ATPS. The first column (Column#1) burst during 
this research project and was replaced by another called Column#2, also made in BIB 
(Table 4). 
 
Column name Coil bore (mm)
Coil    
length     
(m)
Coil 
volume 
(ml)
Rotor 
radius 
(mm)
β-value 
Column#1 2.7 7.9 45.1 50 0.56-0.75
Column#2 2.7 7.9 45.0 50 0.56-0.75
 
Table 4 Parameters of the CCC coils used for the bioreactor studies.  
 
The volume of a column was determined by subtracting the weight of an empty 
coil from the weight of the coil, entirely filled with water. To determine the weight of 
an empty column, the coil was first flushed with acetone to remove any remaining 
water, then, the acetone was blown out and dried by pumping through with 
compressed air. Three measurements were performed and the average taken. 
 
2.2.2. Liquid - handling pump 
The pump used was an analytical HPLC pump K-501, KNAUER (Berlin, 
Germany), designed to be operated at a flow rate 0.1-10ml. The pump was used to 
deliver the stationary phase, mobile phase and a cleaning solution to the system.  
The pump was primed with deionised water before each use, as well as before 
changing a phase from upper to the lower phase and vice versa.  
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2.2.3. Sample loop port 
The sample loop port, which was used to inject a fixed amount of a sample onto 
the column, was designed and made especially for these experiments. It was based on 
a manually operated 6-way selection valve. The sample loop used in most 
experiments was a 0.8mm bore PTFE tube of a total volume 1.72ml, which was 3.8% 
of the 45.1ml coil.  
 
2.2.4. Fraction collector 
To collect fractions from CCC a fraction collector was used, [KNAUER (Berlin, 
Germany), model Foxy Jr.]. Fractions were collected in 2ml tubes (Eppendorf).  
 
2.2.5. UV-detector and the signal recorder 
The UV-detector used for some experiments was a KNAUER model K-2501. It 
was connected via an interface box (KNAUER model IF2) with a computer. The 
software used was the KNAUER “Eurochrom”. The mobile phase passed through the 
UV-detector and the signal was recorded as a chromatogram. The chromatogram 
recording was started when the switch was manually pressed after a sample injection.  
 
2.3. Centrifugal Partition Chromatograph (CPC) experimental set up 
The CPC unit was purchased from Armen Instrument (Vannes, France). It is 
equipped with two 500ml rotating columns that can be operated either singly (500ml) 
or combined (1000ml). Each coil consists of 1008 chambers (0.424ml) which gives a 
the total chromatographically active volume of 429ml. The volume of interconnecting 
passages between the chambers is 71ml. 
The unit is equipped with two pumps. One of them, the binary built-in, twin headed 
pump, is used for pumping the upper and the lower phase. The other pump allows a 
sample injection on the column. There is also an option to use a sample loop instead 
of a pump, and that option was used in this study. The sample loop was a 23.5ml 
PTFE tube.  
A system of valves allows switching between descending and ascending operation 
mode.  
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2.4. Materials  
2.4.1. Aqueous two-phase system (ATPS) 
All aqueous two-phase systems (ATPS), which were used for the bioreactor, were 
composed of polyethylene glycol (PEG) and a salt. The concentration of PEG and salt 
in ATPS was expressed as weight by weight % i.e. 14/14% PEG/salt means that in 
100g of ATPS there is 14g PEG, 14g salt and 72g water. Thus to make ATPS, both 
PEG and salt were weighed out on a balance (accuracy 0.01g). PEG1000 exists in a 
solid form, therefore before use, it was melted at +60°. Both PEG3350 and PEG8000 
are powders, whereas PEG400 is a liquid. All salts used were powders, thus they were 
weighed out in a separate beaker and transferred to the previously weighed PEG. 
Finally a desired amount of deionised water (purity 1.0MΩ cm-1), warmed up to 50-
60°C was added. Then all was mixed until the salt and PEG were entirely dissolved. 
A freshly made ATPS was left, usually overnight, in a separating funnel to bring it to 
room temperature. It was then shaken again and after phase separation the lower 
phase was run off. Each phase was stored in glass bottles in a dark place at room 
temperature for a period no longer than a month.  
Chemicals used for ATPS  CAS Supplier 
Polyethylene glycol mol wt. 400 25322-68-3 Sigma-Aldrich 
Polyethylene glycol mol wt. 1000 25322-68-3 Sigma-Aldrich 
Polyethylene glycol mol wt. 3350 25322-68-3 Sigma-Aldrich 
Polyethylene glycol mol wt. 8000 25322-68-3 Sigma-Aldrich 
Ammonium sulphate 7783-20-2 Fisher 
Potassium sulphate 7778-80-5 Sigma-Aldrich 
Sodium sulphate 7757-82-6 Sigma-Aldrich 
di-Ammonium hydrogen orthophosphate 7783-28-0 Fisher 
Ammonium di-hydrogen orthophosphate 7722-76-1 Fisher 
di-Potassium monohydrogen phosphate 7758-11-4 Fisher 
Potassium dihydrogen phosphate 7778-77-0 Fisher 
di-Sodium monohydrogen phosphate 7558-79-4 Fisher 
Sodium dihydrogen phosphate 13472-35-0 Fisher 
Potassium citrate 6100-05-6 Sigma-Aldrich 
Sodium citrate 6132-04-3 Sigma-Aldrich 
Citric acid 5949-29-1 Sigma-Aldrich 
 
Table 5 List chemicals and their suppliers used to make ATPS.  
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2.4.2. Enzymes tested for the CCC-bioreactor 
2.4.2.1. D-amino acid oxidase (DAAO) 
D-amino acid oxidase (DAAO) was provided by Ingenza Ltd (Wallace Building, 
Roslin BioCentre, Midlothian, EH25 9PP, UK) in the free form and in whole cells of 
Escherichia coli. 
DAAO was originally isolated from Trigonopsis variabilis and expressed in 
thermal induced Escherichia coli in a liquid fermentation. The enzyme’s expression 
was preceded by screening procedures aimed to improve its activity and stability. 
After the fermentation, cells were centrifuged and the pellet, consisting mainly of E. 
coli cells, was either disrupted to obtain the free enzyme or used as the enzyme in 
whole cells. To obtain the free form of the enzyme, the pellet was dissolved in water 
in proportion 1:4 w/w and disrupted by applying a high pressure disruptor (16kpsi), 
and then centrifuged (30min, 10,000 g). The enzyme protein was in the supernatant, 
which was directly labelled as “free enzyme”.  
All those procedures were performed by Ingenza Ltd. The enzyme in the free form 
was sent to BIB frozen and stored at -20°C. For each experiment some of the enzyme 
supernatant was defrosted and stored in a fridge at +4°C, no longer than a month. The 
enzyme in the whole cells was received frozen in dry ice and stored at -80°C. 
 
2.4.2.2. Mono amino acid oxidase (MAO) 
Monoamine oxidase (MAO) was provided by Ingenza in the whole cells of E. 
coli. The enzyme was originated from Aspergillus niger and expressed in E. coli. For 
experiments the enzyme was used both in whole cells and the free form which was 
isolated from E. coli cells. 
 
Isolation of MAO proteins from E. coli 
In order to isolate MAO protein from E. coli, cell were lysed in the presence of 
BugBuster®, benzonase and lysozyme.  
13.6mg of E. coli cells was suspended in 150µL of BugBuster® (Novagen, cat. No 
70584), 1µl of benzonase (Sigma-Aldrich, CAS 9025-65-4) 20U/µl and 10µl of 
lysozyme (Sigma-Aldrich, CAS 12650-88-3) (15mg/ml) and incubated at 37°C for 
20min. The clear lysate was centrifuged for 10 min at 13k rpm (approximately 
7560g). The supernatant, which contained most of the enzyme protein, was gently 
removed from the pellet.  
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2.4.3. Substrates for enzymatic reactions 
2.4.3.1. Substrate and product for DAAO 
For the enzymatic reactions, DL-aminobutyric acid (CAS 2835-81-6) and D-
aminobutyric acid (CAS 2623-91-3) were used. L-aminobutyric acid (CAS 1492-24-
6) and ketobutyric acid (CAS 600-18-0) were used as standards. All those chemicals 
were purchased from Sigma-Aldrich.  
 
2.4.3.2. Substrates and products for MAO 
2-phenylpyrrolidine was purchased from Apollo Scientific Ltd. Amylamine (CAS 
110-58-7) and α-methylbenzylamine (CAS 618-36-0) were purchased from Aldrich.  
 
2.4.4. Reagents for ABA and KBA derivatisation 
ortho-Phthalaldehyde (CAS 463-79-8) and phenylhydrazine (CAS 100-63-0) were 
purchased from Sigma-Aldrich, and N-isobutyryl-L-cysteine (CAS 124529-02-8) 
from Merck. Boric acid (10043-35-3) and potassium hydroxide (1310-58-3) were 
purchased from Fisher Scientific.  
 
2.5. Development of the Analytical Methods  
In this section methods developed to optimise and monitor the CCC-bioreactor are 
presented. These methods are: ABA and KBA HPLC analysis (2.5.1), enzyme activity 
analysis (2.5.2), enzyme stability analysis (2.5.3) and enzyme concentration analysis 
(2.5.4).  
 
2.5.1. Analytical methods for ABA and KBA 
Analytical methods for both ABA and KBA analysis were developed for two 
reasons: to determine substrate consumption and product formation in the CCC-
bioreactor as well as to monitor the elution time of unreacted L-ABA and produced 
KBA. Figure 17 shows analytical methods developed to analyse ABA and KBA. Two 
methods were developed for ABA analysis, a derivatisation with ortho-phthaldehyde 
and a direct analysis on a hydrophilic interaction column (HILIC). For KBA three 
methods were developed, a derivatisation with phenyl hydrazine and two direct 
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analysis methods on anion exchange and HILIC columns. The last method can be 
used to analyse both ABA and KBA.  
Each method had its own particular advantages and disadvantages, which are 
listed in Table 6.  
 
 
Figure 17.  Analytical methods of ABA and KBA  
 
Analysed 
compound 
Method 
name 
 
Method 
No 
Section 
number 
Advantage Disadvantage 
Derivatisation 
with ortho-
phthalaldehyde 
2 2.5.1.2 
Very high sensitivity 
Enables analysis of 
both chiral forms 
Time consuming 
derivatisation 
ABA 
HILIC direct 
analysis 
1 2.5.1.1 
No derivatisation 
needed 
Both ABA and KBA 
can be analysed at the 
same time 
Does not distinguish 
enantiomers of ABA 
Low sensitivity 
Not suitable to ATPS 
Derivatisation 
with phenyl 
hydrazine 
4 2.5.1.4 Very high sensitivity 
Time consuming 
derivatisation KBA 
Anion 
exchange 
column 
 
3 2.5.1.3 
No derivatisation 
needed 
Low sensitivity 
Short lifetime of a column 
 
Table 6 Advantages and disadvantages of ABA and KBA analytical methods 
 
Analysis method N°2  
 
Derivatisation with 
ortho-phthalaldehyde  
Section 2.5.1.2 
Analysis method N°1 
 
HILIC direct 
analysis 
Section 2.5.1.1 
Analysis method N°4 
 
Derivatisation with 
phenyl hydrazine 
Section 2.5.1.4 
Analysis method N°3
 
Anion exchange 
column  
Section 2.5.1.3 
 
 
ABA analysis 
 
 
KBA analysis 
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All analyses on KBA and ABA were performed on HPLC: Waters 2695 Alliance 
with Waters 2996 photodiode array detector operated using Waters EmpowerTM 
software (Waters Elstree, Hertfordshire, UK). 
 
2.5.1.1. Analysis Method N°1: Direct ABA and KBA analysis 
on a HILIC column 
The HILIC column (page 14) allows the analysis of very polar compounds, thus 
both the substrate (ABA) and the product (KBA) of the enzymatic conversion could 
be quantified at the same time. Moreover it is a simple analysis as no derivatisation of 
a sample is required.  
 
The SeQuant ZIC®-HILIC column, which is a hydrophilic interaction 
chromatography column, was purchased from Hichrom Ltd. The column length was 
150mm and the internal diameter 4.6mm. Particle size was 5µm and pore size 200Ǻ. 
 
To separate ABA and KBA a method named “Ingenza SeQuant ACN gradient” 
was developed (Table 7).  
Time 
[min]
Flow 
[ml/min] %A %B %C %D Gradient
1 1.00 0.0 100.0 0.0 0.0
2 0.10 1.00 0.0 100.0 0.0 0.0 Linear
3 5.00 1.00 100.0 0.0 0.0 0.0 Linear
4 8.00 1.00 100.0 0.0 0.0 0.0 Linear
5 9.00 1.00 0.0 100.0 0.0 0.0 Linear
 
Table 7 HPLC conditions to quantify ABA and KBA on the HILIC column. Line A: water, Line B: 
acetonitrile, Method named Ingenza ACN gradient. Total run time 10min.  
 
10µL of the mixture of ABA and KBA in the lower phase of the ATPS 14/14% 
PEG1000/ ammonium phosphate was injected on HPLC and analysed according to 
“Ingenza SeQuant ACN gradient” method set (Table 7). The obtained HPLC 
chromatogram is presented in Figure 18.  
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KBA
ABA
 
Figure 18 HPLC Chromatogram obtained from the HILIC column according to “Ingenza SeQuant 
ACN gradient” method set. The ABA and KBA were dissolved in the lower phase of the ATPS 14/14% 
PEG1000/ammonium phosphate. There are two peaks which elute at 4.2min (KBA) and at 5.1min 
(ABA). Detection 195nm.  
 
There are two sharp peaks in the chromatogram. Both KBA and ABA elute at 
different times (4.2min and 5.1min respectively). The presence of the lower phase of 
the ATPS does not seem to affect the chromatogram. However the HPLC instrument 
was blocked after two injections. It was presumed that ammonium phosphate, which 
was a component of the lower phase, precipitated when injected into pure acetonitrile, 
as the initial condition of the Ingenza SeQuant ACN gradient is 100% acetonitrille.  
A small test was done and the lower phase formed two phases with ACN when 
they were mixed together. Moreover there was a white substance in the interface area.  
The method was modified to reduce the initial concentration of acetonitrile which 
precipitated the salt.  
 
After performing an optimisation, the best conditions for the HILIC column 
method were found to be: 
 
HPLC parameters: 
o Injection volume: 10.0µL 
o Column temperature: 25°C 
o Run time: 7min 
o Detector wavelength: 195nm 
o Isocratic conditions 
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Time 
[min]
Flow 
[ml/min] %A %B %C %D Gradient
1 1.00 0.0 75.0 0.0 25.0
 
Table 8 HPLC conditions to quantify ABA and KBA on the HILIC column. Line B: acetonitrile, Line 
D: 10mM ammonium formate buffer pH 4.5. Total run time 7min. Method named Ingenza SeQuant 
Isocratic 8. 
 
 
Figure 19 HPLC Chromatogram obtained from the HILIC column according to “Ingenza SeQuant 
isocratic 8” method set. The ABA and KBA were dissolved in water. Detection 195nm. ABA elutes at 
3.7min and 5.5min, KBA at 2.3min.  
 
Figure 19 shows a chromatogram for ABA and KBA analysed on the HILIC 
column with “Ingenza SeQuant isocratic 8” method set (Table 8). There are four 
distinct peaks. KBA eluted at 2.3min, whereas ABA is represented by two peaks 
eluted at 3.7min and 5.5min. There were always the two peaks in the chromatogram 
regardless of a chiral form of ABA injected, possibly there were two separation 
methods active within the column. The peak which eluted at 1.8min as well as the 
negative peak (4.9min) always appeared when water was injected and is therefore 
likely to be caused by the hydrophilic interaction of water with the column.  
Having optimised the method for water (Table 8), its compatibility with ATPS 
was tested. Peak shape was lost completely, making the chromatogram unreadable 
when ABA and KBA were dissolved in phase systems made of either PEG3350 or 
PEG8000. When the two compounds were dissolved in an ATPS made of PEG1000 
only ABA eluted as a sharp peak, whereas KBA merged with the neighbouring peak. 
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Therefore, in spite of the possibility of analysing both ABA and KBA at the same 
time, the method was not applied for analysis of fractions eluted from CCC.  
 
2.5.1.2. Analysis Method N°2: Aminobutyric acid (ABA) 
analysis by derivatisation with ortho-phthalaldehyde 
Aminobutyric acid is a very polar, small organic compound. To quantify it, a 
derivatisation with ortho-phthalaldehyde in the presence of 0.4M potassium borate 
buffer pH 10 was applied. Figure 20, taken from Roth et al (1991)143, shows a 
diagram of the derivatisation reaction.  
The original method was obtained from Ingenza and modified according to project 
requirements. The method requires a reducing factor such as 2-mercaptoethanol. 
Initially this chemical was used, however it does not differentiate the two chiral forms 
of ABA and a single peak appeared when analysed on C18 HPLC column.  
Replacing 2-mercaptoethanol by N-isobutyryl-L-cysteine enabled separation of 
the two derivatives on a standard C18 column. That was very convenient as the degree 
of ABA deracemisation could be determined based on one analysis.  
The HPLC column used for this method was a C18 GraceSmart RP, particle size 
5µm, pore size 18nm, 150mm length and internal diameter 4.6mm.  
 
Figure 20. Derivatisation of an amino acid with ortho-phthalaldehyde (OPA) in presence of a reducing 
agent. The derivative can be analysed on HPLC C18 column, detected at 338nm. 
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a) ABA derivatisation in PEG1000/ammonium sulphate 
Initially, ammonium sulphate was chosen as a salt component of ATPS because 
the presence of ammonium ions was required in the process of KBA reduction to 
ABA. This process did not involve CCC and was meant to be applied to recycle KBA 
produced in the CCC-bioreactor.  
Using the method received from Ingenza, it was not possible to quantify ABA in 
the presence of ATPS made of PEG1000/ammonium sulphate, presumably caused by 
interfering ammonium cations with the derivatisation reagent (ortho-phthalaldehyde). 
The derivatisation method was therefore adapted for the presence of the phase system. 
 
ABA derivatisation in the upper phase 
To analyse ABA in the upper phase, the concentration of both ortho-
phthalaldehyde and 2-mercaptoethanol in a derivatisation solution were increased 2.5 
times to have them in excess compared to the ammonium cations. Moreover the 
volume of analysed sample was reduced by half, thus the ratio of both ortho-
phthalaldehyde and 2-mercaptoethanol to the sample was increased five times.  
The samples were prepared as follows: 50µL of sample was premixed with 100µL 
of 0.4M potassium borate buffer pH 10 for 30s. Then 100µL of the derivatisation 
solution (mixture of 67mg ortho-phthalaldehyde, 50µL 2-mercaptoethanol, 0.5mL 
ethanol and 4.5ml 0.4M potassium borate buffer pH 10) was added and incubated for 
approximately 90s at room temperature. Before injecting on HPLC the sample was 
diluted by adding 750µL of water.  
Upon analysing derivatised samples on HPLC a sudden pressure increase in the 
column and declining retention time of the compound was noticed. Flushing the 
HPLC column with methanol revealed a substance accumulated on the HPLC column, 
presumably created in the side reaction between ortho-phthalaldehyde and ammonia. 
Initially the analysis was performed on a C18 column using an isocratic mode of 25% 
acetonitrile and 75% potassium phosphate buffer. However, to avoid the accumulation 
of this ammonium byproduct on the column, a gradient (Table 9) was developed. For 
each run the acetonitrile concentration was increased to 70%. This prevented the side 
reaction product from accumulating on the column. The run time was 10min.  
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Time 
[min]
Flow 
[ml/min] %A %B %C %D Gradient
1 1.00 0.0 25.0 0.0 75.0
2 5.00 1.00 0.0 25.0 0.0 75.0 Linear
3 5.50 1.00 0.0 70.0 0.0 30.0 Linear
4 6.50 1.00 0.0 70.0 0.0 30.0 Linear
5 7.00 1.00 0.0 25.0 0.0 75.0 Linear
 
Table 9. HPLC method for ABA analysis in the upper phase of PEG1000/ammonium sulphate. Solvent 
B: acetonitrile, Solvent D: 15mM potassium phosphate buffer pH 7.0. The total run time 10 min. 
Method named Ingenza ABA upper phase.  
 
Figure 21 shows the calibration curve for ABA dissolved in the upper phase of 
22/22% PEG1000/ammonium sulphate.  
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Figure 21 Calibration curve obtained by dissolving ABA in the upper phase of 22/22% 
PEG1000/ammonium sulphate. Peak area comes from HPLC analysis on C18 column. The method 
used o-phthalaldehyde and 2-mercaptoethanol and did not differentiate between the ABA enantiomers.  
 
ABA derivatisation in the lower phase 
The ABA derivatisation method developed for the upper phase could not be 
applied for ABA analysis in the lower phase due to the high ammonium ion 
concentration in the lower, salt-rich phase. To overcome this, the phase was dried and 
ABA extracted with methanol from the residue. 
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Procedure description: 
100µL of sample was placed into an HPLC vial. The water was evaporated in a 
centrifugal vacuum concentrator at 60°C. Then 400µL of MeOH was added to the 
dried sample. ABA is totally soluble in MeOH, whereas ammonium sulphate is not 
solubilised. To extract ABA trapped in the ammonium sulphate, the sample was 
sonicated for 5min and mixed on a vortex. Then after the sample was centrifuged to 
spin down the insoluble ammonium sulphate, 200µL of the methanol supernatant was 
transferred into a new vial. The MeOH was evaporated and the sample derivatised by 
dissolving it in 200µL 0.4M potassium borate buffer pH 10 and adding 50µL of the 
derivatisation solution (27mg ortho-phthalaldehyde, 20µL 2-mercaptoethanol, 0.5mL 
ethanol and 4.5ml borate buffer). The sample was incubated for 2min and diluted with 
750µL water before analysis on the HPLC.  
In this case, there was no side product of the derivatisation reaction since 
ammonium sulphate had been removed from the sample. Thus an isocratic analysis 
method was developed (Table 10) which reduced the run time from 10 to 5 min per 
sample. 
 
Time 
[min]
Flow 
[ml/min] %A %B %C %D Gradient
1 1.00 0.0 30.0 0.0 70.0
 
Table 10 HPLC method for ABA analysis in the lower phase of PEG1000/ammonium sulphate. 
solvent B: acetonitrile, solvent D: 15mM potassium phosphate buffer pH 7.0. Total run time is 
5minutes. Method named Ingenza ABA lower phase. 
 
Figure 22 shows the calibration curve for ABA dissolved in the lower phase of 
PEG1000/ammonium sulphate and derivatised according to the ABA derivatisation in 
the lower phase procedure described above. The curve is linear only within the range 
of 200-1300µg/ml. Therefore, ABA was only analysed in the lower phase within this 
range of concentration.  
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Figure 22 Calibration curve for quantifying ABA in the lower phase of PEG1000/ammonium sulphate 
using o-phthalaldehyde and 2-mercaptoethanol. Peak area comes from HPLC analysis on C18 column.  
 
b) ABA chiral derivatisation 
The chiral derivatisation method was developed by Ingenza. This analytical 
technique enables quantification of the two ABA enantiomers on a standard C18 
HPLC column. The method cannot be used when ABA is quantified in the presence 
of ammonia salts.  
The reagents used were 0.4M potassium borate buffer, pH 10, and a derivatisation 
reagent made by dissolving 50mg ortho-phthalaldehyde and 110mg N-isobutyryl-L-
cysteine in 0.5ml MeOH and diluted with 4.5ml borate buffer.  
 
Procedure of the chiral derivatisation: 
50µL of an analysed sample was premixed for 30s with 100µL of the borate buffer. 
Then 100µL of the derivatisation reagent was added and incubated at room 
temperature for approximately 90s. 750µL of water was then added and the sample 
analysed by HPLC (C18 column) according to Ingenza ABA chiral separation method 
set (Table 11). 
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HPLC parameters: 
o Injection volume: 10.0µL 
o Column type: C18 GraceSmart RP 
o Column temperature: 30°C 
o Run time: 5min 
o Detector wavelength: 338nm 
o Isocratic conditions (Table 11) 
Time 
[min]
Flow 
[ml/min] %A %B %C %D Gradient
1 1.00 0.0 18.0 0.0 82.0
 
Table 11 HPLC conditions to separate derivatised D- and L-ABA. Solvent B is acetonitrile, solvent D 
15mM potassium phosphate buffer pH 7.0. The method is named as Ingenza ABA chiral separation. 
 
In the chromatogram (Figure 23) there are peaks for L-ABA (2.7min) and D-ABA 
(3.1min) which were identified by injecting enantiopure standards of D-ABA (CAS 
2623-91-3) and L-ABA (CAS 1492-24-6) onto the column. Both standards were 
purchased from Sigma-Aldrich.  
It needs to be noted that the retention times depend on the column and degree of 
column aging. On the C18 column used in this project, L-ABA always eluted before 
D-ABA.  
L-ABA D-ABA
 
Figure 23 HPLC chromatogram obtained for chiral derivatised D- and L-ABA separated on C18 
column. The run time was 5min. Detection 330nm. 
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Both enantiomers, D-ABA and L-ABA give the same peak area when their 
racemic mixture was analysed. Thus when an enzymatic conversion by D-amino acid 
oxidase is performed, L-ABA can be used as an internal standard. It is assumed that 
initially the peak area of both enantiomers was the same.  
 
Figure 24 shows the calibration curve obtained for ABA. Various dilutions of the 
ABA stock solution, made by dissolving in water known amounts of D-ABA and L-
ABA standards, were derivatised and analysed by HPLC. The two enantiomeric forms 
of ABA gave the same signal as the two calibration curves totally coincided.  
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Figure 24 Calibration curves for both D-ABA and L-ABA using a chiral derivatisation method. The 
two curves totally coincide.  
 
c) ABA chiral derivatisation in various ATPS made of different types 
of salts 
It was not found possible to analyse ABA in the ATPS made of PEG1000 and 
ammonium sulphate using the ABA derivatisation method. It was suspected that the 
presence of ammonium ions interacts with the reagents of the derivatisation. To be 
able to use this analytical method, some other salt, not containing ammonium, had to 
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be used. For that reason, ABA peak area was determined in 6 ATPS (14/14%) made 
of PEG 3350 and 6 different salts: 
o potassium phosphate, pH 8.0 
o potassium citrate, pH 7.6 
o sodium phosphate, pH 7.6 
o sodium citrate, unbuffered 
o potassium sulphate, unbuffered 
o sodium sulphate, pH 7.9 
o ammonium phosphate, unbuffered 
 
It was not possible to obtain an ATPS 14/14 % PEG 3350/potassium sulphate, as 
potassium sulphate could not be fully dissolved in presence of PEG 3350. Moreover 
the ATPS made of 14/14 % PEG3350/ammonium phosphate was also tested to prove 
that the presence of ammonium adversely affects results. 
50µL solution including 1.11mg D/L-ABA was dissolved in 4950µL of each 
phase or water for the control. Next 100µL of each sample was derivatised for ABA 
and analysed on HPLC. Results are presented in Table 12. 
 
L-ABA D-ABA
UP 412 418
LP 409 415
UP 404 408
LP 411 419
UP 415 422
LP 403 410
UP 411 416
LP 410 416
UP 412 417
LP 416 420
UP 125 124
LP - -
Potassium 
sulphate
Water - 413 419
ATPS 14/14 % PEG3350/Salt
Salt type Phase UP/LP Peak Area [mVs]
Sodium 
Sulphate
Ammonium 
phosphate
Salt was not soluble in the presence of 
PEG3350
Potassium 
Phosphate
Potassium 
Citrate
 Sodium 
Phosphate
Sodium 
Citrate
 
 
Table 12 HPLC analysis of D-ABA and L-ABA by chiral derivatisation (2.5.1.2b) in 6 different ATPS 
(14/14% w/w) PEG3350 and a salt. The peak area is given separately for D-ABA and L-ABA for each 
phase. UP stands for upper phase, whereas LP for lower phase. 
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Apart from the ATPS made of ammonium phosphate, the peak area for both D- 
and L-ABA was approximately the same in all the tested phases and water (control). 
No peak was obtained when the lower phase of the ATPS made of ammonium 
phosphate was tested. Also the area obtained for the upper phase of that system was 
significantly smaller than the control sample (water) as well as other salts. Thus the 
presented ABA chiral derivatisation can be used in presence of all the tested salts 
apart from ammonium phosphate.  
 
d) Stopping the enzymatic reaction by chiral derivatisation of ABA 
The most accurate method for the determination of enzyme activity seemed to be 
quantification of either the increase of the product created by catalytic action or the 
decrease of the converted substrate. The enzymatic reaction had to be completely 
quenched at a required time to ensure there was no further substrate conversion before 
a sample was analysed on HPLC. In the following experiment, it was investigated if 
adding the derivatisation reagent quenches the enzymatic reaction. 
According to the procedure received from Ingenza (Procedure of chiral 
derivatisation, section 2.5.1.2b), ABA derivatisation consists of two steps:  
1. premixing the sample with borate buffer pH 10 for 30s.  
2. addition of the derivatising reagent to the sample and incubating it for 90s.  
 
In the first experiment it was investigated if the presence of borate buffer, pH 10, 
stops the enzymatic conversion of D-ABA. 3.4mg DL-ABA was placed in 1.9ml of 
50mM potassium phosphate buffer pH 7.5. 100µL of the DAAO supernatant was 
added to start the enzymatic conversion. 1ml of this solution was immediately mixed 
with 1ml of 0.4M borate buffer pH 10. Every 2min 200µL of the solution was 
derivatised with 50µL of the chiral derivatising reagent and analysed on HPLC. 
Table 13 shows that the enzymatic reaction was only partially inhibited when a 
borate buffer, pH 10, was added to a sample, which is the first step of the 
derivatisation procedure. By contrast, the control sample of DL-ABA incubated with 
DAAO for 60min gave a ratio of D-ABA/L-ABA of nearly zero.  
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L-ABA D-ABA
2 2977 2524 0.85
4 3001 2443 0.81
6 3011 2365 0.79
8 3011 2279 0.76
10 2981 2096 0.70
60 2970 1380 0.46
Control 60 3027 20 0.01
Ratio D/L
Borate 
buffer pH 10 
added 
Derivatisation 
time [min]
Peak area [mVs]
 
Table 13 HPLC analysis of D-ABA converted by DAAO in presence of borate buffer pH 10 
 
Since the addition of borate buffer, pH 10, to the sample did not stop the 
enzymatic reaction, it was investigated if the reaction would stop after the addition of 
the derivatisation reagent. 3.4mg DL-ABA was dissolved in 1.9ml of 50mM 
potassium phosphate buffer pH 7.5. 100µL of the DAAO supernatant was added to 
start the enzymatic conversion. 50µL of this solution was immediately derivatised 
with the derivatising reagent premixed with the borate buffer. The rest of the solution 
was incubated in room temperature to complete the enzymatic reaction (control). The 
derivatised sample was injected every 5min on HPLC (repetitive injections). 
It has been found out that the chiral ABA derivatisation stops the enzymatic 
conversion of D-ABA by D-amino acid oxidase (Table 14). The ratio D- to L-ABA 
was constant (0.93) in all 10 injections from 0 to 70min, demonstrating that the action 
of DAAO had been stopped by adding the derivatisation reagents. By contrast the 
control sample of DL-ABA incubated with DAAO for 60min gave a ratio of D-
ABA/L-ABA of zero.  
 
L-ABA D-ABA
0 3032 2825 0.93
5 3039 2819 0.93
10 3027 2826 0.93
15 3044 2827 0.93
20 3046 2837 0.93
25 3051 2833 0.93
30 3037 2814 0.93
35 3060 2844 0.93
40 3029 2825 0.93
45 3027 2823 0.93
70 3029 2820 0.93
Control 60 3022 14 0.00
Ratio D/L
Sample taken 
at the 
beginning of 
the 
enzymatic 
reaction 
derivatised 
and injected 
10 times on 
the HPLC
Time 
[min]
Peak area [mVs]
 
Table 14 Demonstration that the chiral derivatisation method stops the enzymatic action of DAAO in 
D-ABA. HPLC peak area of D-ABA and L-ABA obtained for the derivatised enzymatic solution.  
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Since it would be difficult to predict how much of a substrate was converted in the 
first step, which involves the addition of the borate buffer, a sample needed to be 
derivatised in a single step with the mixture of the derivatising reagent and the borate 
buffer, pH 10.  
It was unknown how elimination of the first step affected the ABA quantification. 
This was investigated in the following experiment. 
The ABA stock solution was derivatised in a single step by adding a mixture of 
the derivatising reagent and the borate buffer. See paragraph above, (Procedure for 
the derivatisation stopping the enzymatic reaction). This was compared to a control 
when the two steps were done according to the procedure given by Ingenza. See 
Procedure of the chiral derivatisation (section 2.5.1.2b). Results are presented in 
Table 15 
 
Method 1 Method 2 
Sample premixed with the 
buffer and then  derivatised  
Sample derivatised with the 
derivatisation solution 
premixed with the buffer 
Peak area [mVs] Peak area [mVs] 
Replication 
L-ABA D-ABA 
Ratio 
L/D L-ABA D-ABA 
Ratio 
L/D 
1 6541 6755 0.968 6270 6371 0.984 
2 6427 6562 0.979 6318 6446 0.980 
3 6425 6556 0.980 6251 6367 0.982 
Mean 6464 6624 0.98 6279 6395 0.98 
St dev 66 113 0.007 34 44 0.002 
St. Dev % 1.03 1.71 0.68 0.55 0.69 0.21 
 
Table 15 Comparison between the two ABA chiral derivatisation methods. Method 1: 30s incubation 
of a sample with a borate buffer prior to derivatisation. Method 2: the sample is derivatised with a 
mixture of the derivatisation solution and a borate buffer.  
 
Premixing with the buffer (Method 1) gave a slightly bigger peak area (3%). That 
is considered more sensitive, as more ABA was derivatised and thus detected on 
HPLC. However, there is a slightly bigger variation between the three replicates, 
which is probably caused by there being two pipetting steps: first buffer was added 
and then the derivatisation solution. The ratio D- to L-ABA was the same for the both 
tested methods. There was no significant difference between the two groups (P value 
equals 0.20). 
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The chiral derivatisation in a single step (2.5.1.2d) was used to determine the 
enzyme activity and stability as well as ABA eluted from the CCC-bioreactor. When 
more accurate ABA quantification was needed (e.g. to determine the D-value), the 
two-step derivatisation (2.5.1.2b) was performed.  
 
For experiments which involved stopping the enzymatic reaction by ABA 
derivatisation, a modified procedure, which is described below, was established. 
 
Procedure for the derivatisation stopping the enzymatic reaction: 
50µL sample was mixed with 150µL of the derivatising reagent (50mg ortho-
phthalaldehyde and 110mg N-Isobutyryl-L-cysteine dissolved in 0.5ml MeOH, 
diluted to 15ml with 0.4M borate buffer pH 10), and incubated for 2min. It was then 
diluted with 800µL water and analysed on an HPLC C18 column (Table 11).  
 
2.5.1.3. Analysis Method N°3: Ketobutyric acid (KBA) 
analysis on an Anion Exchange Column 
KBA is a product of the enzymatic action of the DAAO on D-ABA. Three HPLC 
methods were developed for KBA analysis. The method which used the HILIC 
column allowed detection of both KBA and ABA and was presented in section 
2.5.1.1. Other two methods are: direct analysis on an anion exchange column (this 
section) and derivatisation with phenyl hydrazine (section 2.5.1.4).  
This method, which was given by Ingenza, allows for the direct quantification of 
KBA. It has been successfully applied to the analysis of KBA in a phase system. The 
biggest advantage of this method is its simplicity as no derivatisation is required. Thus 
an analysis sample can be directly injected on HPLC. However, the method is not as 
sensitive as the derivatisation method described in the next section (2.5.1.4).  
 
The method involves a SphereClone 5µm SAX ion exchange column which was 
purchased from Phenomenex. The column length was 150mm and the internal 
diameter 4.6mm.  
HPLC parameters: 
o Injection volume: 10.0µL 
o Column temperature: 40°C 
o Run time: 15min 
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o Detector wavelength: 220nm 
o Gradient conditions given in Table 16 
 
Time 
[min]
Flow 
[ml/min] %A %B %C %D Gradient
1 1.50 90.0 0.0 0.0 10.0
2 0.10 1.50 90.0 0.0 0.0 10.0 Linear
3 10.00 1.50 0.0 0.0 0.0 100.0 Linear
4 12.00 1.50 0.0 0.0 0.0 100.0 Linear
5 13.00 1.50 90.0 0.0 0.0 10.0 Linear
 
Table 16 HPLC Ion Exchange method to quantify KBA. Line A was water and Line D: 10mM 
ammonium phosphate buffer pH 8.0. SphereClone 5µm SAX Ion Exchange column. Method named 
Ingenza KBA IonExchange.  
 
The peak elutes after about 8 minutes (Figure 25). The method allows analysis of 
KBA in both phases of the ATPS.  
 
 
Figure 25 HPLC Chromatogram obtained for KBA analysis with the anion exchange column 
according to “Ingenza KBA Ion Exchange” method set detailed in Table 16. 
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A KBA calibration curve was performed on HPLC using the anion exchange 
column (Figure 26). The KBA solutions (126-2627µg/ml) were made in water. It was 
experimentally confirmed that the presence of a phase system of 
PEG1000/ammonium sulphate does not affect of the KBA peak area. 
Despite its easy use and convenience, the method has some disadvantages. The 
column is expensive and its lifetime is relatively short. It allows for analysis of about 
100 samples only. That creates high costs, especially considering that a single CCC 
experiment generates about 20 fractions. Thus one column can be used for 5-6 sample 
sets before requiring replacement. Moreover the equation of the calibration curve 
obtained from the sample analysis on the anion exchange column was y=3787x 
(Figure 26), whereas for the next method, which was analysing a sample derivatised 
with phenyl hydrazine on a standard C18 column, y=8054x (Figure 32). Therefore 
this method is only half as sensitive as the second method, which is presented below 
(2.5.1.4).  
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Figure 26 Calibration curve for KBA in water obtained on the anion exchange HPLC column 
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2.5.1.4. Analysis Method N°4: KBA derivatisation with 
phenyl hydrazine 
The method is based upon the KBA derivatisation with phenyl hydrazine in the 
presence of 150mM potassium phosphate buffer, pH 8 (Figure 27). 
 
 
Figure 27 Derivatisation of a keto group with phenyl hydrazine. The derivative (phenylhydrazone) can 
be analysed on a C18 HPLC column. 
 
It is known that hydrazones derived from ketones are present as mixtures of two 
isomers in equilibrium144 (Figure 28). Pellegrino et al145 using a liquid 
chromatography column (RP-18) resolved the two isomers of phenylhydrazones 
derived from phenylhydrazine and acetaldehyde. 
 
 
Figure 28 The two isomers for hydrazones derived from ketones144. 
 
Figure 29 shows two isomers of phenylhydrazone derived from phenylhydrazine 
and 2-keto butyric acid. It is possible that the cis-isomer forms a stable 6-membered 
ring structure (Figure 30) which is less polar and therefore should elute after a longer 
time. 
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Figure 29 Two isomers of phenylhydrazone derived from ketobutyric acid (KBA).  
 
 
Figure 30 Possible internal hydrogen bond in cis-isomer of phenylhydrazone.  
 
The HPLC method, suggested by Ingenza, was modified by increasing the 
concentration of methanol in the mobile phase from 7 to 35%. This allowed the 
second KBA derivative to elute. The high concentration of methanol in the mobile 
phase affected the resolution between eluted compounds. That was improved by 
decreasing the flow rate of the mobile phase from 1 to 0.8ml/min. The HPLC 
conditions used for analysis of KBA are presented in Table 17. 
 
Derivatisation procedure:  
200µL of a sample was mixed with 400µL 150mM potassium phosphate buffer pH 
8.0 and 400µL 0.05M phenylhydrazine solution. The incubation time with a 
derivatising reagent is at least 20min at room temperature. 
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HPLC parameters: 
o Injection volume: 10.0µL 
o Column type: C18 GraceSmart RP  
o Column temperature: 40°C 
o Run time: 8min 
o Detector wavelength: 324nm 
o Isocratic conditions 
Time 
[min]
Flow 
[ml/min] %A %B %C %D Gradient
1 0.80 0.0 0.0 35.0 65.0
 
Table 17 HPLC conditions to quantify derivatised KBA. Solvent C is methanol, solvent D 15mM 
potassium phosphate buffer, pH 8.0. The method is named as Ingenza KBA C18. 
 
 
Figure 31 HPLC Chromatogram obtained for KBA derivatised with phenyl hydrazine, analysed on the 
C18 column according to “Ingenza KBA C18” method set (Table 17). There are two peaks for KBA, at 
2.1min and 6min. 
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In the chromatogram (Figure 31) there are two peaks which elute at 2.1min and 
6min. Both of them are proportional to the KBA concentration in a sample. The first 
peak might be the more polar trans-form of KBA-derivative, whereas the second the 
less polar cis-form.  
The area of the first peak (Figure 31), which elutes at 2.1min, is always 2.5 times 
bigger than area of the second peak. Moreover, it is sharper which makes peak 
integration more accurate. Therefore to increase sensitivity, all KBA analysis was 
performed based on the first peak. Figure 32 shows the calibration curve for KBA 
based on the first eluted peak.  
KBA calibration curve
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Figure 32 Calibration curve for KBA based on HPLC analyses. The area of the first peak which eluted 
at about 2min plotted against KBA concentration.  
 
It was confirmed that KBA can be quantified in an ATPS based on ammonium 
sulphate salt. 1ml of KBA stock solution (1.5mg/ml) was placed into 9.0ml of water 
(control), 9.0ml of the upper phase and 9.0ml the lower phase of ATPS 
(PEG1000/ammonium sulphate). Samples were derivatised with phenyl hydrazine and 
analysed by HPLC. Results are presented in Table 18. In all 3 cases the difference in 
the peak areas were within 5% of each other and the values were within 5% of the 
area expected from the calibration curve (Figure 32).  
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Peak area 
[mVs] 
Calculated 
KBA 
concentr. 
[µg/ml] 
Water 1224 152 
Upper phase 1273 158 
Lower phase 1184 147 
Mean 1227 152.3 
SD 44 5.51 
CV [%] 3.62 3.62 
 
Table 18 HPLC analysis of KBA in a phase system of ATPS PEG1000/ammonium sulphate. SD – 
standard deviation of the three values. CV- coefficient of variation calculated by dividing SD by the 
mean and multiplied by 100%.  
 
Injecting the same sample six times over a period of 3 hours shows that the 
derivative (2.1min) is stable for several hours (Figure 33). 
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Figure 33 Stability of KBA-derivative (2.1min) determined on HPLC. The derivatised KBA solution 
was injected 6 times on HPLC. For the sample injected 3h after the derivatisation the peak area was 4% 
smaller compared to the same sample injected 5min after the derivatisation.  
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2.5.2. Enzyme activity determination 
Finding a phase system which did not inactivate the enzyme was found to be 
considerably more difficult then first expected (Chapter 3). For that reason an 
analytical method which enabled determination of enzyme activity in a phase system 
was required.  
Two methods were developed: N°1 a colorimetric enzyme assay (section 2.5.2.1) 
and N°2 monitoring enzyme activity based on the direct HPLC analysis of the 
converted substrate (section 2.5.2.2.). 
 
2.5.2.1. Enzyme activity Method N°1 - assay based on the 
colorimetric reaction 
Materials used for the colorimetric enzyme assay 
 
Name Abbreviation CAS Supplier
3-Hydroxy-2,4,6-
tribromobenzoic 
acid
TBHBA 14348-40-4 Alfa Aesar
4-Aminoantipyrine 4-AAP 83-07-8 Sigma
Dimethyl Sulphoxide DMSO 67-68-5 Fisher Chemical
Peroxidase 
(horseradish roots) HRP 9003-99-0 Sigma
 
Table 19 Suppliers of the reagents used for the colorimetric assay of D-amino acid oxidase (DAAO).  
 
General assay description 
The assay was provided by Ingenza and modified to make it suitable for the 
current project and available equipment.  
The colorimetric assay relies on quantification of hydrogen peroxide (H2O2), the by-
product of the oxidase reaction. The hydrogen peroxide is reacted upon by the second 
enzyme, horseradish peroxidase (HRP), which oxidases the co-substrate, 4-
aminoantipyrine/ 2,4,6-tribromo-3-hydroxybenzoic acid (4-AAP/TBHBA), generating 
a coloured product. Since the assay is based upon the production of H2O2, it can be 
used for testing the activity of any amine oxidase that generates H2O2. 
CHAPTER 2 – Experimental Set up and Development of the Analytical Procedures 
 
 83 
 
 
 
 
 
 
 
                                            Pink colour (detected at 490nm) 
 
Figure 34 Diagram shows the principle of the colorimetric reaction used to determine the activity of an 
amino acid oxidase  
 
The assay was mainly used to determine the activity of the stored enzyme as well 
as its stability in ATPS.  
 
Reagent preparation: 
Stock solution of assay mix: 
10ml 1M potassium phosphate buffer, pH 7.8 
39ml water 
20mg TBHBA in 1ml DMSO 
15.2mg 4-AAP 
 
Assay solution: 
5ml stock solution of assay mix 
0.0104g D-ABA 
4.4ml water 
100µL HRP solution (7750units/ml) 
 
The assay solution can be stored in a freezer for a few months provided that it does 
not contain HRP. HRP can be added just before analysis, after thawing. 
 
R1 R2
NH2
O2 H2O2
R1 R2
NHamine oxidase
horse radish peroxidase
substrate
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Assay performance 
The assay was performed on a 96 well plate. A 10µL sample was placed into each 
well (in triplicate). Next, by means of a 12 channel pipette, 190µL of the assay 
solution was added to each well and mixed with a pipette. The intensity of the colour 
product was measured at 490nm using a 96 well plate reader. The absorbance was 
measured 4-5 times at 1.5 or 2 minute intervals.  
The enzyme activity was proportional to the slope obtained by plotting in Excel 
the absorbance against the time [min] of taken measurements.  
 
Despite the simplicity and convenience, the assay has some features which limit 
its application in phases containing organic solvents, as those could interact with the 
second enzyme (HRP), giving a false result. Moreover an assayed sample, which 
potentially is a tested phase system, is diluted 20 times with the assay solution. This 
contains 0.1M phosphate buffer, pH 7.8, (see below) which creates an optimal 
environment for the enzyme. During an assay the enzyme would work in the buffer 
solution instead of a tested phase system. Therefore to test activity of the enzyme in a 
phase system, HPLC analysis of ABA (section 2.5.2.2) was used.  
 
2.5.2.2. Enzyme activity method N°2 - enzyme activity based 
on a direct D-ABA conversion 
The enzyme activity is proportional to the % of deracemised ABA in a given time. 
To determine the enzyme activity, the enzyme was incubated with a racemic mixture 
of ABA for a given time and derivatised for ABA, which stopped the enzymatic 
reaction. Then the sample was analysed on HPLC. L-ABA was used as an internal 
standard and it was assumed that initial the D- and L-ABA concentrations in a sample 
were the same. Thus the difference between D-ABA and L-ABA peak area, after the 
incubation with the enzyme, is proportional to the enzyme activity.  
This direct assay is more suitable to determine enzymatic activity in a phase 
system compared to the colorimetric assay as the conversion of D-ABA is monitored 
directly.  
CHAPTER 2 – Experimental Set up and Development of the Analytical Procedures 
 
 85 
 
2.5.3. Enzyme stability determination 
The enzyme stability was determined by comparing the enzyme’s activity after a 
certain time of incubation in a phase system with its initial activity in that phase. To 
measure the enzyme activity, both methods were used i.e. the colorimetric assay N°1 
(2.5.2.1) and monitoring D-ABA conversion on HPLC N°2 (2.5.2.2). 
 
2.5.3.1. Determination of the enzyme stability by the 
colorimetric assay (N°1) 
Description of the method: 
2ml of a phase system was placed into a polypropylene tube with a snap cap (1ml 
upper phase and 1ml lower phase). Next 50µL of the enzyme solution was added, 
mixed vigorously with a phase system and 10µL immediately transferred into the well 
of a 96 well plate before the two phases started separating from each other. This was 
done in triplicate so each of three wells was filled with 10µL of the same phase 
system. The assay for the enzyme activity (2.5.2.1) was then performed and the 
activity was recorded as the initial activity. The tubes with the tested systems were 
placed on a rotating wheel so they were continuously mixed, to avoid phase 
separation as well as to simulate conditions in CCC where the enzyme would stay in 
contact with both phases. The samples were analysed again after another 2 and 4 
hours.  
The enzyme stability was expressed as % of the activity after 2 and 4 hours 
compared to the initial activity, which was assumed to be 100%.  
 
2.5.3.2. Determination of the enzyme stability by the direct 
HPLC analysis of converted substrate (N°2) 
1ml of each phase of a phase system was placed into a polypropylene tube with a 
snap cap. Next 50µL of the enzyme solution was added and the tube with the phase 
system was placed onto a rotating wheel so the two phases were continuously mixed. 
After 2 or 4 hours the substrate, DL-ABA was added and the tube was placed back 
onto the rotating wheel. The enzymatic reaction was continued for 10 min and 
stopped by derivatising 50µL of sample with the solution of ortho-phthalaldehyde and 
N-isobutyryl-L-cysteine which stopped the enzymatic reaction. The % of converted 
D-ABA was calculated based on HPLC analysis.  
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For the control, first the substrate solution was added to the phase system, then the 
enzyme. The reaction was carried on for 10min and the sample was derivatised with 
ortho-phthalaldehyde N-isobutyryl-L-cysteine and analysed on the HPLC.  
The enzyme stability was determined based on the % of D-ABA converted by the 
enzyme incubated for 2 or 4 hours in a phase system compared to % the of D-ABA 
converted by the fresh enzyme (initial activity).  
 
2.5.4. Enzyme concentration determination 
To determine an enzyme protein concentration in a sample, a modified Bradford 
method was used. The Bradford assay involves the binding of Coomassie Brilliant 
Blue G-250 to protein, which causes a shift of the absorption maximum of the dye 
from 365 to 595nm. The increase of absorption at 595nm is monitored146. The method 
is based on the observation that Coomassie Brilliant Blue G-250 exists in two 
different colour forms, red and blue. The red form is converted into blue upon binding 
the dye to protein. The complex is formed within 2min and is stable for about 1 hour.  
Zor and Selinger147 (1996) demonstrated the linearity of the ratio of absorbance 
590nm over 450nm with protein concentration. Protein determination by measuring 
A590/A450 ratio is more accurate than a single measurement of A590, giving about a 10-
fold increase in accuracy and sensitivity compared to the standard Bradford assay.  
The method was adapted for determination of enzyme protein concentration. The 
colorimetric reaction was done in a 96 well plate and the absorbance was read after 10 
min on a plate reader (Biohit model).  
5 solutions of albumin (BSA, Sigma-Aldrich, CAS 9048-46-8) were made at 
different concentrations (0.2-1.0mg/mL). 10µL of each concentration was placed into 
the wells of a 96 well plate in triplicate. Then 290µL of Bradford reagent (Sigma-
Aldrich, cat No B6916), which contained Coomassie dye, was added to each well. 
After 10min the absorbance was read at 450, 600 and 630nm on the plate reader. The 
plate reader used was factory-equipped with 4 filters which allowed measurement of 
absorbance at 405, 450, 490 and 630nm. An extra 600nm filter was available only for 
the time of the experiment. 
Results are presented in the Figure 35. A higher sensitivity (greater slope), was 
obtained when the ratio of the two measurements (A600/A450 and A630/A450) rather than 
single measurements (A600 and A630) were plotted against the protein concentration. 
CHAPTER 2 – Experimental Set up and Development of the Analytical Procedures 
 
 87 
This agrees with the report of Zor and Selinger 147. Also measuring the absorbance at 
600nm rather than at 630nm gave a better sensitivity.  
The slopes (absorbance/concentration) obtained for A600/A450 and A630/A450 were 
0.99 and 0.84 respectively. However, for the subsequent protein analysis the ratio of 
A630/A450 was used. 
Rep 1 Rep 2 Rep 3 Mean St. 
error
Rep 1 Rep 2 Rep 3 Mean Rep 1 Rep 2 Rep 3 Mean St 
error
1.0 0.996 1.052 1.121 1.056 0.036 0.698 0.735 0.816 0.750 1.427 1.431 1.374 1.411 0.019
0.8 0.868 0.926 0.938 0.911 0.022 0.755 0.753 0.741 0.750 1.150 1.230 1.266 1.215 0.034
0.6 0.786 0.804 0.813 0.801 0.008 0.805 0.791 0.783 0.793 0.976 1.016 1.038 1.010 0.018
0.4 0.686 0.686 0.69 0.687 0.001 0.841 0.847 0.833 0.840 0.816 0.810 0.828 0.818 0.005
0.2 0.548 0.571 0.563 0.561 0.007 0.897 0.925 0.902 0.908 0.611 0.617 0.624 0.617 0.004
Rep 1 Rep 2 Rep 3 Mean St. 
error
Rep 1 Rep 2 Rep 3 Mean Rep 1 Rep 2 Rep 3 Mean St 
error
1.0 0.923 0.979 1.045 0.982 0.035 0.698 0.735 0.816 0.750 1.322 1.332 1.281 1.312 0.016
0.8 0.816 0.866 0.875 0.852 0.018 0.755 0.753 0.741 0.750 1.081 1.150 1.181 1.137 0.030
0.6 0.754 0.769 0.775 0.766 0.006 0.805 0.791 0.783 0.793 0.937 0.972 0.990 0.966 0.016
0.4 0.673 0.677 0.679 0.676 0.002 0.841 0.847 0.833 0.840 0.800 0.799 0.815 0.805 0.005
0.2 0.564 0.585 0.581 0.577 0.006 0.897 0.925 0.902 0.908 0.629 0.632 0.644 0.635 0.005
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Figure 35 The calibration curve for albumin obtained on the plate reader by measuring the absorbance 
at 450, 600 and 630nm.  
 
2.5.4.1. Enzyme concentration in the E. coli extract 
The concentration of D-amino acid oxidase protein in the supernatant obtained 
from Ingenza, as determined by the Bradford assay (2.5.4), was 20mg·ml-1. The 
concentration was calculated from the ratio of the two absorbances measured at 
CHAPTER 2 – Experimental Set up and Development of the Analytical Procedures 
 
 88 
630nm and 450nm. The supernatant of DAAO was diluted 50-fold in four replications 
with water to fit the linear range of bovine serum albumin solutions used as a protein 
concentration reference (0.2-1.0mg·ml-1). 
 
2.5.4.2. Enzyme concentration in ATPS 
Albumin in the concentration of 40, 70 and 100mg/ml was dissolved in each phase 
of 14/14% (w/w) PEG1000/ammonium phosphate and water as a control. Then 
proteins were analysed by the modified Bradford method (2.5.4). Figure 36 shows the 
ratio of OD630 to OD450 against albumin concentration in the three tested solvents. 
Values for water and the upper phase at all 3 concentrations are very close. The ratio 
obtained for the lower phase is much higher. Presumably, the high concentration of 
salt in the lower phase interferes with the Coomassie dye making the Bradford assay 
for the lower phase of the ATPS made of ammonium phosphate unsuitable.  
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Figure 36 Comparison of Bradford protein assay in upper and lower phases of PEG/salt ATPS. The 
ratio of OD630 to OD450 of three solutions of albumin at concentrations: 40, 70 and 100mg/ml 
determined by the Bradford assay in water, upper and lower phases are plotted against concentration. 
 
2.6. Determination of distribution ratio in a phase system 
In this thesis, the distribution ratio (D) is expressed as the total concentration of an 
analyte in the upper phase [A]upper to its total concentration in the lower phase [A]lower 
at equilibrium. 
lower
upper
A
A
D ][
][
=  Equation 7 
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However in terms of CCC the distribution ratio (D) is expressed as the total 
concentration of an analyte in the stationary phase to its total concentration in the 
mobile phase.  
mobile
stationary
A
A
D ][
][
=  Equation 8 
 
In the CCC-bioreactor the upper phase was used as the stationary phase, therefore: 
mobile
stationary
lower
upper
A
A
A
A
D ][
][
][
][
==  Equation 9 
 
Since either phase, can be used as the stationary phase, equation 9 is true only if 
the upper phase is used as the stationary one. Otherwise an inverse value needs to be 
used. 
 
2.6.1. Distribution ratio of ABA and KBA in a phase system  
To determine the distribution ratio, a solution of an analyte was added to a phase 
system. If the analyte was dissolved in water, the total volume added to the phase 
system was not higher than 0.5% of the phase system volume, to avoid altering the 
composition of the phase system markedly. The two phases were mixed and left for at 
least 10 min to achieve phase separation. Then the concentration of ABA/KBA was 
determined on HPLC. The distribution ratio was determined as follows: 
lower
upper
ABA ABA
ABA
D ][
][
=  Equation 10 
lower
upper
KBA KBA
KBA
D ][
][
=  Equation 11 
 
2.6.2. Distribution ratio of the enzyme in a phase system  
The distribution ratio of the enzyme was determined based on the enzymatic 
activity in both phases of a phase system. It was expressed as the enzyme activity in 
the upper phase to the activity in the lower phase at equilibrium following the 
colorimetric assay.  
lowerphase
upperphase
enzyme Activity
Activity
D =  Equation 12 
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To determine the distribution ratio of the enzyme in a tested phase system the 
same amount (5ml) of both phases was placed into a glass vial. Next 50µL of the 
aqueous enzyme solution was added, shaken vigorously and left for about 10min to 
allow the two phases to separate. Then 10µL of the upper phase was placed into each 
of 3 wells of a 96 well plate. The same was done for the lower phase and then the 
enzyme activity was determined according to the procedure described in section 
2.5.2.1.  
 
As mentioned above, the D-value was determined based on the enzyme activity. 
Therefore it might happen that even if the enzyme was equally distributed between the 
phases, the determined distribution ratio based on the activity could be different from 
1 if the upper or lower phase caused loss of enzyme activity to different degrees. 
However all analysis were performed 10min after placing the enzyme into a phase 
system. This time was given to allow for separation of the two-phase system and was 
relatively short, after which the enzyme retained most of its initial activity, as 
illustrated in section 3.3.5.2. In addition to the distribution ratio, the enzyme stability 
in a tested phase system was determined. By repeated measurement over a given 
period of time, the exact value of D could only be determined for those systems in 
which the enzyme was stable. However, only for these systems was an exact D-value 
required, since only these could be used for the CCC-bioreactor. In the case of 
unstable systems, an approximate value could be generated, which was sufficient to 
observe some trends.  
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3. DEVELOPMENT AND OPTIMISATION OF A PHASE 
SYSTEM FOR THE CCC-BIOREACTOR 
 
3.1. Introduction 
Phase system selection plays a key role in the CCC separation as the technique is 
based on the differential partitioning between two immiscible phases. It is even more 
challenging to find an appropriate phase system for the CCC-bioreactor since there 
are other parameters that an ideal system must satisfy. The enzyme must totally 
partition into the stationary phase so it remains in the column, otherwise continual 
eluting with the mobile phase would cause the enzyme to contaminate the product. In 
addition, the solvent system should not cause enzyme activity degradation. The 
distribution ratio (D-value) for the substrate of the reaction (ABA) needs to be high so 
it stays it the column long enough to react. However, it cannot be too high so that its 
unreacted form (L-ABA) can elute from the column after a reasonable time. Finally 
the distribution ratio for KBA must be different from that of ABA so the two 
compounds elute at a different time.  
There are some other important criteria for the solvent system selection that are 
related to the machinery of the CCC centrifuge. For example the viscosity of the 
phase system is one of the limiting factors as certain pumps, as well as narrow bore 
tubing (0.8mm), cannot cope with viscous solvents. Moreover the stationary phase 
must be retained in the column.  
 
3.2. Overview of Chapter 3 
In sections 3.3 to 3.5 there were three different groups of two-phase systems 
tested as a potential phase system for the CCC-bioreactor: 
• Aqueous Two-Phase Systems (ATPS) as a solvent system for the CCC-bioreactor 
(section 3.3) 
• Aqueous-organic systems as solvent systems for the CCC-bioreactor (section 3.4) 
• Ionic liquids as solvent systems for the CCC-bioreactor (section 3.5) 
Due to its mild nature and reported use in separations of biologically active 
compounds in CCC, ATPS based on polyethylene glycol (PEG) and a salt was a first 
choice as a phase system for the CCC-bioreactor.  
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Figure 37 shows the diversity of ATPS which can be obtained by using one of 
four molecular weight PEGs and one of seven salts, at various concentrations.  
 
 
 
Figure 37 Parameters of ATPS made of PEG and salt that needed to be optimised to meet the criteria 
of a phase system for the CCC-bioreactor. 
 
Based on the literature review and the project requirement, ammonium sulphate at 
a concentration of 18/18% w/w was chosen (3.3.1) as a phase system for the CCC-
bioreactor. Unexpectedly, there was no bioconversion detected (3.3.1.4) when this 
phase system was applied. The enzyme was then found to be unstable in the selected 
phase system (3.3.1.6). Therefore, to find out more about the enzyme activity and 
stability in ATPS a further investigation involving a broad range of ATPS was 
performed (3.3.2 to 3.3.3).  
After this research was completed, PEG was considered to be the factor 
destabilising the enzyme. Testing a broad range of ATPS in various concentrations, 
made of 3 different molecular weight PEG (3.3.3), gave rise to the indication of two 
potential phase systems for the CCC-bioreactor: 14/14% PEG3350/salt and 14/14% 
PEG1000/salt. The first phase system maintained the enzyme activity well but due to 
ATPS 
PEG molecular weight Salt type Concentration of PEG 
and salt 
400 
1000 
3350 
8000 
Ammonium sulphate 
Ammonium phosphate 
Potassium phosphate 
Potassium citrate 
Sodium sulphate 
Sodium phosphate 
Sodium citrate 
12/12% 
14/14% 
16/16% 
18/18% 
20/20% 
22/22% 
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unfavourable partitioning of the enzyme to the lower, salt-rich phase, it required the 
use of enzyme in the PEGylated form (3.3.4.1).  
Having determined PEG1000 as the optimum polymer for the CCC-bioreactor, 
attention was then turned to the determination of the best salt. Ammonium sulphate, a 
salt component of ATPS used for the first CCC-bioreactor experiment, was replaced 
by potassium phosphate. The enzyme was found to be more stable in the presence of 
phosphate (3.3.5.2) and the potassium cation did not affect the chiral analysis of ABA 
as was found in the case of the presence of ammonium cations (2.5.1.2c).  
ATPS 14/14% PEG1000/potassium phosphate, which due to the favourable 
partitioning of the enzyme did not require the use of its PEGylated form, was selected 
as a phase system for the CCC-bioreactor.  
 
3.3. Aqueous Two-Phase Systems (ATPS) as a solvent system for 
the CCC-bioreactor 
Because of its mild nature, the ATPS based on PEG1000 and a salt is the most 
commonly used solvent system for partitioning of biomolecules such as enzymes. In 
that kind of system, most proteins partition into the upper phase, which would suit the 
CCC-bioreactor. A PEG phase is usually easier to retain in the column, compared to a 
salt phase. Moreover the final product is easier to extract from a salt phase than from a 
PEG phase, e.g. using anion exchange columns.  
 
3.3.1. ATPS of PEG1000/ammonium sulphate 
Based on the literature review and other requirements, an aqueous two-phase 
system made of PEG1000 and ammonium sulphate was chosen as a phase system for 
the first testing of the CCC-bioreactor. The presence of ammonium ions was required 
for the next stage, which was a reduction of the KBA produced in the CCC-bioreactor 
to DL-ABA. This made a PEG1000/ ammonium sulphate system an obvious first 
choice.  
Having decided which phase system to use for the preliminary studies, the salt and 
PEG concentration had to be selected. That was done based on ABA and KBA 
partitioning, as well as the ability of a system to be retained in CCC.  
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3.3.1.1. ABA partitioning in PEG1000/ammonium sulphate 
The effect of ATPS concentration on the ABA distribution ratio was tested by 
determining the D-value of ABA in 5 different concentrations of ATPS made of 
PEG1000 and ammonium sulphate (Table 20). After settling of the two phases, 
samples were taken separately from the upper and the lower phase and analysed on 
HPLC for ABA according to the procedure described in the section 2.5.1.2b. There 
were no replications done as 5 concentrations were enough to get a trend line. Results 
are shown in Figure 38. 
 
ATPS 
concentration 
[% w/w]
PEG1000 [g] Ammonium 
sulphate [g] Water [g]
0.2M ABA 
[ml]
14/14 1.4 1.4 6.7 0.5
16/16 1.6 1.6 6.3 0.5
18/18 1.8 1.8 5.9 0.5
20/20 2.0 2.0 5.5 0.5
22/22 2.2 2.2 5.1 0.5
 
Table 20 Composition of ATPS used to determine ABA distribution ratio.  
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Figure 38. Partitioning of aminobutyric acid (ABA) in different concentration APTS made of 
PEG1000/ammonium sulphate. The distribution ratio was determined by dividing the peak area of 
ABA in the upper phase by the ABA peak area in the lower phase. 
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The higher the PEG and the salt concentration in the ATPS, the less ABA 
partitioned into the top phase. For the CCC-bioreactor the D-value of ABA should be 
high so it stays in the stationary phase long enough to react. For this reason a lower 
concentration ATPS, where more ABA partitions to the PEG phase, would be more 
suitable. 
 
3.3.1.2. KBA partitioning in PEG1000/ammonium sulphate 
The effect of ATPS concentration on KBA partitioning was examined. That was 
done for 6 concentrations of ATPS made of PEG1000 and ammonium sulphate.  
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Figure 39 Partitioning of ketobutyric acid (KBA) in different concentration APTS made of PEG1000/ 
ammonium sulphate. The composition of the phase system is presented in Table 20, ABA solution was 
replaced by 0.2M KBA solution. The upper and the lower phase were analysed on HPLC for KBA 
using an anion exchange column (2.5.1.3). The distribution ratio was obtained by dividing the peak 
area for KBA in the upper phase by the KBA peak area in the lower phase. 
 
Most KBA partitioned into the top, PEG-rich phase. The higher the PEG and salt 
concentration, the more KBA molecules goes to the top phase (Figure 39). The higher 
the D-value, the more time is required to elute KBA from the CCC.  
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3.3.1.3. Retention of the phase in CCC using 
PEG1000/ammonium sulphate 
To obtain a good resolution in CCC, a reasonable percentage of the stationary 
phase must retain in the CCC coil. Even if there is no specification regarding the 
amount of the stationary phase in the coil, it is known that the more stationary phase 
in the coil, the better the resolution148.  
Using aqueous organic two-phase systems, Wood149 demonstrated a linear 
correlation between the volume of the stationary phase displaced and the square root 
of the mobile phase flow rate.  
To determine the retention of the ATPS made of PEG1000 and ammonium 
sulphate on the “Milli” CCC machine, retention studies were performed for 4 different 
concentrations of ATPS: 16/16, 18/18, 20/20 and 22/22% w/w. The top PEG-rich 
phase was used as the stationary phase. Initially the coil was entirely filled with that 
phase. The coil was then rotated in clockwise direction at 1800 rpm. The mobile 
phase was pumped (head to tail) through the rotating coil, partially displacing a 
portion of the PEG-stationary phase. The volume of the displaced stationary phase 
was recorded after equilibrium was achieved, when there was no more of the 
stationary phase coming out from the coil. The same was done for higher flow rates. 
The volume of the stationary phase retained in the coil (stationary phase retention) 
was plotted against the square root of a flow rate to give a linear correlation149. 
Results are presented in the Figure 40.  
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Figure 40 Retention studies of four concentrations of ATPS made of PEG1000 and ammonium 
sulphate tested in “Milli” CCC, 45.1ml coil volume, 2.7mm bore. The mobile phase was pumped in the 
Head to Tail direction. Initially the coil was entirely filled with the upper phase. Then the mobile phase 
was pumped at a very low flow rate through the rotating 1800rpm coil. The displaced stationary phase 
was collected in a measuring cylinder till equilibrium was reached, when no further stationary phase 
came out. The volume of the displaced stationary phase was recorded. Then the flow rate of the mobile 
phase was increased and the mobile phase pumped till equilibrium for that flow rate was reached and 
the additional volume of the stationary phase displaced at that flow rate noted.  
 
It was possible to retain ATPS 14/14% PEG1000/ammonium phosphate on the 
CCC coil. Moreover the stationary phase retention was stable and depended on both 
the ATPS concentration and the mobile phase flow rate. The Wood plot performed for 
this phase system shows that the volume of the stationary phase displaced depends 
linearly on the square root of the mobile phase flow rate. The higher the ATPS 
concentration, the better the stationary phase retention. This results from a larger 
density difference between the two phases in more concentrated ATPS. Du et al150 
have shown that for organic solvents, the stationary phase retention decreases 
proportionally to the square root of the mobile phase flow rate. That was also true for 
the ATPS PEG1000/ammonium sulphate (Figure 40). As expected the higher the 
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mobile phase flow rate, the more stationary phase was displaced, thus the lower the 
stationary phase retention. 
 
Using the data obtained from the experiments above, the theoretical retention time 
of ABA and KBA for different concentrations of ATPS and different mobile phase 
flow rates was calculated (Table 21). The retention time is proportional to the D-value 
and inversely proportional to the flow rate. Therefore in the case of KBA, whose D-
value strongly depends on ATPS concentration (Figure 39), the higher the ATPS 
concentration, the greater the KBA elution time. There is an opposite trend for ABA, 
which would elute earlier if a higher ATPS concentration was applied. Since the D-
value slightly decreases as the ATPS concentration goes up (Figure 38), changing 
ATPS concentration slightly affects the ABA elution time (Table 21). Therefore 
selection of ATPS concentration was made mainly based on KBA retention time. The 
standard mobile phase flow rate for a 45.1ml CCC coil is 1ml/min. At that flow rate 
the KBA would elute after 139min if 18/18% ATPS was used. In the case of 20/20%, 
197min was regarded as an excessively long run time. If 16/16% ATPS was used, 
KBA would elute after 99min, which is acceptable, however for this concentration, 
the stationary phase retention is the poorest (Figure 40), which will affect the 
resolution148. Therefore, the phase system 18/18% w/w PEG1000/ammonium sulphate 
was selected as a compromise. 
 
16/16 18/18 20/20 22/22 16/16 18/18 20/20 22/22
0.25 135 416
0.5 69 64 58 203 284 394
1 35 32 29 27 99 139 197 272
2 18 17 15 14 47 67 99 136
4 9 9 7 7 23 32 48 68
6 6 6 5 5 15 20 31 43
8 5 4 4 4 11 15 22 32
10 3 3 18 25
Flow rate 
[ml/mim]
Theoretical retention time [min]
KBA 
ATPS concentration [%w/w]
ABA 
ATPS concentration [%w/w]
 
Table 21 The theoretical retention time of ABA and KBA in CCC based on the stationary phase 
retention, distribution ratio and a flow rate calculated according to Equation 3 (section 1.3.3). The 
volumes of the mobile phase (VM) the stationary phase (VS) were calculated based on the stationary 
phase displaced (Figure 40) using Equation 4 and Equation 5. The phase system used was ATPS 
PEG1000/ammonium sulphate. The upper PEG-rich phase was used as the stationary. The mobile, 
lower, salt-rich phase was pumped from head to tail.  
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3.3.1.4. CCC-bioreactor using PEG1000/ammonium sulphate 
Having selected the solvent system, the next stage was performing the CCC-
bioreactor. Since the subsequently developed chiral method of ABA analysis was not 
available at that time, only one enantiomer, D-ABA was used to perform the first 
CCC-bioreactor.  
The substrate (D-ABA) was injected onto the equilibrated CCC column, with the 
enzyme, DAAO, in the stationary, PEG-rich phase, to convert D-ABA into KBA. The 
mobile phase coming out from the CCC was passed through a UV-detector and the 
signal (λ=220nm) was recorded. In addition the mobile phase was analysed off line 
for KBA using HPLC.  
In the chromatogram from the UV-detector, (Figure 41), there is a single peak for 
ABA, which eluted after 31min. The theoretical elution time for ABA, based on its 
distribution ratio, the displaced stationary phase volume and the mobile phase flow 
rate, was 32min. There is no peak for KBA, which was expected to elute at 139min. 
Furthermore HPLC analysis (2.5.1.3) did not indicate any presence of KBA in any of 
analysed fractions. Thus no bioconversion took place.  
 
 
Figure 41 Chromatogram obtained from UV detector at 220nm on the CCC-bioreactor. 47.1mg D-
ABA was injected onto the column. Temperature 30°C, rotational speed 1800rpm. Stationary phase 
displaced 23ml (Sf =51%). The stationary phase was the top phase with the enzyme, DAAO (2ml of the 
enzyme supernatant dissolved in 98ml of the upper phase). The mobile phase was the lower phase of 
18/18% PEG1000/ ammonium sulphate (pH 7.6) pumped from head to tail direction at a flow rate 
1ml/min.  
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3.3.1.5. Enzyme activity in PEG1000/ammonium sulphate 
In was presumed that the failure of CCC-bioreactor, presented in the previous 
section, might have been caused by a low enzyme activity in the selected phase 
system. Therefore the conversion of ABA in 18/18% PEG1000/ammonium sulphate 
was performed in a test tube, rather then in the CCC-bioreactor. The KBA produced 
by enzyme activity was analysed on HPLC.  
The enzyme activity was analysed separately for the upper and the lower phase. 
Moreover, to investigate the effect of the phase system pH on the activity, the 
experiment was performed at the pH of the phase system (pH 5) and also at pH 7.5, 
the optimum pH for DAAO151, achieved by adding a drop of ammonia solution.  
Into each test tube was placed 4.8ml of a phase (top or bottom) or water (control), 
100µL of the enzyme supernatant and 100µL of a substrate solution containing 10mg 
D-ABA. The enzyme activity was determined by HPLC by analysing the KBA 
produced as a result. 
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Figure 42 DAAO activity in the ATPS 18/18% w/w PEG1000/ammonium sulphate determined by 
KBA produced by enzymatic activity as analysed on HPLC (anion exchange column) 
 
Figure 42 shows the DAAO activity in the ATPS 18/18% w/w PEG1000/ 
ammonium sulphate at the two tested pH. The enzyme activity in the ATPS was much 
lower than in the control (water) at both pH. Thus the pH of a phase does not seem to 
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be a key parameter in the enzyme activity in ATPS. A very low enzyme activity in the 
tested phase system can explain the lack of KBA in the mobile phase coming out from 
the CCC-bioreactor (Figure 41), especially as the substrate (ABA) elutes after only 
32min. 
 
3.3.1.6. Enzyme stability in PEG1000/ammonium sulphate 
Since it was discovered that the enzyme was not very active in the ATPS 18/18% 
PEG1000/ammonium sulphate (3.3.1.5), the enzyme stability in that system was 
determined. ATPS was initially chosen as a solvent system because of its mild nature. 
No publications had been found indicating that enzyme instability might be caused by 
an ATPS. Therefore it was suspected that the enzyme instability might have been 
caused by some contaminant present in the PEG. For that reason enzyme stability was 
tested in ATPS made of three different PEG1000, purchased from two different 
suppliers, Merck and Fisher. PEG purchased from Merck was in two different grades; 
for synthesis (F. synth.) and Ph Eur.  
The stability was determined by measuring the enzyme activity after exposure to 
the upper phase, lower phase and 50% aqueous solution, for 0, 1 and 2 hours. The 
concentration of PEG in aqueous solution was chosen to be 50% as that was the 
maximum estimated concentration of PEG in the upper phase. The enzyme 
supernatant was placed separately into the tested solutions using a colorimetric assay 
(2.5.2.1). For a control, the activity of the enzyme solution in water was tested.  
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Water
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Ph Eur 
UP
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Ph Eur 
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Merk Ph 
Eur 
PEG50%
 Merck 
F.synth. 
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 Merck 
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Fisher 
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Fisher 
PEG 
50%
0 0.153 0.130 0.146 0.169 0.116 0.136 0.160 0.127 0.134 0.150
1 0.141 0.009 0.065 0.146 0.007 0.069 0.118 0.005 0.082 0.142
2 0.138 0.003 0.040 0.141 0.002 0.040 0.119 0.002 0.049 0.141
0 0.002 0.004 0.001 0.003 0.003 0.003 0.002 0.002 0.003 0.005
1 0.002 0.000 0.002 0.001 0.000 0.001 0.002 0.000 0.001 0.005
2 0.002 0.000 0.000 0.001 0.000 0.002 0.004 0.000 0.001 0.001
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Figure 43 DAAO stability in ATPS made of 18% ammonium sulphate and 18% PEG1000 from 
different sources. The enzyme supernatant (50µL) was dissolved in 4950µL of tested phase. The 
enzyme activity was measured by the colorimetric assay after 0, 1 and 2 hours exposure to the tested 
phase.  
 
The enzyme was found to be unstable in both phases of the ATPS 18/18% 
PEG1000/ammonium sulphate (Figure 43). The PEG supplier, as well as purity grade, 
did seem to make any difference. The biggest inactivation was noticed in the upper 
phase, where within 1 hour the enzyme lost 94% of the initial activity. That is 
unfavourable for the CCC-bioreactor, where the enzyme is distributed in the upper 
phase. That might explain the failure of the CCC-bioreactor described in section 
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3.3.1.4, as by the time the substrate was injected onto the CCC column, the enzyme 
had been in the stationary phase for about 40min and was presumably already 
inactivated.  
Also the lower phase caused loss of enzyme activity. After 1h there was half of 
the initial activity (48% loss). Interestingly, the enzyme is quite stable in 50% PEG 
solutions (15% loss). For comparison, in the same time the enzyme dissolved in water 
lost only 8% of its initial activity. Since the upper phase made of PEG1000 and 
ammonium sulphate inactivates the enzyme the most, further investigation focussed 
on other phase systems, where the enzyme may remain active. 
 
3.3.2. Enzyme stability in ATPS 
Having identified the enzyme instability in ATPS as a potential drawback of the 
CCC-bioreactor, further investigations were done using a broad range of different 
ATPS. Therefore the next studies were done to understand which factors cause 
enzyme inactivation. 
 
3.3.2.1. Enzyme stability in PEG solutions 
From Figure 43 it was concluded that the enzyme is particularly unstable in the 
upper phase. Given that the upper phase is a PEG-rich phase, the enzyme stability was 
determined in various solutions of different molecular weight PEG (polyethylene 
glycol): 
o PEG400 5% (pH 7.7), 15% (pH 6.4) and 30% (pH 7.2) 
o PEG1000 5% (pH 7.2), and 30% (pH 7.4) 
o PEG8000 5% (pH 7.1), 15% (pH 7.0) and 30% (pH 7.5) 
 
The studies revealed that the enzyme stability might be dependent on the PEG 
molecular weight (Figure 44). The enzyme stayed totally active in a solution of 30% 
PEG8000 but was losing activity in 30% solutions of PEG1000 and PEG400 (Figure 
44d). After 2 hours incubation of the 30% PEG solutions, the activity expressed as % 
of the initial activity was 69% in PEG400, 81% in PEG1000 and 109% in PEG8000. 
For PEG400 and PEG1000, concentration of the solution also affected the enzyme 
activity (Figure 44a and b). The inactivation was quicker in a more concentrated 
PEG400 solution. The enzyme seems to be stable in 5% and 15% PEG400 solution 
but lost its activity in 30% solution (Figure 44a). The highest activity was retained in 
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the presence of PEG8000. It is worth noting that the enzyme seems to be more stable 
in aqueous solutions of PEG8000 than in water (Figure 44c). 
The experiment showed that the enzyme might not be stable in aqueous solutions 
of low molecular weight PEG, especially PEG400. Based on these results, PEG8000 
appears the best to use as a component of ATPS for the CCC-bioreactor, with 
PEG1000 second. 
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Figure 44 PEG molecular weight effect on the enzyme stability; a) Effect of PEG400 concentration on 
the enzyme stability, b) Effect of PEG1000 concentration on the enzyme stability, c) Effect of 
PEG8000 concentration on the enzyme stability, d) PEG molecular weight effect on the enzyme 
stability determined in 30% PEG solutions (PEG 400, PEG 1000, PEG 8000) 
50µl of the enzyme as dissolved in 4950µl of a PEG solution. The enzyme activity was determined by 
the colorimetric assay (2.5.2.1) at the time 0, 1 and 2h.  
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3.3.2.2. Enzyme stability in salt solutions 
The enzyme stability was also determined for 40% ammonium sulphate solution 
and 40% ammonium phosphate solution. It is known that the concentration of salt in 
the salt phase of the ATPS 18/18% PEG1000/ammonium sulphate is of the order of 
40%. The enzyme was found to be stable in both tested solutions of ammonium 
sulphate and ammonium phosphate (Figure 45). The activity measured after 2h was 
equal to the initial activity.  
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Figure 45 DAAO stability in 40% ammonium sulphate and 40% ammonium phosphate solutions. 50µl 
of the enzyme as dissolved in 4950µl of a salt solution. The enzyme activity was determined by the 
colorimetric assay (2.5.2.1) at the time 0, 1 and 2h.  
 
3.3.3. Relationship between PEG molecular weight/concentration, 
enzyme stability and the partitioning of all components 
At this stage a successful CCC-bioreactor run had still not been achieved. This 
was considered to be due to the loss of activity of the enzyme in the PEG phase. It 
was previously demonstrated (3.3.2.1) that the enzyme is totally stable in aqueous 
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solutions of PEG8000. However, it was losing activity in solutions of PEG400 and 
PEG1000, especially at higher concentrations (30%) as found in the upper phase of 
ATPS (Figure 44). For that reason it was reasonable to test the enzyme activity and 
the distribution ratio in ATPS made of PEG with molecular weights higher than 1000. 
Since solutions of PEG8000 are very viscous and therefore difficult to use in CCC, 
PEG3350 was tested as a compromise molecular weight, compared in each case to the 
PEG8000 in which the enzyme was known to be stable. 
It seemed that there were two factors that affected the enzyme stability, PEG 
molecular weight and PEG concentration (3.3.2.1). Therefore, an extensive analysis of 
the enzyme stability was performed in a range of ATPSs made of different molecular 
weight PEG (400, 1000 and 3350) and potassium phosphate salt at the concentration 
of 12/12, 14/14, 16/16 and 18/18 % w/w. This salt was used as it was compatible with 
the chiral derivatisation of ABA (2.5.1.2c). PEG400 at the concentration of 12/12% 
and 14/14 % did not made a two-phase system with potassium phosphate. Since other 
important parameters in phase system selection are the distribution ratios of the 
enzyme, ABA and KBA, these were also determined. All the experiments were done 
in triplicate and results are presented in the Table 22.  
 
Distribution ratio 
Enzyme ABA KBA 
PEG 
mol. 
weight 
 ATPS * 
concentration 
[% w/w] 
Enzyme 
stability ** SD 
D-Value SD D-Value SD D-Value SD 
16/16 27.3 6.0 15.7 2.2 0.9 0.04 2.2 0.19 PEG 
400  18/18 13.0 2.4 15.9 3.8 1.2 0.12 4.8 0.29 
14/14 30.4 1.9 15.2 3.0 0.6 0.01 2.2 0.03 PEG 
1000 16/16 7.8 0.5 4.5 1.3 0.6 0.05 3.4 0.10 
12/12 87.2 1.5 0.1 0.0 0.6 0.03 2.0 0.02 
14/14 87.4 3.5 1.5 0.1 0.4 0.03 2.7 0.03 PEG 3350 
16/16 75.2 4.3 21.2 9.2 0.3 0.02 3.7 0.05 
 
Table 22 Effect of PEG molecular weight and ATPS concentration for ATPS of PEG and potassium 
phosphate on the stability of DAAO and the distribution ratios of the enzyme, ABA and KBA.  
*ATPS concentration expressed as % w/w PEG/potassium phosphate pH 7.6 
**enzyme stability is a % of the initial activity incubation of enzyme for 2 hours in a phase 
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The conclusions were as follow: 
o The enzyme is more stable in ATPS made of PEG 3350 and less stable in 
ATPS made of PEG400 
o ATPS concentration plays a key role in the enzyme stability. Enzyme is more 
stable in less concentrated ATPS (true for all molecular weight PEG)  
o Distribution ratio of KBA increases with PEG molecular and with increasing 
ATPS concentration 
o Distribution ratio of ABA decreases with ATPS concentration 
 
Regarding the ability to maintain the enzyme activity, the best ATPSs are made of 
PEG3350. A problem that would arise from using those phase systems in the CCC-
bioreactor comes from unfavourable partitioning of the enzyme to the lower, salt-rich 
phase. Although, at the concentration of 16/16% w/w the D-value of the enzyme is 
21, there was a big inconsistency between both the three replications (SD=6.2), as 
well as between 3 wells on a microplate into which a sample from the same 
replication was placed. Furthermore, the upper phase was very cloudy and phases 
seemed not to be separated properly. In addition, partitioning of ABA and KBA were 
not as favourable as in other phase systems. ABA with the D-value of 0.3 might not 
stay long enough in the coil to be totally converted before it elutes. In turn, the D-
value of KBA 3.7 means a long retention time which would delay a potential second 
injection of substrate.  
Both ABA and KBA partition more favourably in ATPS 14/14% PEG3350/salt. 
Also the enzyme seems to be more stable in this phase system, however it does not 
partition into the upper, PEG-rich phase. Using this phase system would require a 
method such as PEGylation of the enzyme, which would drive it to the top, PEG-rich 
phase.  
Other potential phase systems that arise from the data in Table 22 are ATPS made 
of PEG400 at the concentration of 16/16% and PEG1000 at the concentration of 
14/14%. Distribution ratios of ABA and KBA are more favourable in these phase 
systems than in PEG3350/salt at the concentration of 16/16% or even 14/14%. The D-
value of ABA is higher in comparison to the previously mentioned phase systems, 
which means a longer retention time and as a consequence of this, a longer reaction 
time. In turn, the D-value of KBA is lower than that obtained for 16/16% or 14/14% 
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PEG3350/salt, which is preferred as the compound would require less time to elute. 
This would reduce both the time of the separation process and the mobile phase 
consumption. The drawback of these phase systems is their poor ability to maintain 
the enzyme activity compared to PEG3350/salt. ATPS made of PEG1000 can be used 
a concentration as low as 14/14%, which reduces PEG and salt consumption, 
compared to PEG400 which needs to be used at a concentration of 16/16% (w/w). 
Therefore, ATPS made of PEG1000 rather then PEG400 was further investigated.  
In the next sections the ability of the two selected two-phase systems (14/14% 
PEG3350/salt and 14/14% PEG1000/salt) for the CCC-bioreactor will be tested.  
 
3.3.4. ATPS of PEG3350 with enzyme PEGylation 
One of the two phase systems selected for the CCC-bioreactor was 14/14% 
PEG3350/salt (3.3.3). Due to unfavourable partitioning of the enzyme to the lower, 
salt-rich phase, a method which alters the partition of the enzyme had to be developed 
and proven in the selected phase system. This was PEGylation. 
In the next sections will be described the methodology of enzyme PEGylation 
(3.3.4.1), the distribution ratio of the PEGylated enzyme in ATPS made of PEG3350 
(3.3.4.2) and the activity (3.3.4.3) and stability (3.3.4.4) of the PEGylated enzyme. 
Finally the effect of salt type on PEGylated enzyme will be described (3.3.4.5).  
 
3.3.4.1. Methodology of enzyme PEGylation 
PEGylation is the process of covalent attachment of polyethylene glycol to 
another molecule. It is commonly used to mask the surface of therapeutic proteins to 
avoid their removal by exposure to antibodies and reduction of renal clearance152.  
Gavasane and Gaikar153 (2003) examined several different PEG-derivatives (PEG-
benzonate, PEG-phosphate, PEG-trimethylamine, PEG-palmitate, PEG-
phenylacetamide) to extract penicillin acylase from E. coli using ATPS made of 10% 
PEG4000 and 7.5% sodium sulphate. Penicillin acetate, in the tested ATPS, 
partitioned into the bottom salt phase. Adding any of the PEG-derivatives above a 
certain concentration drove the target protein to the upper-PEG phase. The same 
phase system was used to purify glucose isomerase which partitioned into the top-
PEG phase in the presence of PEG-benzoate and PEG-palmitate154. 
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Slavica et al155 (2007) performed PEGylation of DAAO from Trigonopsis 
variabilis using polyethylene glycol maleimide (MPEG-Mal), whose structure is 
presented in Figure 46. The PEGylation was performed in the presence of 50mM 
sodium phosphate buffer, pH 7.5, using a two-fold molar excess of reactive PEG over 
protein cysteine groups. The reaction was completed immediately after adding 
MPEG-Mal to the enzyme. In SDS-PAGE the PEGylated enzyme migrated as a single 
band whose molecular mass increased by ≈15 kDa compared with the native enzyme 
(55 kDa PEGylated protein, 40 kDa native enzyme). This suggested that each 
molecule of the enzyme was combined with three molecules of MPEG-Mal.  
 
 
Figure 46 The structure of PEG maleimide (MPEG-Mal), n≈110.  
 
In this project, the PEGylation of the DAAO enzyme was achieved as follows: 
200µL of DAAO obtained from Ingenza (0.1µM subunits) was incubated for 10 min 
at 4°C with 6 mg of MPEG-Mal (1.2µM subunits) in the presence of 0.8ml of 50mM 
sodium phosphate buffer, pH 7.5. Proportions of DAAO to MPEG-Mal were the same 
as used by Slavica and co-workers155.  
 
3.3.4.2. Distribution ratio of PEGylated enzyme in 
PEG3350/salt 
The effect of MPEG-Mal on the enzyme distribution ratio in the ATPS (12/12% 
PEG3350/ammomium phosphate) was tested. ATPS at the concentration of 12/12% 
was used to demonstrate the contrast in partitioning of the native enzyme, which in 
this phase system partitions almost entirely into the lower phase (Table 22) and the 
PEGylated form. At this stage of the research, ammonium phosphate was still used as 
the salt component of ATPS. 
50µL of the PEGylated enzyme was mixed with 475µL upper phase and 475µL 
lower phase of the ATPS (12/12% PEG3350/ammonium phosphate). After vigorously 
shaking and settling the two phases, the enzyme activity was determined for both 
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phases in the colorimetric assay (2.5.2.1). As a control, a solution of non-PEGylated 
enzyme was placed in the ATPS.  
Results (Figure 47) showed, as expected, that when non-PEGylated enzyme was 
used there was much more activity in the lower phase (0.253abs/min, 94.8%) than in 
the upper phase (0.014abs/min, 5.2%). At the same time there was a high enzyme 
activity (0.186abs/min, 93%) in the upper phase when the PEGylated enzyme was 
placed into the ATPS. The activity in the lower phase was 0.014abs/min, 7%. This 
suggested that PEGylation drives the enzyme from the lower salt-rich phase to the 
upper-PEG-rich phase. Based on the activity, the distribution ratio of the enzyme was 
calculated. The distribution ratio of the PEGylated enzyme was found to be 13, an 
increase of over 200-fold compared to the control.  
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Figure 47 The effect of DAAO PEGylation with MPEG-Mal on the partitioning in the ATPS (12/12% 
w/w PEG3350/ammonium phosphate) determined by the colorimetric assay.  
 
3.3.4.3. Activity of PEGylated enzyme 
Using the chiral HPLC analysis of D/L-ABA, the activity of PEGylated DAAO in 
the ATPS and a buffer was compared to the activity of the native (non-PEGylated) 
form of DAAO. These made four combinations which were tested in duplicate.  
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In all 4 cases a reaction volume was 2030µl. 1920µl of this was the ATPS (960µl 
of each phase) or the buffer. 10µl was DL-ABA solution (130.9mg/ml). PEGylated 
enzyme (3.3.4.1) was added in a volume of 100µl, which contained 20µl of the 
enzyme. The native enzyme was used in the volume of 20µl together with 80µl of 
water added to obtain the same final volume of 2030µl in all vials. The reaction was 
carried out for 10min at room temperature and stopped by the chiral derivatisation 
(2.5.1.2d) of 100µl of a sample. Results can be found in Table 23.  
 
Peak Area [mVs] 
  
L-ABA D-ABA 
D-ABA 
converted 
[%] 
Mean 
conversion 
[%] 
Rep. 1 1261 703 44 Dried 
enzyme Rep. 2 1169 641 45 45 
Rep. 1 1264 566 55 Native Control Rep. 2 1233 536 57 56 
Rep. 1 1233 1115 10 Dried 
enzyme Rep. 2 1192 1072 10 10 
Rep. 1 1217 1072 12 PEGylated Control Rep. 2 1193 1047 12 12 
 
Table 23 Activity of the PEGylated DAAO and the native form of DAAO in a buffer (50mM sodium 
phosphate, pH 7.6) and ATPS (14/14% w/w PEG3350/potassium phosphate), determined by HPLC 
analysis of converted D-ABA.  
 
100% conversion of D-ABA was achieved when the reaction was performed by 
the native form of the enzyme both in the buffer and in the ATPS. The PEGylated 
enzyme was less active, 55% D-ABA was converted in the ATPS and only 32% in the 
buffer. Surprisingly the PEGylated enzyme was more active in the ATPS than in a 
buffer. 
 
3.3.4.4. Stability of PEGylated enzyme 
PEG maleimide was stored in the presence of phosphorus pentoxide in a freezer as 
for stability it must be stored under anhydrous conditions. Each time a portion of 
MPEG-Mal was taken, the package was refilled with fresh phosphorus pentoxide. 
Therefore, if a larger amount of the enzyme was PEGylated and stored in the 
PEGylated form, this would be more convenient, provided the PEGylated enzyme 
was stable on storage. 
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Therefore, the stability of the PEGylated enzyme was tested. The activity of the 
stored PEGylated enzyme (23 days at +4°C) was compared with the freshly 
PEGylated one. Moreover, for comparison, the activity of the non-PEGylated enzyme 
was also determined.  
The activity, determined by direct HPLC analysis of converted D-ABA, was 
expressed as % D-ABA converted by the enzyme within the same time. Results are 
presented in Table 24. The freshly PEGylated enzyme was able to convert nearly 
twice more D-ABA (57%) than the 23 days old solution of PEGylated one (29%). The 
native (non-PEGylated) enzyme was even more active (79% converted D-ABA). 
These results show that PEGylation not only decreases the enzyme activity but also its 
stability. 
Subsequently it was found that the enzyme lost activity even if stored in an 
aqueous or a buffer solution. Thus it was not clear if the PEGylated enzyme lost its 
activity as a consequence of PEGylation or because it was stored in a buffer solution. 
However, the conclusion was that PEGylated enzyme could not be stored at 4°C for 
longer than a few hours and must therefore be made fresh each day. 
Slavica et al155 reported that the PEGylated DAAO could be stored at -25°C for 
several weeks without detectable loss of activity. However, in the current project, in 
contrast to the work of Slavica et al, the excess of MPEG-Mal was not removed. This 
might have been the reason for further instability of DAAO. At +4°C further 
PEGylation of the enzyme at Cys298, which is a part of the catalytic centre of the 
enzyme, might have happened. It has been proven156 that PEGylation of this amino 
acid inactivates the enzyme.  
 
Peak Area 
[mVs] 
  
L-ABA D-ABA 
D-ABA 
converted 
[%] 
Mean 
conversion 
[%] 
Rep. 1 141 31 78 Native 
enzyme Control Rep. 2 147 29 80 79 
Rep. 1 117 51 56 Freshly 
PEGylated Rep. 2 119 52 57 57 
Rep. 1 105 75 29 
PEGylated 
enzyme Stored 23 
days  Rep. 2 101 73 28 29 
 
Table 24 Stability of the PEGylated enzyme determined by HPLC analysis of converted D-ABA.  
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3.3.4.5. Effect of salt type on the PEGylated enzyme 
The chiral analysis of ABA is described in section 2.5.1.2b. It was shown 
(2.5.1.2c) that the presence of ammonium sulphate, the salt component of ATPS used 
for the first CCC-bioreactor experiment (3.3.1.4), affects this assay. Therefore, the 
activity and stability of the PEGylated enzyme was determined in ATPS made of 
PEG3350 and five different salts (potassium phosphate, potassium citrate, sodium 
phosphate, sodium citrate and sodium sulphate), which were known to be compatible 
with the assay (2.5.1.2c).  
The initial enzyme activity was determined at time 0, just after the enzyme was 
added to phase systems, and after 2h of enzyme incubation in ATPS. To determine the 
initial enzyme activity, 20µL of a substrate solution (1.66mg D/L-ABA) was added to 
1.9ml of each ATPS. Next 100µL of PEGylated enzyme solution was added. Closed 
test tubes were placed on the rotating wheel with both phases being mixed for 10 min. 
After the elapsed time, the reaction was stopped by derivatisation of 50µL of sample 
with the mixture of orthophthalaldehyde and N-Isobutyryl-L-cysteine. The sample 
was analysed on HPLC. 
To determine the enzyme activity after 2h, 100µL of PEGylated enzyme solution 
was added to 1.9ml ATPS and the samples were incubated for 2h on the rotary wheel. 
Then 20µL of a substrate solution (1.66mg D/L-ABA) was added to initiate the 
enzymatic reaction which was continued for 10min. Then the reaction was stopped by 
derivatisation of 50µL of sample for ABA (section 2.5.1.2d), which was analysed on 
HPLC.  
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Figure 48 The initial PEGylated DAAO activity and the activity after 2h in ATPS 14/14% PEG3350 
and a salt, determined by HPLC. The activity is expressed as a % of D-ABA converted within 10min of 
the enzymatic reaction.  
 
The initial activity (green bar Figure 48) is the highest (53% converted D-ABA) 
for potassium phosphate and the lowest for the sodium sulphate (35% converted D-
ABA). Based on the activity after 2h (red bar Figure 48) the enzyme is most stable in 
the presence of sodium phosphate (37% converted D-ABA) and the least stable in 
sodium sulphate (10% converted D-ABA).  
 
The next stage was determining the distribution ratio of the PEGylated enzyme, 
DL-ABA and KBA in ATPS made of PEG3350 and the 5 chosen salts. Only 4 were 
tested as the ATPS 14/14% PEG3350/potassium citrate made a single phase when the 
enzyme and substrate solutions were added. That might have been caused by fact that 
ATPS PEG3350/potassium citrate at the concentration of 14/14% was close to the 
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binodal, the border of two phases. Therefore, a single phase was created when another 
component was added. 
 
UP LP UP LP UP LP UP LP
Potassium Phosphate 206 535 0.39 211 546 0.39 1466 660 2.2 0.190 0.006 31.3
 Sodium Phosphate 315 968 0.33 324 983 0.33 1457 607 2.4 0.166 0.006 27.6
Sodium Citrate 433 878 0.49 448 901 0.50 1190 791 1.5 0.210 0.015 14.2
Sodium Sulphate 289 929 0.31 300 952 0.31 1322 594 2.2 0.156 0.006 24.9
Ratio Ratio RatioActivity
Salt type
ABA
KBA Enzyme
L-ABA D-ABA
Peak area
Ratio Peak area Peak area
 
Table 25 Distribution ratio of ABA, KBA and the PEGylated enzyme in the ATPS 14/14% w/w 
PEG3350/ salt. Both ABA and KBA were analysed on HPLC on C18 column according to methods 
described in section 2.5.1.2b for ABA and 2.5.1.4 for KBA. Peak areas [mVs] in upper (UP) and lower 
phase (LP) are given. The enzyme distribution ratio was determined based on its activity [abs/min] in 
both phases as determined by the colorimetric assay (2.5.2.1).  
 
The distribution ratios of ABA and KBA, were within the range which was 
acceptable in all the tested systems (Table 25). Based on the distribution ratio and the 
enzyme stability, the best salt for the ATPS 14/14% PEG3350/salt was sodium 
phosphate where the enzyme stability was the highest. However, sodium phosphate 
was found to be susceptible to precipitation when used as part of ATPS 14/14% 
PEG3350. This could potentially block the coil of the CCC-bioreactor. For that reason 
potassium phosphate was selected as a salt for the ATPS.  
 
3.3.4.6. CCC-bioreactor with PEG3350/potassium phosphate 
and PEGylated enzyme 
To prove the compatibility of 14/14% PEG3350/ potassium phosphate with the 
CCC-bioreactor the experiment presented below was performed.  
The enzyme was PEGylated prior to the experiment according to the procedure 
described in section 3.3.4.1.  
2ml of DAAO obtained from Ingenza was incubated for 10 min at 4°C with 60 mg 
of MPEG-Mal in the presence of 8ml of 50mM sodium phosphate buffer, pH 7.5. 
This was then dissolved in 90ml of the upper, PEG-rich phase of 14/14% PEG3350/ 
potassium phosphate, used as the stationary phase. The mobile phase was pumped 
from head to tail of the coil at a flow rate of 0.5ml/min. 38.03mg DL-ABA was 
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injected onto the equilibrated CCC column. Fractions of the mobile phase eluted from 
CCC were analysed for ABA using the chiral derivatisation method (2.5.1.2b).  
Figure 49 shows a fractogram reconstructed based on HPLC analysis of ABA. In 
the graph there are two sets of bars, which correspond to peak areas of the two 
enantiomers in each fraction, plotted against the elution time. In each fraction a peak 
area of D-ABA peak is smaller than a peak area of L-ABA, which is assumed to be 
caused by the enzymatic conversion of D-ABA. The total D-ABA conversion ratio 
was 22.8%. Although this is far from 100%, which is the requirement of the project, it 
demonstrates the potential of both the selected phase system as well as the CCC 
instrument used as a bioreactor.  
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Figure 49 Elution profile of ABA from the CCC-bioreactor (Milli, coil volume 45.1ml ref. section 
2.2.1). 38.06mg DL-ABA was injected onto the column. Rotational speed 1800rpm. Stationary phase 
displaced 19.5ml. The mobile phase was the lower phase of 14/14% PEG3350/ potassium phosphate 
(pH 7.5) pumped from head to tail direction at the flow rate 1.0ml/min. The stationary phase was the 
top phase with the PEGylated enzyme DAAO (10ml of the enzyme PEGylated enzyme dissolved in 
90ml of the upper phase). The temperature was 20°C. 
 
3.3.5. ATPS of PEG1000 with native enzyme 
ATPS made of PEG1000 in concentration 14/14% was one of the two potential 
phase systems selected for the CCC-bioreactor (3.3.3). Section 3.3.1.4 presents the 
unsuccessful CCC-bioreactor with no bioconversion detected, using the ATPS made 
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of PEG1000 and ammonium sulphate as a phase system. However, the phase system 
used in that experiment was employed without consideration of the enzyme stability, 
which was subsequently found to be a critical issue in the process. However, different 
salts had been found to affect the enzyme stability at different rates so PEG1000 was 
revised in the light of this new knowledge and with the aim of optimising enzyme 
stability for the experiment.  
 
3.3.5.1. Overview of section 
From Table 22 it is known that for the desirable enzyme partitioning the 
concentration of ATPS made of PEG1000 should be not higher than 14/14%. Based 
on the studies presented in the next sections, ammonium phosphate provided better 
enzyme partitioning as well as stability (3.3.5.2) than ammonium sulphate, which was 
used for the first CCC-bioreactor (section 3.3.1.4). It was also discovered that the 
PEGylated enzyme was more stable in the presence of phosphates, rather than in the 
presence of the sulphate anion (3.3.4.5). It has to be mentioned that ATPS made of 
PEG1000 does not require the PEGylated enzyme.  
The ammonium cation, which cannot be used with the chiral detection method of 
ABA (2.5.1.2c), was therefore replaced by the potassium cation. Furthermore, the 
sodium cation was also rejected as, at the concentration used in ATPS, sodium 
phosphate is susceptible to precipitation.  
 
3.3.5.2. Identification of optimum salt for PEG1000 ATPS 
To identify a suitable salt anion, two experiments were performed to determine the 
difference in the enzyme partitioning and stability in the presence of sulphate and 
phosphate salts. Previously (section 3.3.1.4) sulphate salts had been used with the 
CCC-bioreactor but data form the PEGylation experiments (section 3.3.4.5) suggested 
that phosphate salts were more suitable. Therefore these two salt anions were 
compared as follows.  
The enzyme distribution ratio was determined in the following ATPS: 
o 14/14 % (w/w) PEG1000/ ammonium sulphate 
o 14/14 % (w/w) PEG1000/ ammonium phosphate 
 
100µl of the enzyme supernatant was dissolved in 5ml of the upper and 5ml of the 
lower phase. The phases were mixed and left for 10min to allow them to settle. The 
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enzyme activity was then determined in the upper and in the lower phase in the 
colorimetric assay. A D-value was determined by dividing the enzyme activity 
(absorbance/min) in the upper phase by the enzyme activity in the lower phase. 
In both cases the enzyme partitioned into the upper, PEG-rich phase (Table 26). 
The distribution ratio was higher when the phosphate salt was used, therefore ATPS 
made of that salt would better suit the CCC-bioreactor, as the enzyme has to remain 
immobilised in the stationary phase of the CCC-bioreactor purely by distribution for 
the process to operate effectively.  
 
Upper 
phase
Lower 
phase
Upper 
phase
Lower 
phase
0.128 0.006 20.5 0.099 0.015 6.7
0.141 0.014 10.3 0.107 0.015 6.9
PEG1000/sulphate 14/14%
Activity
D-value D-value
Activity
PEG1000/phosphate 
14/14%
 
 
Table 26 DAAO distribution ratio in ATPS 14/14% PEG1000/ ammonium phosphate and 14/14% 
PEG1000/ ammonium sulphate.  
 
In the same phase systems, the enzyme stability was tested as follows: 50µl of the 
enzyme supernatant was added separately to 4950µl of the upper and the lower phases 
the tested phase systems. Then the enzyme activity was determined by the 
colorimetric assay (2.5.2.1) immediately after mixing the enzyme with the phase 
system (time 0) and subsequently after 1 and 2 hours of incubation at room 
temperature (22°C).  
Figure 50 shows the results of enzyme stability in 14/14% w/w 
PEG1000/ammonium sulphate and in 14/14% w/w PEG1000/ammonium phosphate. 
It was found that the enzyme lost part of its activity in the tested ATPS. After 2h the 
enzyme lost 48% of its initial activity in the upper phase of 14/14% 
PEG1000/ammonium phosphate and 59% in the upper phase of 14/14% 
PEG1000/ammonium sulphate. Therefore, the DAAO stability was slightly better 
when the phosphate salt was used rather than the sulphate one.  
This experiment confirmed that the enzyme lost activity quicker in an upper PEG-
rich phase, compared to a bottom, salt-rich phase. That was true for the both examined 
salts. Despite the enzyme being more stable in the lower phases, they could not be 
used as the stationary phase in the CCC-bioreactor due to partitioning of the enzyme 
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into the PEG-rich phase. In addition, it is more difficult to retain the salt-rich phase in 
CCC. Figure 73 (section 5.3.1) shows that there was more stationary phase displaced, 
which means poorer retention, when the lower-salt rich phase was used as the 
stationary phase. Another reason to use the salt-rich phase as the mobile phase is that 
the extraction of L-ABA is easier than from the upper-PEG rich phase.  
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Figure 50 Stability of DAAO in 14/14% PEG1000/ammonium sulphate and 14/14% 
PEG1000/ammonium phosphate. 50µl of the enzyme supernatant was dissolved in 4950µl of each 
phase separately. Samples were incubated at room temperature (22°C). Enzyme activity was 
determined by the colorimetric assay at the time 0, 1 and 2 hours.  
 
3.3.5.3. CCC-bioreactor using PEG1000/ potassium phosphate 
and native enzyme 
The experiment was performed to evaluate ATPS made of PEG 1000 as a phase 
system for the CCC-bioreactor. All experimental conditions, apart from the tested 
phase system and the form of the enzyme, were the same as in experiment presented 
in section 3.3.4.6. Since the tested ATPS was made based on PEG1000, no 
PEGylation of the enzyme was required. 2ml of the enzyme was dissolved directly in 
98ml of the upper phase so the concentration of the enzyme in the phase system was 
the same as in the experiment presented in section 3.3.4.6. 
Figure 51 shows the fractogram obtained based on HPLC analysis of ABA eluted 
from the CCC-bioreactor using 14/14% PEG1000/potassium phosphate as the phase 
system. The total conversion of D-ABA was 22.6%, which was very close to that 
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obtained with PEG3550 and the PEGylated enzyme (22.8%). Although this is a long 
way from the ideal conversion rate of 100%, this figure of 22.6% was obtained using 
a CCC-bioreactor whose operating parameters had not been optimised and it therefore 
only shows compatibility of the tested phase system for the CCC-bioreactor. 
Optimisation of the CCC-bioreactor operating parameters is the subject of Chapter 4.  
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Figure 51 Elution profile of ABA from the CCC-bioreactor (Milli, coil volume 45.1ml ref. section 
2.2.1) using 14/14% PEG1000/ potassium phosphate as a phase system. 38.08mg DL-ABA was 
injected onto the column. Rotational speed 1800rpm. Stationary phase displaced 25ml. The mobile 
phase was the lower phase, pumped from head to tail direction at the flow rate 1.0ml/min. The 
stationary phase was the top phase with enzyme DAAO (2ml of the enzyme dissolved in 98ml of the 
upper phase). The temperature was 20°C.  
 
3.3.6. Comparing the two ATPS systems made of PEG1000 and 
PEG3350 
The two two-phase systems, 14/14% w/w PEG3350/potassium phosphate and 
14/14% w/w PEG1000/potassium phosphate, were compared in terms of their ability 
to maintain the enzyme activity. For ATPS made of PEG1000 the native form of the 
enzyme (20µl) was used, whereas for the ATPS made of PEG3350 100µl of the 
PEGylated form (containing 20µl of the native form) was used. The experiment was 
done in triplicate. Table 27 shows volumes of the enzyme solution and phases used 
for the experiment.  
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PEG1000/potassium 
phosphate Buffer
PEG3350/potassium 
phosphate Buffer
Enzyme* 20 20 100 100
UP 980 0 900 0
LP 1000 0 1000 0
Buffer 0 1980 0 1900
Total 2000 2000 2000 2000
Volume [µl]
PEGylated enzyme Native enzyme 
 
Table 27 Volume (µl) of the enzyme, upper phase (UP), lower phase (LP) and buffer (50mM 
potassium phosphate pH 7.8).  
* the enzyme was used in the native form for PEG1000 ATPS, and the PEGylated form for the ATPS 
made of PEG3350. The volume of the enzyme supernatant added in both cases was 20µl 
 
The enzyme was incubated with the tested phase systems on the rotating wheel for 
2 and 4 hours. After that time, 20µl the substrate DL-ABA at the concentration of 
150mg/ml was added directly to a phase system. The reaction was stopped after 
10min by derivatising 50µl of a sample using the ABA chiral derivatisation method, 
described in section 2.5.1.2d. Results are presented in Figure 52.  
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Figure 52 Comparison between the two-phase systems 14/14 PEG1000/potassium phosphate (native 
enzyme) and 14/14 PEG3350/potassium phosphate (PEGylated enzyme) performed by HPLC 
measuring converted D-ABA.  
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Unfortunately, the results showed that both the enzyme activity and stability are 
better in 14/14% w/w PEG3350/potassium phosphate. In 14/14 % w/w 
PEG1000/potassium phosphate the enzyme was less active and less stable. However, 
despite the slightly lower activity it was decided to do a CCC-bioreactor with 
PEG1000/potassium phosphate and the native enzyme as a comparison to the 
previous bioreactor run using PEG3350/potassium phosphate and the PEGylated 
enzyme.  
 
3.3.7. Conclusions on ATPS as solvent system for the CCC-
bioreactor 
Experiments presented in sections 3.3.4.6 and 3.3.5.3 show the potential of both 
phase systems to be applied for the CCC-bioreactor. Both phases were tested in the 
same conditions. The bioconversion of D-ABA was the same for both phases (22.8%, 
with PEG3350; 3.3.4.6 and 22.6% with PEG1000; 3.3.5.3).  
Due to a favourable partitioning of the enzyme, the main advantage of using 
14/14% w/w PEG1000/potassium phosphate over the alternative 14/14% 
PEG3350/potassium phosphate is that this phase system does not require the use of 
the PEGylated enzyme. Therefore, because of the simplicity and the fact that 
PEGylating of the enzyme might cause an extra variable, affecting reproducibility of 
other experiments, the second solvent system, 14/14% w/w PEG1000/ potassium 
phosphate, was selected for optimising the CCC-bioreactor, which is presented in 
chapter 4.  
Before then, the potential for using a completely different, non-ATPS  phase 
system was studied. Aqueous-organic systems are studied in section 3.4 and aqueous-
ionic liquid systems in section 3.5. 
CHAPTER 3 – Development and Optimisation of a Phase System for the CCC-Bioreactor 
 
 123 
 
3.4. Aqueous-organic systems as solvent systems for the CCC-
bioreactor 
3.4.1. Introduction 
It has been assumed that the best solvent system suitable for the CCC-bioreactor 
was an aqueous two-phase system (ATPS). However, using this type of system caused 
challenges, such as problems with enzyme stability and distribution ratio, product and 
substrate analysis. Moreover ATPS can be very viscous and cause problems with the 
pumping system and the viscosity also results in poor stationary phase retention, 
requiring the use of a wide bore CCC coil. Also, poor mixing of the phases is 
suspected due to the high viscosity of the PEG and this results in slow mass transfer 
of molecules between the phases.  
To overcome all, or at least some, of these problems, the possibility of using 
organic solvents was tested. There would be a lot of advantages of using organic 
systems. Organic solvents are easy to make, cheaper and more suitable for CCC 
because of their low viscosity. The product can be easily isolated from a fraction by 
evaporating the solvent. Moreover, separations of compounds and the behaviour of 
aqueous-organic phase systems in CCC has been far better studied than with ATPS.  
The deciding factor in using organic solvents in a CCC-bioreactor is enzyme 
activity and stability. For the vast majority of enzymes, an aqueous environment is the 
most natural and they demonstrate the highest activity there. However the literature 
shows numerous enzymatic reactions performed in even a totally anhydrous 
environment157,158,159.  
 
This section investigates the testing of D-amino acid oxidase (DAAO) activity in 
36 aqueous-organic two-phase systems. 
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3.4.2. Experimental 
Materials 
Enzyme D-amino acid oxidase (DAAO) was received from Ingenza. The received 
crude material was centrifuged on the Micro Centaur centrifuge at 10,000 rpm for 
5min. For all subsequent analysis, the enzyme supernatant was taken. 
The activity of D-amino acid oxidase was tested in 36 organic solvents systems 
developed by Dr Ian Garrard for the collaborative project on “Anti-angiogenic 
activities of the volatile oil of Angelica sinensis”160. These 36 systems represented a 
wide range of two phase organic systems commonly used for the CCC separation of 
natural compounds. All the 36 solvent system were made by means of a liquid-
handling robot (6.4.3.3), using 12 organic solvents and water. The compositions of all 
36 solvent systems are presented Table 28. 
 
Determination of enzyme activity in organic systems 
To each 5 ml test tube containing 2ml of each phase system, 10µl D/L-ABA 
(133mg/ml) water solution was added. Next the enzymatic reaction was initiated by 
adding 20µl enzyme supernatant to every test tube with a 30s interval. A rotating 
wheel provided continuous phase mixing during the reaction. The bioconversion was 
stopped after 30 min (timer) by derivatisation of the sample. Derivatised samples were 
analysed by HPLC.  
The enzyme activity was expressed as a percent of unreacted D-ABA that 
remained after the 30 minute reaction. L-ABA was used as an internal standard, the 
amount of which was assumed to be identical to the initial amount of D-ABA. 
 
Sample analysis 
50µl sample (a mixture of upper and lower phase) was derivatised with 150µl 
mixture of ortho-phthalaldehyde and N-isobutyryl-L-cysteine in 0.4M potassium 
borate buffer pH 10 and after 90s diluted to 1ml with water. As mentioned above, the 
L-ABA present in each sample was used as an internal standard. Thus it was not 
important how complete the derivatisation process was as both forms D- and L- are 
derivatised to the same degree. Also an accurate mixing of both phases before taking a 
sample does not play any important role as both forms of the amino acid are present in 
equal amounts in any given phase. 
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3.4.3. Result and Discussion 
The enzyme activity was expressed as percent of converted D-ABA after a 30 min 
reaction (Table 28). The higher the value, the higher was the enzyme activity in a 
system, as more D-ABA must have been converted. In the last column enzyme 
activity is shown using different colours. A green colour shows very high enzyme 
activity, whereas red indicates very low.  
As expected, the enzyme shows very low activity in most of the tested systems 
(red colour). The highest conversion was obtained for systems No 4 (water/ethyl 
acetate) and 27 (water/tert-butyl methyl ether). These two systems consist of water 
and a nonpolar solvent. According to Kral et al54 (2002), solvents with a log P>3, such 
as xylene (log P = 3.1) or hexane (log P = 3.9) are less deactivating than those with a 
low log P, such as ethanol (log P = -0.24). A big difference in polarity of these 
systems might keep the two phases completely separated, the lower phase consisting 
only of water whereas the upper of nonpolar organic solvent. The enzyme, being a 
naturally hydrophilic molecule, is totally distributed in the water phase, which has 
limited contact with the strongly nonpolar organic solvent (the contact is limited only 
to the interfacial area). It is interesting to note that the enzyme shows relatively high 
conversion in the totally organic environment consisting of heptane and acetonitrile 
(No. 15). However the peak areas for both D- and L-ABA are very low compared 
with the other systems. This is because of the very low solubility of ABA in organic 
solvents.  
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Heptane EtOAc MeOH Butanol Water ACN Toluene Acetic Acid Acetone tBME DCM Ethanol Propanol L-ABA D-ABA
1 0 0 0 1000 1000 0 0 0 0 0 0 0 0 513 486 5
2 0 400 0 600 1000 0 0 0 0 0 0 0 0 518 493 5
3 0 800 0 200 1000 0 0 0 0 0 0 0 0 477 453 5
4 0 1000 0 0 1000 0 0 0 0 0 0 0 0 686 192 72
5 145 855 145 0 855 0 0 0 0 0 0 0 0 620 553 11
6 250 750 250 0 750 0 0 0 0 0 0 0 0 574 552 4
7 400 600 400 0 600 0 0 0 0 0 0 0 0 572 553 3
8 545 455 545 0 455 0 0 0 0 0 0 0 0 539 522 3
9 715 285 715 0 285 0 0 0 0 0 0 0 0 647 618 5
10 835 165 835 0 165 0 0 0 0 0 0 0 0 644 621 4
11 950 50 950 0 50 0 0 0 0 0 0 0 0 588 559 5
12 1000 0 1000 0 0 0 0 0 0 0 0 0 0 676 646 4
13 1000 0 900 0 0 100 0 0 0 0 0 0 0 608 578 5
14 1000 0 600 0 0 400 0 0 0 0 0 0 0 913 874 4
15 1000 0 0 0 0 1000 0 0 0 0 0 0 0 44 17 62
16 1000 0 0 0 0 900 100 0 0 0 0 0 0 55 27 50
17 1000 0 0 0 0 600 400 0 0 0 0 0 0 122 111 9
18 0 0 0 950 950 0 0 100 0 0 0 0 0 177 157 11
19 0 0 0 900 900 0 0 200 0 0 0 0 0 64 49 24
20 800 0 560 0 240 0 0 0 0 0 400 0 0 452 426 6
21 0 0 0 400 1000 200 0 0 0 400 0 0 0 550 528 4
22 625 250 500 0 0 625 0 0 0 0 0 0 0 327 309 5
23 0 0 0 842 1052.5 0 0 0 105.5 0 0 0 0 534 515 4
24 333 333.5 0 0 333.5 0 0 0 1000 0 0 0 0 541 442 18
25 1000 0 800 0 0 0 0 0 200 0 0 0 0 571 559 2
26 0 0 0 400 1000 200 0 0 0 400 0 0 0 535 518 3
27 0 0 0 0 1000 0 0 0 0 1000 0 0 0 452 0 100
28 0 0 800 0 533.5 0 0 0 0 0 666.5 0 0 346 335 3
29 1000 0 0 0 0 800 0 0 0 0 200 0 0 260 210 19
30 750 0 0 0 625 0 0 0 0 0 0 625 0 677 653 4
31 513 513 0 0 307.5 0 0 0 0 0 0 666.5 0 574 550 4
32 0 800 0 0 800 0 0 0 0 0 0 400 0 518 498 4
33 0 500 0 800 600 0 0 0 0 0 0 100 0 474 455 4
34 0 0 0 889 889 0 0 0 0 0 0 222 0 508 484 5
35 1000 0 0 0 750 0 0 0 0 0 0 0 250 575 552 4
36 1143 0 457 0 114.5 0 0 0 0 0 0 0 285.5 778 752 3
Water 2000 550 0 100
Water 2000 568 0 100
> 50
30-50
10-29
< 10
D-ABA conversion 
[%]
System 
No.
Solvent [ul] Peak Area [mVs] D-ABA 
conversion 
[%]
 
Table 28 Conversion of D-ABA by DAAO in a range of aqueous-organic two phase systems. The table shows the composition of 36 organic two-phase systems which are 
combinations of 12 organic solvents and water. In two columns are shown peak areas of D- and L-ABA derivatised and analysed on the HPLC after 30 min bioconversion. In the last 
column percent of unreacted D-ABA is given. The conversion ratio is marked with different colours. In green are marked systems with a very high conversion ratio - less than 50% 
D-ABA stayed unconverted. Whereas, in red colour are shown systems in which the conversion was very low, more than 90% D-ABA stayed unreacted 
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The experiment was repeated for 7 solvent systems in which the D-ABA 
conversion was greater then 50% (Table 28). Results are presented in Table 29. 
 
Table 29 The composition of 7 aqueous-organic and organic-organic two phase solvent made of 9 
organic solvents and water. The volume of each solvent is given in µL. The total volume of each phase 
was 2ml. In the last column is given a conversion ratio of D-ABA after 30min. of incubation with 
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The highest conversion ratio (100%) was achieved in the system No.27, composed 
of water and tBME. Good conversions were obtained in systems No. 4 and 15, 69% 
and 56%, respectively. In contrast to the experiment presented in Table 28, this time 
in systems No. 16 and 19 the conversion ratios were only 2 and 10%, respectively. 
The reason of such a difference is unknown but it shows a lack of robustness of these 
phase systems and therefore they were rejected.  
The next tested parameter was the ABA partitioning. It was tested in the 3 solvent 
systems; 4, 15 and 27, selected based on the enzyme activity In those 3 systems, the 
D-ABA conversion was >50% as expressed in Table 29. The partitioning results are 
presented below in Table 30.  
 
L-ABA D-ABA L-ABA D-ABA L-ABA D-ABA
4 0 0 2298 2368 0.00 0.00
15 24 27 61 63 0.39 0.42
27 0 0 2270 2350 0.00 0.00
Peak area [mVs]
Distribution ratioSystem 
No. Upper phase Lower phase
 
Table 30 Distribution ratio of ABA was tested in 3 solvent systems (No4 EtOAc-water, No15 heptane-
ACN and No27 water-tBME) by HPLC.  
 
As expected ABA, which is a very polar compound, totally partitions into the 
lower, water phase in systems No 4 and 27. As previously mentioned, it is possible 
that also the enzyme stayed active in these systems only because it totally partitioned 
into the water phase, not having any contact with the water-immiscible organic phase. 
ABA was equally distributed only in the system No 15 (heptane/ACN) D=0.4. 
However the peak area is very small, which suggests poor solubility of the tested 
compound in organic solvents. A very polar ABA might have partitioned into the 
interface area or even precipitated, as both components of the system heptane and 
acetonitrile are nonpolar.  
However, the results suggest that in the aqueous-organic two-phase systems, 
where the ABA partitioned completely to the aqueous phase, one possible way to 
drive ABA from the lower-water phase to the upper-organic phase would be applying 
a third nonpolar but water miscible solvent, such as acetonitrile. This solvent, being 
miscible with both water and most organic solvents, would reduce the difference in 
polarity between an extremely polar water phase and a nonpolar organic phase. 
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Moreover acetonitrile seems to be the best choice for this third solvent as the enzyme 
was active in system No 15, composed of acetonitrile and heptane (Table 29). 
Therefore, system No 27 was modified by replacing a part of water and tBME by 
acetonitrile. The enzyme activity was determined by measuring D-ABA conversion 
ratio after 30min. Results are given in the Table 31.  
Results show that any presence of acetonitrile in the solvent system makes the 
enzyme totally inactive. A full D-ABA conversion took place only in case of the 
control (water) and system No 27 (water and tBME). Lack of any D-ABA conversion 
in the presence of acetonitrile may be explained by the fact that the solvent makes 
tBME more polar, thus more accessible to the enzyme, and therefore inactivating it.  
 
Water tBME ACN L-ABA D-ABA
27 A 1000 1000 0 364 0 100
27 B 816 816 367 709 724 0
27 C 690 690 621 714 734 0
27 D 597 597 806 578 595 0
27 E 526 526 947 514 525 0
Water 2000 0 0 611 0 100
Peak Area [mVs] D-ABA 
converted  
Solvent volume System 
No.
 
Table 31 DAAO activity in two-phase systems composed of water tBME and ACN determined by 
HPLC analysis of converted D-ABA.  
 
It should be noted that the enzyme activity was performed by determining its 
substrate conversion ratio. If the enzyme did not show any activity, this could be 
caused by its inactivation/inhibition or by the lack of available substrate which is de 
facto insoluble in organic solvents. 
 
3.4.4. Conclusions on aqueous-organic systems as solvent systems 
for the CCC-bioreactor 
Conversion of D-ABA was not possible in most of the tested organic systems. 
However, a 100% conversion was achieved in two of the tested water/organic solvents 
systems: water/heptane and water/tBME. The biggest obstacle to using a 
water/organic solvent system in the CCC-bioreactor comes from the unfavourable 
distribution ratio of the substrate and in all probability, the product of the reaction as 
well. Thus of the tested organic systems, none of them totally satisfied all the 
requirements presented in the Introduction (3.1).  
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3.5. Ionic liquids as solvent systems for the CCC-bioreactor  
3.5.1. Introduction 
Ionic liquids (IL) are salts that do not crystallise at room temperature. Most of 
them are not soluble with water, with which these form two-phase systems. Therefore 
their liquid states make them possible candidates as solvents in CCC.  
Ionic liquids have been tested for use as a main component of a solvent for CCC 
separation. Berthod and Carda-Broch161 (2004) tested a phase system based on an IL, 
1-butyl-3-methylimidazolium hexafluorophosphate [BMIM][PF6] and water as a 
phase system for CCC. The study of the partitioning of aromatic solutes between 
water and [BMIM][PF6] demonstrated the solvent capacity of IL. However, it was 
found that due to a very high viscosity of ionic liquids at room temperature, they 
cannot be used directly as a solvent system in countercurrent chromatography. 
Therefore, acetonitrile was the third component added in order to reduce the very high 
viscosity of [BMIM][PF6]. A composition of 40:20:40% w/w water-acetonitrile- 
[BMIM][PF6] was proposed as a phase system for CCC.  
There has been reported the use of an IL for protein separation in CCC162. 
[BMIM][Cl] was used instead of PEG, to make an aqueous two-phase system with 
potassium dibasic phosphate (K2HPO4). There was no separation with the system as 
all four tested proteins were totally distributed in the IL-stationary phase. This 
behaviour would be ideal for the work on the CCC-bioreactor described in this thesis, 
with the enzyme totally distributed in an IL-stationary phase, as it would eliminate the 
problem of enzyme eluting with the mobile phase. 
The activity and stability of free and immobilised D-amino acid oxidase (DAAO) 
has been tested in the presence of five alkylimidazolium based ionic liquids by Lutz-
Wahl et al in 2006163. The immobilised enzyme was most active in the presence of 
[BMIM][BP4] and [MMIM][MMPO4], which however had the undesirable property 
of being miscible with water. For the two tested, water insoluble ILs, [BMIM][Tf2N] 
and [BMIM][PF6], the activity was reduced by 50%. The authors proposed mass 
transfer limitation as the explanation of the lower velocity of the reaction in water-
insoluble ILs. However, the enzyme stability for the two water-insoluble ILs was 
relatively high (over 80% activity after 24h incubation at 30°C), compared with water 
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soluble ILs. This would be a great advantage of using IL for the CCC-bioreactor, 
considering that enzyme stability in the stationary phase is a challenge. 
In this section the results of the enzymatic conversion of D-amino butyric acid in 
two-phase systems made of eight different ionic liquids are presented. These ILs were 
provided by Northern Ireland's Queen's University Ionic Liquids Laboratories 
(QUILL) for examination for use in CCC.  
 
3.5.2. Experimental 
Materials 
Enzyme D-amino acid oxidase (DAAO) was received from Ingenza. The received 
crude material was centrifuged on the Micro Centaur centrifuge at 10,000 rpm for 
5min. For all subsequent analysis the enzyme supernatant was taken. 
 
The activity of D-amino acid oxidase (DAAO) was tested in 8 Ionic Liquids, 
obtained from QUILL:  
1. [C6, 6, 6, 14P][NTf2] 
2. [C6, 6, 6, 14P][N(CN)2] 
3. [BMIM][PF6] 
4. [BMIM][BF4] 
5. [EMIM][NTf2] 
6. [N,N,N,N-dimethyl-ethyl-methoxyethyl-ammonium][NTf2] 
7. 1-allyl-3-methlyimidazolium][NTf2] 
8. 1-methoxyethyl-3-methylimidazolium][NTf2] 
 
The enzyme activity was tested in two-phase systems made of IL and 50mM 
sodium phosphate buffer pH 7.6.  
 
Determination of enzyme activity in Ionic Liquid systems 
To each 5 ml test tube containing 1ml of IL, and 0.98 ml buffer, 20µl D/L-ABA 
(100mg/ml) water solution was added. To confirm that the presence of IL does not 
affect the ratio of L- to D-ABA peak area, both phases were mixed and after phase 
separation, 50µl of the buffer phase was derivatised and analysed on HPLC.  
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The enzymatic reaction was then initiated by adding 20µl enzyme supernatant to 
every test tube with a 30s interval. A rotating wheel provided continuous phase 
mixing during the reaction at room temperature (25°C). The bioconversion was 
stopped after 30 min (timer) by derivatisation of each sample with the mixture of 
ortho-phthalaldehyde (OPA) and N-isobutyryl-L-cysteine in 0.4M potassium borate 
buffer. Derivatised samples were analysed on HPLC. As a control, 20µl D/L ABA 
(100mg/ml) was dissolved in 0.98ml buffer. 
 
Sample analysis 
Before adding the enzyme, 50µl of buffer phase was premixed with 100µl 0.4M 
potassium borate buffer, pH 10, and next derivatised with 50µl OPA/ N-isobutyryl-L-
cysteine solution. After 90s, the samples were diluted with 800µl of water and 
analysed on HPLC using a C18 column.  
 
In order to stop the enzymatic reaction 50µl of buffer phase was mixed with OPA/ 
N-isobutyryl-L-cysteine solution premixed with 0.4M potassium borate buffer, pH 10. 
As mentioned above, the L-ABA present in each sample was used as an internal 
standard. Thus it was not important how precise the derivatisation process was as both 
forms D- and L- are derivatised to the same degree.  
 
3.5.3. Results and Discussion 
The enzyme activity was expressed as a percent of converted D-ABA after the 30 
min. reaction. L-ABA was used as an internal standard, the amount of which was 
assumed to be identical to the initial amount of D-ABA. 
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L-ABA D-ABA L-ABA D-ABA
[C6, 6, 6, 14P][NTf2] 1731 1762 -1.8 1637 1234 25 Buffer IL
[C6, 6, 6, 14P][N(CN)2] 1705 1718 -0.8 1326 0 100 IL Buffer
[BMIM][PF6] 1823 1853 -1.6 1741 588 66 Buffer IL
[BMIM][BF4] 879 878 0.2 837 726 13
[EMIM][NTf2] 1832 1864 -1.8 1727 1343 22 Buffer IL
[N,N,N,N-dimethyl-ethyl-methoxyethyl-
ammonium][NTf2] 1870 1903 -1.7 1767 901 49 Buffer IL
1-allyl-3-methlyimidazolium][NTf2] 1873 1906 -1.7 1739 674 61 Buffer IL
1-methoxyethyl-3-
methylimidazolium][NTf2] 2057 2090 -1.6 1923 354 82 Buffer IL
Control - buffer 1816 1849 -1.9 1766 0 100 - -
Upper 
phase
Lower 
phase
miscible
Ionic liquid name Peak Area [mVs] D-ABA 
conversion 
[%]
Before enzyme was added After 30min incubation with the 
enzyme
Peak Area [mVs] Ratio of D-
ABA to L-ABA 
[%]
D-ABA conversion 
[%]
> 80
60-79
30-59
< 30
 
Table 32 DAAO activity tested in two-phase systems based on ionic liquids and 50mM sodium phosphate buffer, pH 7.6. The activity was expressed as percent of D-ABA 
converted within 30 min based on the ratio of D-ABA and L-ABA analysed on HPLC. Peak area of D- and L-ABA was determined twice for each sample: before the enzyme 
was added and 30min after the enzyme addition.  
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[BMIM][BF4] made a single phase with the buffer. All the other ILs were 
immiscible with water, making two-phase systems. Apart from [C6, 6, 6, 14P] 
[N(CN)2] which was the main component of the upper phase, the rest of the water 
immiscible ILs formed the lower phase of a system.  
Before adding the enzyme, the ratio of area for both chiral forms of ABA was 
closely similar for all the tested IL (Column IV, Table 32). Within the error of HPLC 
integration, the presence of IL does not affect the ratio D-ABA to L-ABA. Thus the 
enzyme activity can be expressed as the ratio of the two peaks. 
Column VII of the Table 32 shows the enzyme activity as % of D-ABA converted 
after the 30min reaction. There was some conversion in all eight tested systems. 
Enzyme was most active in [C6, 6, 6, 14P][N(CN)2], where 100% D-ABA were 
converted. The smallest activity (13% D-ABA converted) occurred for the 
[BMIM][BF4]/buffer system. As [BMIM][BF4] was totally miscible with water, it 
had a better contact with the enzyme and might have inactivated it or decreased its 
activity.  
Lutz-Wahl et al 163 have demonstrated that DAAO activity depends on the ionic 
liquid concentration. In an 20% [BMIM][BF4] solution, the DAAO showed 29% 
activity (compared to the enzyme activity in a buffer), whereas when the 
[BMIM][BF4] concentration was increased to 60%, the enzyme activity dropped to 
15%. For the experiment to generate the data in Table 32 the concentration of 
[BMIM][BF4] and all the other tested ionic liquids was 50%. According to Lutz-Wahl 
et al 163, the native DAAO showed very high activity in [MMIM][MMPO4], which is 
also a water miscible IL (129% in 40% solution), but when its concentration was 
increased to 60% the enzyme activity sharply dropped to 2%.  
The enzyme was also very active in a two-phase system made of a buffer and 
[1-methoxyethyl-3-methylimidazolium][NTf2], 82% of D-ABA was converted. A 
moderate activity was shown in [BMIM][PF6] and 1-allyl-3-methlyimidazolium] 
[NTf2]. 
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3.5.4. Conclusions on Ionic Liquid systems as solvent systems for 
the CCC-bioreactor 
There was some enzymatic conversion in the presence of all of eight ionic liquids. 
The highest D-ABA conversion ratio was found in trihexyltetradecylphosphonium N-
cyano cyanamide, [C6, 6, 6, 14P][N(CN)2] (100% conversion) and [1-methoxyethyl-
3-methylimidazolium][NTf2] (82% conversion). The lowest conversion ratio was in 
the presence of [C6, 6, 6, 14P][NTf2] and [EMIM][BNTf2], 25 and 22%, 
respectively. [BMIM][BF4] was miscible with water and therefore did not create a 
two-phase system with the buffer.  
 
ILs are solvents of a relatively high viscosity. In order to use an IL as a solvent 
system for a CCC separation, it needs to be diluted with an organic solvent, which 
reduces viscosity 161. However, organic solvent has been shown to inactivate DAAO 
(section 3.4). Therefore, despite high D-ABA conversion in the presence of some of 
them, ionic liquids did not show much promise as a solvent system suitable for the 
CCC-bioreactor and the project continued with ATPS instead.  
 
3.6. Final conclusions on identifying a solvent system for the CCC-
bioreactor 
A number of ionic liquid (IL) two-phase systems and the range of tested aqueous 
organic two-phase systems were found unsatisfactory due to the high enzyme 
instability in those systems.  
The enzyme was found to be considerably more stable in some aqueous two-phase 
systems (ATPS). Moreover these systems are far more widely described in the 
literature, making it easier to tailor the phase system to match the criteria of an ideal 
phase system for the CCC-bioreactor.  
Two aqueous two-phase systems were selected as a potential phase system for the 
CCC-bioreactor: 14/14% (w/w) PEG3350/potassium phosphate and 14/14% (w/w) 
PEG1000/potassium phosphate, both at pH 7.6. Unfavorable partitioning of the 
enzyme in the first phase system was overcome by applying the reaction of 
PEGylation of the enzyme. Although, the enzyme showed slightly better stability and 
equal activity in 14/14% (w/w) PEG3350/potassium phosphate, the 14/14% (w/w) 
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PEG1000/ potassium phosphate phase system was chosen as a solvent system for the 
CCC-bioreactor, as it had the advantage of not requiring a PEGylated enzyme.  
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4. OPTIMISATION OF THE CCC-BIOREACTOR 
 
4.1. Introduction 
In this research project, a CCC-bioreactor was developed to obtain 
enantiomerically pure L-amino butyric acid (L-ABA) from a racemic mixture of 
amino butyric acid (DL-ABA), consisting of equal amounts of D- and L- forms. As 
both enantiomers have the same physical properties, their distribution ratio (D-value) 
between a mobile and a stationary phase is the same, therefore these two forms cannot 
be separated by the standard CCC operation mode. To separate these two forms, one 
of them (the unwanted D-form) needs to be derivatised in order to change its D-value.  
If a racemic mixture of amino butyric acid (ABA) is injected onto the CCC-
bioreactor column, the enantiomeric form D-ABA is oxidised by the enzyme which is 
immobilised in the stationary phase. The other form, unreacted L-ABA being the 
target compound, is eluted unchanged from the coil. The enzyme, D-amino acid 
oxidase (DAAO), present in the stationary phase, oxidases only D-ABA, which is 
converted into its keto analogue ketobutyric acid (KBA). Since the D-value of the 
produced KBA and the unreacted L-ABA are different, the separation of these two 
compounds is possible. However to obtain pure L-ABA, the D-ABA conversion has 
to be 100%, otherwise unreacted D-ABA would elute together with L-ABA, thus 
contaminating it. 
In a series of experiments conducted in the CCC-bioreactor, the effect of different 
parameters (substrate and enzyme concentration, temperature, rotational speed, the 
mobile phase flow rate, sample loop volume) has been tested. In each experiment only 
one parameter e.g. the substrate injection amount, was varied, keeping all the other 
parameters fixed. All experiments were conduced on the J-type centrifuge called 
“Milli CCC”, designed and made in the Brunel Institute for Bioengineering. The 
volume of the coil was 45.1ml, 2.7mm bore. In all experiments, the solvent system 
was 14/14% (w/w) PEG1000/potassium phosphate. The stationary phase was the 
upper, PEG-rich phase in which the enzyme was dissolved, whereas the mobile phase 
was the lower, salt rich phase. 
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4.2. Materials and methods 
4.2.1. Materials 
Enzyme, D-amino acid oxidase (DAAO), was obtained in a frozen form from 
Ingenza Ltd, Roslin Centre, Edinburgh, UK. The defrosted liquid was centrifuged for 
15min at 10,000 g on a Sigma centrifuge (rotor 9.8cm) to remove cell debris. For the 
bioreactor experiments the supernatant was taken. 
The enzyme substrate, which is DL-amino butyric acid (DL-ABA), was obtained from 
Sigma-Aldrich (Cat. 162663). 
Polyethylene glycol (average molecular weight, Mr=1000) was obtained from 
Sigma-Aldrich (Cat. P3515). Dipotassium hydrogen orthophosphate (Cat. P5240/53) 
and potassium dihydrogen orthophosphate (Cat. P4800/53) were obtained from Fisher 
Scientific. 
 
Aqueous two-phase preparation 
For all experiments ATPS 14/14% (w/w) PEG1000/potassium phosphate (280g 
PEG1000, 58.6g potassium dihydrogen orthophosphate, 221.3g dipotassium hydrogen 
orthophosphate, and 1440 ml water) was used. Since PEG1000 exists in a solid form 
at room temperature, it was warmed up to 60°C before using, in order to melt it. Next 
all components were placed into a 2L glass bottle and shaken vigorously until the salt 
and PEG had dissolved. ATPS was left overnight to cool to room temperature. It was 
then shaken again, left to settle and both phases were separated using a separation 
funnel.  
 
4.2.2. CCC operation 
Prior to each experiment, the CCC coil was flushed with at least 500ml of water 
(over 10 coil volumes).  
In order to remove all air bubbles from the coil, the CCC was initially operated in 
a reverse, “empty”, mode at the lowest 500rpm rotational speed. The coil was flushed 
with 100ml of upper phase and then filled with 100ml of stationary phase (upper 
phase with the dissolved enzyme). With the appropriate rotational speed set up, the 
mobile phase was pumped at 2ml/min flow rate till the coil was equilibrated. Next 
after setting up the desired flow rate, a sample was injected (DL-ABA dissolved in the 
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lower phase). The entire process from filling the coil to injection took about 30 min in 
each case. Fractions eluted from CCC were collected in Eppendorf vials. 
 
4.2.3. Sample analysis 
4.2.3.1. Amino butyric acid analysis 
In order to determine the ABA conversion ratio in the CCC, every 3 min 3 drops 
of eluted mobile phase were collected. 50µl of this eluent was derivatised with 150µl 
mixture of ortho-phthalaldehyde and N-isobutyryl-L-cysteine in 0.4M potassium 
borate buffer, pH 10. After 90s the samples were diluted to 1ml with water. 
Derivatised samples then were analysed on HPLC using a C18 column (see section 
2.5.1.2b). 
 
4.2.3.2. Ketobutyric acid analysis 
If KBA analysis was being performed, 50µl was taken for the ABA analysis, as 
described above and the rest was incubated for 2 min at 100°C in order to stop the 
possible enzymatic reaction.  
Next 200µl of each fraction was mixed with 400µl 150mM potassium phosphate 
buffer, pH 8 and 400µl 0.05M phenyl hydrazine aqueous solution, in order to 
derivatise the KBA present (2.5.1.3). Derivatised samples were analysed on HPLC 
using a C18 column.  
 
4.2.4. Determination of the D-ABA conversion ratio 
Fractions were collected every 3 min starting at a point shortly before the expected 
elution of the first peak. HPLC analysis of each fraction gave the peak area of both L- 
and D-ABA. The difference between these two areas (L-D) was expressed as a 
percentage of the L-ABA peak area to give the percent conversion, since L-D is 
equivalent to the amount of D-ABA that has been converted as L-ABA is unaffected 
by the reaction. Table 33 shows an example of a table used to calculate the D-ABA 
conversion ratio eluted from CCC.  
CHAPTER 4 – Optimisation of the CCC-Bioreactor 
 
 140 
 
Peak area [mVs] Fraction 
No 
Time 
[min] L-ABA D-ABA L-D 
D-ABA 
conversion 
[%] 
1 24 0 0 0   
2 27 42 7 34 82.7 
3 30 153 43 110 71.9 
4 33 709 386 323 45.6 
5 36 1337 929 407 30.5 
6 39 1447 1069 377 26.1 
7 42 977 654 323 33.1 
8 45 412 207 204 49.6 
9 48 154 34 119 77.6 
10 51 46 2 44 95.1 
11 54 17 2 15 88.5 
12 57 0 0 0   
 
 
    
Total 
  
5293 333 1958 37.0 
 
Table 33 Analyses of D- and L-ABA to determine the % of D-ABA that converted in CCC 
 
4.3. Results and Discussion 
4.3.1. Effect of substrate injection amount on the D-ABA 
conversion ratio 
The first parameter tested was the amount of substrate injected. In seven separate 
experiments, the substrate amount injected onto the CCC column was varied from 
6.2mg to 38.1mg, each in the same injection volume of 1.72ml. All the other 
parameters were fixed (enzyme concentration in the stationary phase 2%, temperature 
20°C, rotational speed 1800rpm, flow rate 1ml/min.) 
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Figure 53 D-ABA total conversion ratio [%] as a function of the amount of DL-ABA injected [mg]. 
Enzyme concentration in the stationary phase 2%, temperature 20°C, rotational speed 1800rpm, flow 
rate 1ml/min. The mobile phase was the lower phase of 14/14% (w/w) PEG1000/potassium phosphate 
pumped from head to tail direction. The stationary phase displaced was in the range of 24-25.5ml. 
 
D-ABA conversion ratio [%] calculated from the HPLC analysis was plotted 
against the initial DL-ABA injection amount [mg] (Figure 53). The data shows a 
definite trend with an excellent fit, R2=0.993. The higher the substrate injection 
amount, the lower the D-ABA conversion ratio. According to the equation obtained 
from Figure 53, the substrate injection amount that would be converted with 100% 
yield is 5.7mg DL ABA, under these experimental conditions. 
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Figure 54 D-ABA converted [mg] against different DL ABA injection amount [mg] 
 
Figure 54 shows the amount of converted D-ABA [mg] was plotted against the 
amount of injected DL-ABA [mg].  
 
These data can also be analysed by “Lineweaver-Burk” double reciprocal plots to 
provide an apparent Km for this system of 3.07mg injected and a maximum 
conversion of 4.4mg at very high substrate concentration (Figure 55). 
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Figure 55 Effect of concentration of DL-ABA on the conversion of D-ABA by DAAO. Data from 
Figure 54 has been expressed as a double reciprocal plot (Lineweaver-Burk plot) as used in classical 
enzymology.  
 
These data indicate that the enzyme is behaving with Michealis-Menten kinetics in 
the CCC-centrifuge and provides evidence for the behaviour of the “bioreactor” 
feature of the bioreactor-separator, with respect to substrate load, being predictable. 
This indicates that the bioreaction can be modelled.  
 
4.3.2. Effect of enzyme concentration in the stationary phase on the 
D-ABA conversion ratio 
A series of six experiments was performed in which the only parameter changed 
was the enzyme supernatant concentration (0.1-4% v/v) in the stationary phase. All 
the other parameters were constant (substrate injection amount 14.9mg, temperature 
20°C, rotational speed 1800rpm, flow rate 1ml/min). In Figure 56, the D-ABA 
conversion ratio was plotted against the enzyme supernatant % in the stationary phase.  
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Figure 56 Effect of the enzyme concentration in the stationary phase [%] on the total D-ABA 
conversion ratio (substrate injection amount 14.9mg, temperature 20°C, rotational speed 1800rpm, flow 
rate 1ml/min). The mobile phase was the lower phase of 14/14% (w/w) PEG1000/potassium phosphate 
pumped from head to tail direction. The stationary phase displaced was in the range of 23-27ml. 
 
The shape of the curve is classical for an enzymatic reaction. By increasing the 
enzyme concentration in the stationary phase, the total D-ABA conversion increases, 
reaching a plateau at about 2% enzyme in the stationary phase. From that point, even 
when the enzyme concentration was doubled, the conversion ratio increased only 
slightly, from 48% (for 2% enzyme) to 52% (for 4% enzyme in the stationary phase). 
It was therefore concluded that there is no significant advantage in having the enzyme 
concentration higher than 2% (v/v). 
 
4.3.3. Effect of mobile phase flow rate on the D-ABA conversion 
ratio 
In this experiment, the only parameter changed was the mobile phase flow rate. 
All other parameters were kept constant (substrate injection amount 14.9mg, enzyme 
concentration in the stationary phase 2%, temperature 20°C, rotational speed 
1800rpm). 
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According to the chromatography process, a substrate migrates through the CCC 
coil with the mobile phase. Thus the higher the mobile phase flow rate, the shorter the 
retention time of a compound. In the case of the CCC-bioreactor, a higher flow rate 
meant both a shorter time for the substrate being in the column and less contact time 
with the enzyme.  
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Figure 57 Effect of the mobile phase flow rate on the total D-ABA conversion ratio [%]. In the graph 
total D-ABA conversion ratio was plotted against the retention time of ABA. The mobile phase was the 
lower phase of 14/14% (w/w) PEG1000/potassium phosphate pumped from head to tail direction. The 
stationary phase displaced was in the range of 24-25ml. 
 
As might be expected, it was found that the longer the time of the substrate being 
in the coil (elution time), the higher the D-ABA conversion ratio (Figure 57). The 
correlation was linear over this range of flow rates. Extrapolation indicated that 100% 
conversion for the tested DL-ABA would require 187min, achieved with a flow rate 
of 0.2 ml/min on this system.  
Berthod et al135 have reported that for the catalytic reduction of benzaldehyde to 
benzylic alcohol by sodium formate in a CCC-bioreactor, more product was obtained 
with a lower flow rate.  
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4.3.4. Effect of CCC rotational speed on the D-ABA conversion 
ratio 
Three experiments were conducted at three different rotational speeds (1000, 
1400, 1800 rpm) with all the other parameters fixed (substrate injection amount 
14.9mg, enzyme concentration in the stationary phase 0.5%, temperature 20°C, flow 
rate 1ml/min). 
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Figure 58 Effect of the CCC rotational speed on the total D-ABA conversion ratio (substrate injection 
amount 14.9mg, enzyme concentration in the stationary phase 0.5%, temperature 20°C, flow rate 
1ml/min). The mobile phase was the lower phase of 14/14% (w/w) PEG1000/potassium phosphate 
pumped from head to tail direction. The stationary phase displaced was in the range of 23.5-26.5ml. 
 
As shown by the graph, there is no major effect of rotational speed effect on the 
D-ABA conversion ratio within this rpm range. However it is known148 that rotational 
speed has an important effect on stationary phase retention. An increase in rotational 
speed increases stationary phase retention which will improve the resolution between 
the unreacted ABA and the KBA product. 
 
4.3.5. Effect of temperature on the D-ABA conversion ratio 
In five separate experiments, the only parameter varied was the temperature. Both 
the CCC coil and the mobile phase reservoir were controlled by a thermostat. The 
stationary phase was not thermostatically controlled to eliminate the effect of enzyme 
stability due to temperature before an experiment. It was assumed that after 10 min of 
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pumping the stationary phase reservoir onto the thermostated coil and a further 15min 
of coil equilibration using the thermostated mobile phase, the temperature of the 
stationary phase before injection had reached the target value. 
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Figure 59 The temperature effect on the D-ABA conversion ratio (substrate injection amount 14.9mg, 
enzyme concentration in the stationary phase 2%, rotational speed 1800rpm, flow rate 2ml/min). The 
mobile phase was the lower phase of 14/14% (w/w) PEG1000/potassium phosphate pumped from head 
to tail direction. The stationary phase displaced was in the range of 24-26ml. 
 
Figure 59 shows that, with increasing temperature above 15°C, there is a decrease 
in D-ABA conversion. This was unexpected as generally reactions including enzymes 
are faster with increasing temperature.  
Unlike the classical enzymatic reaction, the D-ABA conversion was highest (42%) 
at lower temperatures 13-15°C. The higher the temperature, the lower the conversion 
D-ABA ratio (16% at 30°C). 
According to Pollegioni et al164, DAAO from Trigonopsis variabilis is the most 
active within the temperature range of 50 to 55°C and is fully stable up to 40°C, then 
shows a decrease and inactivation at 65°C. However the activity was determined in 
the presence of a relatively weak buffer (15mM). In these CCC-bioreactor 
experiments, the concentration of PEG and salt in ATPS is much higher (14g salt and 
14g PEG per 100g ATPS), and this may be the cause of the higher activity at lower 
temperature.  
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Figure 60 The temperature effect of the ABA peak shape. Substrate injection amount 14.9mg, enzyme 
concentration in the stationary phase 2%, rotational speed 1800rpm, flow rate 2ml/min. The mobile 
phase was the lower phase of 14/14% (w/w) PEG1000/potassium phosphate pumped from head to tail 
direction. The stationary phase displaced was in the range of 24-26ml. 
 
The lower conversion at a higher temperature might also be explained by the 
temperature effect on the ABA peak shape as it elutes from the CCC-bioreactor. In 
Figure 60, the HPLC peak area of L-ABA is plotted against elution time from the 
CCC. Moreover, Table 34 shows the width of each peak [ml] at 10% of a peak height, 
measured from the baseline. There is a correlation between the temperature and the 
shape of the peak. The higher the temperature, the narrower the peak. This effect is 
well known in chromatography. It is caused by a lower viscosity of liquid phases at a 
higher temperature, which gives better mixing and thus higher efficiency.  
CHAPTER 4 – Optimisation of the CCC-Bioreactor 
 
 149 
 
Temperature 
[°C] 
Peak width 
[min] 
13 15.7 
15 13.3 
20 11.0 
22 9.1 
30 7.7 
 
Table 34 Peak width [min] measured at 10% of a peak height from the baseline. Data measured from 
peaks shown in Figure 60. 
 
Although the sharper peak is good for the separation process, it might not be 
desired for the bioconversion. The substrate migrates through the coil with the mobile 
phase as a single bolus. At any moment, the only enzyme working is that in contact 
with the small bolus of substrate. At 30°C a narrow and concentrated slug of the 
substrate passes through the coil, involving a small fraction of the enzyme within the 
whole length of the coil at any one time. The rest of the enzyme is idle. Thus at 30°C 
a very small amount of the enzyme struggles with the relatively concentrated bolus of 
the substrate. In contrast, decreasing the temperature to 15°C, the resolution of the 
ABA is poorer. The substrate passes through the coil as a broader, less concentrated 
slug, involving more enzyme. It is possibly that this effect might have caused the 
higher D-ABA conversion at lower temperatures.  
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4.3.6. Effect of injection volume on the D-ABA conversion ratio 
Four experiments were performed to determine the effect of substrate 
concentration on the conversion ratio. Using four different sample loops, the same 
amount of substrate at different concentrations was injected onto the coil. 
 
Sample loop 
volume [ml] 
% of the 
45.1ml CCC 
coil  
D/L-ABA 
injection 
amount 
[mg] 
D/L ABA 
concentration 
[mg/ml] 
D-ABA 
conversion 
ratio [%] 
0.56 1.2 8.0 14.3 60.4 
1.24 2.7 8.0 6.5 60.2 
2.48 5.5 8.0 3.2 58.4 
4.95 11.0 8.0 1.6 62.7 
 
Table 35 Effect of injection volume on the D-ABA conversion ratio. (substrate injection amount 8mg, 
enzyme concentration in the stationary phase 2%, temperature 20°C, flow rate 2ml/min, rotational 
speed 1800rpm). 
 
In the four experiments performed (Table 35), the percentage of D-ABA 
converted ranged from 58.4-62.7%. No trend between the conversion and the sample 
loop volume was observed. The small difference in conversion is assumed to be 
within experimental error. It was expected that the D-ABA conversion would increase 
when a bigger sample loop and a less concentrated sample was used, keeping the 
amount of sample injected the same. It was thought that it would be easier to convert a 
less concentrated substrate passing through the column rather than a very concentrated 
small slug of it. 
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Figure 61 L-ABA (first peak) and KBA (second peak) in fractions collected from CCC. Four 
experiments were performed each time using different volumes of sample loop (marked by different 
colours). Substrate injection amount 8mg, enzyme concentration in the stationary phase 2%, 
temperature 20°C, flow rate 2ml/min, rotational speed 1800rpm. The mobile phase was the lower phase 
of 14/14% (w/w) PEG1000/potassium phosphate pumped from head to tail direction. The stationary 
phase displaced was in the range of 25-26ml. 
 
There was no significant difference in peak shape and retention time between the 
peaks obtained from the four experiments (Figure 61). Even when the largest sample 
loop was used (4.95ml), which is nearly 11% of the column volume, the same 
resolution was obtained. However, it is known in chromatography that often a better 
resolution is obtained if a sample is injected in a smaller volume. In the current 
experiment there was no difference between sample loops from 1.2 % of the CCC coil 
volume to nearly 11%.  
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4.3.7. Enzyme degradation within the CCC instrument 
The experiment was performed to investigate the effect of physical conditions in 
the CCC on the enzyme stability. It was suspected that friction between the two 
phases or the high g-force within the instrument might be contributing to the enzyme 
inactivation. To investigate this, the enzyme activity in the stationary phase blown out 
from the CCC was compared with the activity of enzyme simultaneously incubated in 
the same phase system for the same period of time. In the second case the enzyme was 
not exposed to the physical conditions within the CCC. The experiment was 
performed at two temperatures: 20°C and 30°C. 
2ml of the enzyme supernatant was dissolved in 98ml of the upper, PEG-rich 
phase of 14/14% PEG1000/ammonium phosphate (stationary phase). Next the 
enzyme activity in the stationary phase was determined by colorimetric assay and 
expressed as the initial activity. 5ml of that phase was taken as a control and 
incubated at room temperature, measured as 22°C. The rest of the prepared stationary 
phase was used to fill the CCC column, warmed up to 20°C, the temperature at which 
the CCC is usually operated. Next the mobile phase was pumped at a flow rate of 
2ml/min while the column was rotating at 1800rpm. A proportion of stationary phase 
was displaced by the mobile phase until equilibrium had been achieved. The enzyme 
activity was determined in the stationary phase displaced as well as in the control, 
incubated at room temperature (22°C). The mobile phase was then pumped through 
the column continuously. After 2h the flow rate was stopped and all the coil content 
was blown out by compressed air. The enzyme activity was determined for the 
extruded stationary phase and also for the control (the upper phase incubated at 22°C). 
The same experiment was done at 30°C in which the temperature of the CCC coil 
was 30°C and the enzyme was incubated in the upper phase at 30°C.  
 
Since the two experiments were performed one after the other, for each one the 
control was the enzymatic activity of aqueous enzyme solutions incubated at room 
temperature (22°C). Results are presented in Table 36 and Figure 62. 
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Time 
[min]
Control 1 - enzyme 
activity in water 
(22°C)
Enzyme activity in the 
upper phase incubated 
at room temp (22°C)
Enzyme activity in the 
stationary phase from 
the CCC run at 20°C
0 0.232 0.198 0.198
50 0.196 0.131 0.113
120 0.210 0.121 0.033
0 0.006 0.004 0.004
50 0.001 0.009 0.003
120 0.003 0.002 0.001
Time 
[min]
Control 2 - enzyme 
activity in water 
(22°C)
Enzyme activity in the 
upper phase incubated 
at 30°C 
Enzyme activity in the 
stationary phase from 
the CCC run at 30°C
0 0.224 0.211 0.211
55 0.186 0.091 0.064
120 0.198 0.052 0.002
0 0.002 0.002 0.002
55 0.001 0.003 0.001
120 0.003 0.002 0.000
Activity 
[abs/min]
St. error
Enzyme activity at 20°C [abs/min]
Enzyme activity at 30°C [abs/min]
Activity 
[abs/min]
St. error
 
Table 36 Enzyme stability in the phase system from CCC by the colorimetric assay. 
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Figure 62 Enzyme stability (by the colorimetric assay) in the stationary phase of the CCC, operated at 
20°C and 30°C. 
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The activity of the enzyme in the stationary phase blown out from the CCC was 
lower than that of the control (incubated upper phase with the enzyme), at both the 
tested temperatures. There was hardly any activity (1%) in the stationary phase after 
2h when the CCC was operated at 30°C and about 17% of the initial activity when the 
CCC was operated at 20°C. Thus at the higher temperature (30°C) the enzyme seems 
to lose activity quicker both in the CCC as well as in the control.  
The conclusion that can be drawn from this experiment is that the CCC should be 
operated at 20°C rather than 30°C. The D-value of the enzyme in 14/14% 
PEG1000/ammonium phosphate ATPS determined at room temperature was 19. 
Therefore, it is not known if the lower activity in the stationary phase blown from the 
column equilibrated at 30°C was caused by the enzyme activity declining or its 
unintentional elution with the mobile phase during the CCC run as the higher 
temperature might have affected the partitioning of the enzyme. That can be 
determined by measuring enzyme protein concentration in the stationary phase.  
 
Thus in the following experiment two assays were performed. The colorimetric 
enzyme assay was used to determine the enzyme activity and Bradford assay to 
measure enzyme protein present in the stationary phase. It had previously been 
demonstrated that the upper phase of 14/14% PEG1000/ammonium phosphate does 
not interfere with the Bradford assay (2.5.4.2).  
The stationary phase was made by dissolving 2ml of enzyme supernatant in 98ml 
of the upper phase of 14/14% PEG1000/ammonium phosphate. Then both the initial 
enzyme activity (colorimetric assay) and the enzyme concentration (Bradford assay, 
section 2.5.4) were determined. After that, 2ml of the stationary phase was mixed with 
2ml of the lower phase and placed on the rotary wheel (room temperature). This was a 
control for the CCC. The rest of the stationary phase was pumped onto the column 
warmed up to 20°C. Next the mobile phase was pumped at a flow rate of 1ml/min 
while the coil was rotating at 1800rpm. After 1.5h the flow rate and the coil rotation 
were stopped and the stationary phase blown out by compressed air. The enzyme 
concentration and activity was determined again (Final). The activity in the phase 
system on the wheel (control) was also determined in the upper phase after the phases 
had settled down. In Table 37 it can be seen that in the stationary phase, blown out 
from the coil, both the enzyme concentration and its activity are lower than the initial 
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values. There was 76% of the initial enzyme concentration detected and only 27% of 
the initial activity in the stationary phase blown out from the coil, which shows a 
greater loss of the activity than enzyme concentration.  
 
Enzyme activity [abs/min] 
  
Initial SD Final (2h) SD 
Enzyme 
concentration 
[mg/ml] 
SD 
Enzyme in water 0.213 0.009 0.231 0.003 0.42 0.043 
Upper phase from 
the wheel 0.214 0.001 0.138 0.005 0.46 0.017 
Upper phase from 
the CCC 0.214 0.001 0.063 0.002 0.35 0.017 
 
Table 37 DAAO activity (colorimetric enzyme assay) and protein enzyme concentration (Bradford 
method) determined in the stationary phase. The enzyme concentration was determined at the final 2 
hour point. The measurement was performed in triplicate.  
 
Figure 63 shows the values for specific activity of the enzyme calculated as the 
ratio of enzyme activity to the protein concentration. This ratio, just after the enzyme 
was added to the upper phase, was 0.47 and dropped to 0.30 for the stationary phase 
incubated on the wheel for 2h (control). In the case of the phase blown out from the 
CCC column, the loss of enzyme activity was even bigger and the final ratio was 0.18. 
It shows that not only the ATPS but also the CCC increases the enzyme instability.  
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Figure 63 Ratio of the enzyme activity to the enzyme protein concentration for water (control), 
stationary phase before pumping onto the CCC column, stationary phase from the CCC, stationary 
phase (upper phase) from the wheel. 
 
4.3.8. Effect of oxygen addition on the D-ABA conversion ratio 
An important parameter, which may limit the D-ABA conversion, may be the 
oxygen content. DAAO, as a flavoenzyme catalyst, conducts an O2-dependent 
transformation of amino acids. Since the reaction takes places inside the CCC coil, the 
whole available oxygen must be dissolved in the solvent. This is made even more 
difficult as the salt concentration in the mobile phase is over 30% and this reduces the 
content of dissolved oxygen. 
Three experiments were performed using ATPS 14/14% (w/w) PEG1000/ 
potassium phosphate (the substrate injection amount 14.9mg, 2% enzyme in the 
stationary phase, rotational speed 1800rpm, flow rate 2ml/min, CCC temperature 
20°C). The mobile phase temperature was 6°C. The mobile phase was oxygenated by 
bubbling pure oxygen into it with a nozzle. Two control experiments were performed. 
In both cases the mobile phase (6°C and 20°C) was not oxygenated. 
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Temperature of CCC/temperature of MP D-ABA conversion [%]
20°C / 20°C 40
20°C / 6°C 41.6
20°C / 6°C oxygenated 46.5
 
Table 38 D-ABA conversion ratio [%] obtained when the oxygenated mobile phase (MP) at 6°C was 
used. For the control, two experiments with non-oxygenated mobile phase at 6°C and 20°C were 
performed. 
 
It is well known that the oxygen solubility increases as the temperature decreases. 
In the current experiment, decreasing the temperature from 20° to 6° did not improve 
the reaction yield by much. By saturating the mobile phase with oxygen, its 
concentration in solution was estimated to increase 5 fold. However the D-ABA 
conversion increased only 4% compared to the control. In conclusion, there is no 
major benefit from bubbling the mobile phase with pure oxygen.  
 
4.3.9. Effect of catalase addition on the D-ABA conversion ratio 
The catalytic activity of DAAO on D-ABA leads to KBA, ammonia and H2O2 
(hydrogen peroxide), which is a by-product of the reaction. H2O2 is a strongly 
oxidising agent, therefore it might inactivate the enzyme by oxidation of some 
sensitive residues of the protein (methionine, cysteine). Pollegioni et al110 reported 
partial inactivation of DAAO in the presence of hydrogen peroxide but at a high 
concentration of H2O2 (100 mM). The most sensitive enzyme to the presence of 
hydrogen peroxide was DAAO isolated from pork kidney, which after 2 hours 
maintained only 28% of the initial activity. DAAO from Rhodotorula gracilia and 
Trigonopsis variabilis was more stable, maintaining, respectively 60, and 80% of the 
initial activity after 2 hours.  
Catalase, which can be found in nearly all organisms exposed to oxygen, catalyses 
the decomposition of hydrogen peroxide to oxygen and water. It has been found that 
co-immobilization of DAAO with catalase eliminates much more hydrogen peroxide 
in comparison to the separate immobilization of the two enzymes165. 
Since catalase degrades H2O2, releasing free oxygen which is required for D-ABA 
conversion, the presence of catalase in the CCC-bioreactor on the yield of the reaction 
was investigated. Five experiments were performed, varying the amount of catalase 
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added to the stationary phase, while the D-ABA conversion ratio was recorded. 
Results are presented in Figure 64.  
 
Effect of catalase addition on the D-ABA conversion ratio in 
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Figure 64 Effect of catalase present in the stationary phase on the D-ABA conversion ratio. The 
concentration of catalase was varied from 0 to 150mg in 100ml of the stationary phase. All other 
parameters were fixed (substrate injection amount 14.8mg, enzyme concentration in the stationary 
phase 2%, rotational speed 1800rpm, flow rate 1ml/min, temperature 22°). The mobile phase was the 
lower phase of 14/14% (w/w) PEG1000/potassium phosphate pumped from head to tail direction. The 
stationary phase displaced was in the range of 23-24ml. 
 
The conclusion was that the addition of catalase to the stationary phase did not 
seem to affect the D-ABA conversion ratio (Figure 64). The achieved D-ABA 
conversion ratio was between 44 and 46.9% with the highest of these values at 0ml 
catalase added, therefore no advantage was seen with the use of catalase and the CCC-
bioreactor was subsequently operated without its addition.  
 
4.3.10. Repetitive substrate injection 
It was clearly a big advantage to the technique if repetitive injections were 
possible. That would allow use of the same phase system and enzyme several times. 
To test this possibility, equal amounts of substrate were injected 4 times into the 
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column every 20 min. Fractions of the mobile phase coming from CCC were analysed 
for ABA to determine the total D-ABA conversion ratio for each CCC injection. The 
results are presented in Figure 65.  
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Figure 65 Conversion ratio obtained for the repetitive DL-ABA injection. The same amount of DL-
ABA (9.5mg) was injected every 20 min. (enzyme concentration in the stationary phase 2%, rotational 
speed 1800rpm, flow rate 2ml/min, temperature 20°C). The time was started when the enzyme was 
added to the stationary phase.  
 
The D-ABA conversion ratio was highest for the first injection (56%). Then the 
conversion ratio gradually decreased, reaching 30% for the last injection.  
The target, which is pure L-ABA, can only be achieved if 100% D-ABA is 
converted within the CCC. From Figure 65, the conversion achieved for each 
injection was lower than the previous injection. A 100% conversion may be possible 
for the first injection by optimising the run parameters but seems unlikely to be 
achieved for the second injection. Therefore, only one injection is possible. Even a 
small amount of unconverted D-ABA appearing during next injection would 
contaminate the product.  
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4.4. Conclusion 
Experiments presented in this chapter established the effect of various parameters 
such as substrate and enzyme concentration, temperature, rotational speed, the mobile 
phase flow rate, sample loop volume, mobile phase oxygenation and the presence of 
catalase, on the D-ABA conversion ratio in the CCC-bioreactor.  
The bioconversion of D-ABA depends most on the substrate injection amount and 
the mobile phase flow rate. In order to achieve a high conversion, a relatively small 
amount of the substrate at a low mobile phase flow rate needs to be injected. Other 
important parameters are the concentration of enzyme in the stationary phase and the 
temperature of the coil. The enzyme protein concentration at the received activity in 
the stationary phase should be around 0.4mg/ml. The optimal temperature is 20°C. 
The bioconversion of D-ABA was not dependent on the rotational speed of the CCC 
coil. Neither the presence of catalase nor the sample loop volume had any effect on 
the analysed process within the parameter ranges tested.  
Table 39 shows the optimal conditions of the CCC-bioreactor which are likely to 
produce 100% D-ABA conversion.  
 
Parameter Value 
Substrate injection amount 8.0mg 
Enzyme concentration 2% [v/v] 
Mobile phase flow rate 0.5ml/min 
CCC rotational speed 1800rpm 
Temperature 20°C 
Injection volume 1.72ml 
Oxygen addition None 
Catalase addition None 
Injection repeats No repeats 
 
Table 39 Operational conditions of the CCC-bioreactor to achieve 100% conversion of D-ABA. 
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5. BIOCONVERSION AND SEPARATION IN 
COUNTERCURRENT CHROMATOGRAPHY 
 
5.1. Introduction 
In this chapter, the successfully performed CCC-bioreactor is described (5.3.3). 
By selecting the solvent system indicated in chapter 3 and the operating conditions 
optimised in Chapter 4, L-ABA of 99% enantiomeric purity was achieved in a single 
step totally separated from KBA. To achieve a total L-ABA and KBA separation, a 
Multiple Dual-Mode was applied. 
 
The CCC can be operated in two modes, either in Single Flow Mode (5.2) or 
Multiple Dual-Mode (5.3). Single Flow Mode is the standard mode, when the 
direction of the mobile phase is the same during the whole separation. In this case, the 
mobile phase was the lower salt-rich phase pumped from the head to the tail of the 
column. 
Since both the mobile phase as well as the stationary phase are liquids, the flow 
direction and the pumped phase can be altered at any time so that the mobile phase 
becomes the stationary and vice versa. This is called the Multiple Dual-Mode 
(MDM)166.  
 
5.2. Bioconversion and separation using single flow mode 
In this mode the column was initially filled with a stationary, upper phase where 
the enzyme was partitioned and the lower phase was pumped as the mobile phase. 
These experiments were performed on Milli CCC (2.2.1). The coil was rotated at 
1800rpm in a clockwise direction. The mobile, salt-rich phase was pumped from head 
to tail direction at a flow rate of 0.5ml/min.  
 
5.2.1. Separation of ABA and KBA in CCC 
Before performing the CCC-bioreactor, the resolution of ABA and KBA was 
tested in the system. The upper, PEG-rich phase was used as the stationary phase. 
There was no enzyme in the stationary phase as only a separation was performed.  
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To predict the elution time and a shape of KBA, the theoretical model design by 
Joost de Folter and Ian Sutherland 167 was used. The program can predict an elution 
time and shape of a peak based on a D-value of a compound, the mobile phase flow 
rate, stationary phase retention and a number of mixing and settling zones during a 
separation. For the D-values of ABA and KBA, a clear separation was predicted. 
Results are presented in Figure 66.  
 
 
Figure 66 Theoretical model generated by the program CCC2 made by Joost de Folter and Ian 
Sutherland at Brunel Institute for Bioengineering, Brunel University. The program can be used to 
predict the shape and elution time of peaks on the basis of their D-value, as well as the mobile phase 
flow rate and stationary phase retention.  
 
 
This was confirmed experimentally. A mixture of DL-ABA (8.1mg) and KBA 
(4.4mg) was injected onto the equilibrated column. Fractions of the mobile phase 
eluting from CCC were collected every 3min and analysed for ABA and KBA. A 
reconstructed chromatogram, based on the HPLC analysis, is presented in Figure 67 
which agrees with the theoretical profile of Figure 66. 
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The two injected components were almost completely separated. The resolution 
factor is 1.03. There is a strong similarity between the chromatogram from the 
obtained experimental data (Figure 67) and the chromatogram from the theoretical 
model (Figure 66).  
Since the separation of ABA and KBA at the chosen conditions was possible, the 
next step would be performing the CCC-bioreactor with the enzyme present in the 
stationary phase, so the separation would become that of the unreacted L-ABA with 
KBA formed within the coil. 
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Figure 67 Resolution of ABA and KBA in the Milli CCC. The phase system used was 14/14% (w/w) 
PEG1000/potassium phosphate. The PEG-rich phase was used as the stationary phase. The flow rate of 
the mobile, salt-rich, phase pumped in the head to tail direction, was 0.5ml/min. The coil (45ml) was 
rotated clockwise at 1800rpm. The temperature was 20°C. The stationary phase displaced was 24ml. 
 
5.2.2. Performing the CCC bioreactor-separator 
As mentioned before, in order to get a satisfactory L-ABA separation from its 
racemic mixture, 100% conversion of D-ABA has to be achieved. Otherwise 
unreacted D-ABA co-eluting with L-ABA would contaminate the product. 
Therefore the best conditions (Table 39) for achieving 100% D-ABA conversion were 
selected based on studies presented in Chapter 4. Thus a relatively small amount of 
DL-ABA (8mg) was injected onto the CCC. In order to extend the reaction time, the 
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conversion was performed at a low flow rate (0.5 ml/min). The solvent system was 
ATPS 14/14% (w/w) PEG1000/potassium phosphate. No extra oxygen or catalase 
was used. 2ml of the enzyme, DAAO, was mixed with 98ml of the upper phase. The 
experiment was conducted at 20°C at 1800 rpm rotational speed. Fractions taken 
during the experiment were analysed for both ABA and KBA. Results are shown in 
Figure 68 and Figure 69. 
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Figure 68 Peak area of L-ABA for fractions taken from the CCC. The dark blue line shows the D-ABA 
conversion for each fraction. 
 
The retention time for ABA was 78min. Within that time, all injected D-ABA was 
converted into KBA. Every fraction consisted of only the L-form of ABA (Figure 68 
and Figure 69). The dark blue line in Figure 68 shows that 100% conversion of D-
ABA was achieved for all fractions.  
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Figure 69 Bioconversion and separation in CCC - single flow mode. Chromatogram reconstructed 
based on HPLC analysed fractions eluted from CCC. Unreacted L-ABA (blue line) and produced KBA 
(red line) eluted from the CCC after the bioconversion. 2ml of the enzyme supernatant was mixed with 
98ml of the upper, stationary phase of 14/14% (w/w) PEG1000/potassium phosphate. Substrate 
injection amount 8mg, temperature of the coil 20°C, rotational speed 1800rpm. The mobile phase was 
the lower phase pumped from head to tail direction at the flow rate of 0.5ml/min. The stationary phase 
displaced was 25ml. Resolution factor between the peaks was 0.35.  
 
From the CCC, two peaks eluted, unreacted L-ABA (blue line) and produced 
KBA (red line, Figure 69). L-ABA eluted after 78min, whereas the retention time for 
produced KBA was 114-120 min. As mentioned before, all the D-ABA was converted 
to KBA. Thus there was no D-ABA in any fractions. There is a visible separation of 
unreacted L-ABA and produced KBA. However each fraction of L-ABA was 
contaminated with a certain amount of produced KBA.  
In Figure 69 the retention time of KBA is about 120min. That is different from the 
time predicted (145min) using the CCC2 program (Figure 66) and confirmed 
experimentally (Figure 67). It needs to be noted that, as shown in Figure 67, the KBA 
was injected on the column and passed its whole length before eluting, whereas in 
Figure 69 DL-ABA was injected and KBA produced inside the column. Since D-
ABA was gradually converted as it was travelling within the coil, KBA was produced 
in various parts of the coil. The KBA produced in a further part of the coil had a 
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smaller distance to travel and therefore eluted earlier than expected from the CCC2 
program.  
Moreover, in Figure 69, KBA shows a tailing effect. That can also be explained 
by the fact that KBA was produced in different parts of the CCC coil, therefore the 
peak is not symmetric.  
 
Figure 68 and Figure 69 demonstrate that CCC can be used as a simultaneous 
bioreactor and separator. It was possible to partially isolate the desired L-ABA from 
the racemic mixture using the CCC-bioreactor. As a bioreactor, it can be optimised 
towards a high D-ABA conversion ratio by selecting optimal operational parameters. 
The most critical parameters are the substrate injection amount and the mobile phase 
flow rate, which determines the reaction time. As demonstrated, it is possible to 
achieve 100% conversion. However the separation needs to be improved.  
 
5.2.3. Centrifugal Partition Chromatography (CPC) 
Despite 100% D-ABA conversion being achieved, the separation in CCC was not 
satisfactory as L-ABA coeluted with KBA (Figure 69). Since the cascade phase 
mixing in CPC is far more efficient than the wave mixing that is characteristic for 
CCC, the CPC (1.3.4.2) was examined as a bioreactor-separator for the comparative 
purposes. The following experiments were performed on a CPC centrifuge purchased 
from Armen Instrument (2.3).  
 
5.2.3.1. Separation using CPC 
Before performing the CPC-bioreactor, the ability of CPC to separate of ABA and 
KBA was tested. There was no enzyme in the stationary phase as the CPC was used 
only as a separator. The phase system used was 14/14% PEG1000/potassium 
phosphate. The stationary phase was the upper, PEG-rich phase. The coil was rotated 
at 2000rpm. The mobile, salt-rich phase was pumped from direction at flow rate 
5ml/min in descending mode. 
On the equilibrated column, a mixture of ABA and KBA dissolved in the lower 
phase was injected. Fractions were collected every 5 min and analysed on HPLC for 
ABA and KBA. The reconstructed chromatogram is presented in Figure 70.  
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Figure 70 Resolution of ABA and KBA in CPC. The phase system was 14/14% PEG1000/potassium 
phosphate. DL-ABA (87mg) and KBA (43.5mg) were injected on the equilibrated column. The 
stationary phase displaced was 135ml. The mobile phase was the lower phase pumped at 5ml/min in 
descending mode. The coil was rotating at 2000rpm. CPC was operated at room temperature (20°).  
 
There is a large separation between the peaks. The resolution factor is 4.29, 4 
times greater then the Milli CCC (5.2.1).  
 
5.2.3.2. Bioconversion and separation using CPC 
Having achieved a better resolution of ABA and KBA in CPC (5.2.3.1) than in 
CCC (5.2.1), two experiments were done when both CPC and CCC were used as 
bioreactors in order to compare the two instruments. The D-ABA conversion ratio, as 
well as the resolution between L-ABA and KBA, were compared for the two 
machines. It has to be noted that the CPC (429ml) coil volume is 9.5 times bigger than 
the CCC “Milli”; (45ml) coil. To get comparable results, the substrate injection 
amount and the flow rate were scaled up 9.5 and 10 times, respectively (Table 40). 
The substrate injection amount per coil volume was the same for both CCC and CPC 
(0.4mg DL-ABA per 1ml of a coil). Since all parameters, such as the enzyme 
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concentration, were either maintained or scaled up according to the coil size (substrate 
injection amount, flow rate) a difference in obtained D-ABA conversion is believed to 
be caused primarily by the different method of mixing in the two coils, not by the 
difference in their size, although it has to be noted that the scale-up of the CCC-
bioreactor has not yet been proven. 
 
 
CCC CPC 
Scale 
factor 
Coil volume [ml] 45 429 9.5 
Sample loop volume [ml] 1.75 23.8 13.6 
D/L-ABA amount [mg] 17.4 166.3 9.5 
D/L-ABA / coil volume [mg/ml] 0.4 0.4 0 
Enzyme in the stationary phase [v/v] 2/100 10/50 0 
Flow rate [ml/min] 0.5 5.0 10 
Rotational speed  1800 2000 n/a 
Temperature 20°C 20°C n/a 
D-ABA conversion [%] 56 12  
Table 40 Parameters of the coil size, injection amount and flow rate used for the comparison between 
the CCC and CPC. In the last row there are conversion ratios of D-ABA obtained in the CCC-
bioreactor and CPC-bioreactor. 
 
It also needs to be noted that, compared to the previous example of a successful 
bioconversion (5.2), this time a larger substrate amount was used. Based on Figure 53 
(section 4.3.1), by increasing the substrate injection amount in CCC from 8mg to 
17.4mg the total D-ABA conversion ratio should have reduced to about 50%. If the 
previously injected substrate amount guaranteeing 100% conversion was applied, it 
would not be easy to determine how much better is the conversion ratio in the CPC, as 
the conversion ratio in both cases would be 100%. So the conditions were deliberately 
chosen to give approximately 50% conversion ratio.  
 
Analysis of the result showed that the D-ABA conversion ratio achieved in the 
CCC was 56%. The D-ABA conversion in CPC was only 12%, much poorer than the 
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conversion in CCC. In Figure 71, chromatograms obtained for the two experiments 
are overlaid.  
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Figure 71 Comparison between ABA and produced KBA in the CCC and CPC in bioreactor-separator 
mode.  
 
The difference between L-ABA peak shape eluting from CCC and CPC is 
noticeable. The peak for L-ABA which elutes from the CPC is more than twice higher 
and much narrower than the peak obtained for CCC. That is presumably caused by the 
more effective mixing characteristic for CPC. However as mentioned before (section 
4.3.5; Figure 60), this might not be desired for the bioconversion. In CPC, D-ABA 
travels through the column as a narrow and very concentrated band contacting only a 
small amount of the enzyme. Even if the enzyme was distributed equally in the whole 
coil, only a small portion, that which was in contact with the substrate, was working. 
In the case of CCC, the substrate was migrating through a coil as a broader, less 
concentrated band involving more enzyme. Thus relatively more ABA could be 
converted in CCC.  
Due to the low D-ABA conversion achieved in CPC, the technique does not seem 
to be a suitable tool for the reactor-separator.  
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5.3. Bioconversion and separation using Multiple Dual-Mode (MDM) 
Although applying the standard CCC mode to the bioreactor allowed D-ABA to 
be totally converted, the resolution between L-ABA and KBA was not satisfactory 
(Figure 69). Furthermore, the conversion of D-ABA in CPC was not complete (Figure 
71). Resolution (RS) in CCC increases with the length of the coil (L); LRα . Thus 
one approach to improve the resolution in the CCC would be to increase the length of 
the CCC coil. To obtain a complete resolution (RS=1.25) under the condition shown in 
Figure 69, it was calculated that the coil length would need to be increased from 8 to 
100m. This would be impossible to wind on the small bobbin of the Milli CCC. An 
alternative way to increase the effective length of a coil was applying a Multi Dual –
Mode of operation.  
Both the mobile and the stationary phases in CCC are liquid, therefore it is 
possible to reverse the elution mode, such that the initial mobile phase becomes the 
stationary phase and vice versa as shown in Figure 72. This allows the column length 
to be effectively increased, improving the resolution on the same instrument. This is 
called Multiple Dual-Mode and can be performed on a standard Milli CCC.  
 
Head
Head
Tail
Tail
1)
2)
 
 
Figure 72 Multi Dual-Mode. Both the mobile phase as well as the flow direction are altered when one 
of separated compounds is about to elute.  
 
5.3.1. Retention studies done on Milli CCC using the ATPS 
14/14% PEG1000/potassium phosphate 
Prior to using the Milli CCC in Multiple Dual-Mode, retention studies were 
performed using the ATPS 14/14% PEG1000/potassium phosphate. That was done to 
obtain a better understanding of the behaviour of this system in CCC. Three 
parameters were varied: the stationary phase (upper and lower phase), direction of coil 
CHAPTER 5 – Bioconversion and separation in Countercurrent Chromatography 
 
 171 
rotation (clockwise or counter clockwise) and flow direction (head to tail or tail to 
head), which in total makes eight combinations.  
Figure 73 shows the volume of stationary phase displaced plotted against the 
square root of the flow rate for each of the tested possibilities. The less stationary 
phase displaced, the more the stationary phase in the coil which means better 
resolution between peaks.  
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Figure 73 Retention studies of ATPS made of 14/14% PEG1000 and potassium phosphate tested in 
“Milli” CCC, 45.1ml coil volume, 2.7mm bore. The coil was first filled with a phase. The coil was 
rotated at 1800rpm and the mobile phase was pumped through at a low flow rate till equilibrium was 
achieved, which meant that no more stationary phase eluted from the coil. The volume of the stationary 
phase displaced was recorded. The flow rate was increased and the volume of further stationary phase 
displaced was recorded. 
 
The PEG-rich upper phase, where the enzyme partitions, has to be used as the 
initial stationary phase which makes the lower, salt-rich phase the mobile phase. 
Based on the results presented in Figure 73, either pumping the lower phase from 
head to tail with the coil rotating in a clockwise direction, or from tail to head in the 
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counter clockwise direction, guarantees good stationary phase retention. Although 
there was little SP displaced when the MP was pumped from tail to head with the coil 
rotating in clockwise direction, the system was sensitive to changes in mobile phase 
flow rate. A slight increase in flow rate resulted in a greater volume of SP displaced 
compared to the two previously described conditions.  
Out of the two highlighted conditions from Figure 73, pumping the lower phase 
from head to tail with the coil rotating in a clockwise direction was not applied. This 
is because after switching the flow mode in MDM, the stationary phase would not 
have retained in the coil when the upper mobile phase is pumped from tail to head. 
Therefore, the Multiple Dual-Mode operating conditions selected were: the coil 
rotated in a counter clockwise direction, the initial mobile phase as the lower phase 
pumped from tail to head, to be altered to the upper phase pumped from head to tail 
direction. 
 
5.3.2. Separation of ABA and KBA in Multiple Dual-Mode 
Before performing the CCC-bioreactor in Multiple Dual-Mode, first the resolution 
of ABA and KBA under these conditions was tested. The mixture of ABA and KBA 
was injected with the mobile, lower phase. Then, when ABA was about to elute, both 
the mobile phase and the flow direction were altered so the upper phase became the 
mobile phase. That mode was held for 40min at which time the conditions were 
returned the initial conditions, so again the lower phase was the mobile phase. 
Fractions were collected every 4min and analysed on HPLC for ABA and KBA.  
The solvent system used was an aqueous two-phase system: 14/14% PEG1000/ 
potassium phosphate, the stationary phase was the upper, PEG-rich phase. The 
mixture of DL-ABA (8.15mg) and KBA (4.23mg) was injected with the mobile 
(lower, salt rich) phase, pumped at 0.5ml/min in tail to head direction. After 45min, 
when ABA was about to elute, both the mobile phase and the flow direction were 
altered and for the next 40min the upper PEG rich phase was pumped as the mobile 
phase from head to tail. After that time the operating mode was brought to the initial 
conditions so that the mobile phase was the lower, salt rich phase. All that time the 
coil was rotating in a counter clockwise direction at 1800rpm. The temperature of the 
coil was 20°C. A reconstructed chromatogram is presented in Figure 74. 
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Figure 74 Separation of ABA and KBA in Multiple Dual-Mode. The chromatogram was reconstructed 
based on HPLC analysed fractions eluted from CCC. 
 
ABA and KBA are totally separated with the resolution factor of 1.59. This is 
higher than 1.03, obtained for the standard Single Flow-Mode used on the same 
machine (5.2.1). Thus, applying MDM to the 8m coil allowed separation of the two 
peaks with a resolution which, in Single Flow Mode, would have required a 19m long 
coil. 
 
5.3.3. Performing the CCC bioconversion in Multiple-Mode 
Having achieved a successful separation in Multiple Dual-Mode, the next step was 
performing a CCC-bioreactor in this mode. The coil was initially filled with the 
stationary phase, which was the upper, PEG-rich phase with the enzyme (2ml enzyme 
supernatant in 100ml of the stationary phase). Then the mobile phase which initially 
was the lower, salt-rich phase was pumped in the tail to head direction through the 
coil rotating at 1800rpm in a counter clockwise direction. The flow rate was 
0.5ml/min. The substrate DL-ABA was injected in the amount of 7.98mg with the 
mobile phase. When ABA was about to elute (45min), both the mobile phase and the 
flow direction were altered. Thus the upper phase was pumped the from head to tail 
direction for the next 40min, after which the flow mode was brought back to the 
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initial conditions. Fractions taken every 3min were analysed on HPLC for ABA and 
KBA.  
An aqueous two-phase system, 14/14% PEG1000/potassium phosphate, was used 
as the solvent system. The temperature was 20°C. A reconstructed chromatogram 
based on the HPLC analysis is presented in Figure 75. 
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Figure 75 Bioconversion and separation in CCC – Multiple Dual-Mode Chromatogram reconstructed 
based on HPLC analysed fractions eluted from CCC. 
 
There was a total conversion of D-ABA: there was no D-ABA present in any of 
the fractions. L-ABA is also totally separated from the KBA (Figure 75), which was 
produced inside the column. Thus total conversion and total separation has been 
achieved and a successful, working CCC-bioreactor/separator has been created.  
 
5.4. Comparison between three different bioreactor modes 
In Table 41 the three ways of isolating L-ABA using CCC are compared. In the 
first column “Conversion and separation” the bioreaction was performed in a test tube 
and only the separation of the reaction mixture performed by CCC. The experimental 
conditions were as follows: to 46.6mg DL-ABA dissolved in 10ml ATPS (14/14% 
PEG1000/potassium phosphate) was added 200µL of the enzyme. The reaction was 
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carried out for 5h till the deracemisation was completed (confirmed on HPLC). The 
ability of CCC to separate ABA and KBA had been already demonstrated (Figure 67).  
The last two columns of Table 41 refer to the CCC-bioreactor performed in Single 
Flow Mode (5.2) and Multiple Dual-Mode (5.3.3).  
As can be seen in Table 41, key parameters such as the enzyme concentration in 
the stationary phase, substrate injection amount, flow rate, the phase system and 
temperature were the same. What differs for these experiments is the separation time, 
the enzyme consumption and the achieved resolution between ABA and KBA. The 
poorest resolution (0.35) was obtained when the CCC-bioreactor was performed in 
Single Flow Mode. Complete separation was achieved when the CCC-bioreactor was 
performed in the Multiple Dual-Mode and when the test tube reaction mixture was 
simply separated on the CCC. In the first case, the enzyme consumption was 
relatively high: 1.4ml of the enzyme supernatant was used. This technique requires 
more enzyme than the Single Flow Mode (1ml) as during the reverse phase mode the 
upper phase with the enzyme was pumped as the mobile phase. Much less enzyme 
was needed to convert the same amount of D-ABA in a test tube. Only 35µl of the 
enzyme would have been used to convert 4mg of D-ABA in a volume of 1.72ml, 
which was the volume of the CCC sample loop. Armstrong et al140 have reported that 
much lower enzyme consumption was achieved by performing the reaction in an 
external chamber, rather than in CPC where the enzyme was distributed in the whole 
column volume. 
However, performing the reaction and separation in a single step, with Multiple 
Dual-Mode, took 300min, whereas the separate conversion and purification required 
300min to complete the deracemisation and another 250min for the CCC separation, 
which in total makes 550min, nearly twice as long. 
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Conversion and 
separation
CCC-bioreactor 
Single Flow 
Mode
CCC-bioreactor 
Dual Flow Mode
Bioconversion 300
Separation 250
Total time 550 250 300
200/10ml 1000/50ml 1400/70ml
50 250 350
0.275 0.295 0.294
0.0466 0.0465 0.0464
1.72 1.72 1.72
8 8 8
1800 1800 1800
Counter 
clockwise Clockwise
Counter 
clockwise
0.5 0.5 0.5
22 22 22
100 100 100
1.05 0.35 0.97
Solvent system
Time [min]
250
ATPS 14/14 PEG1000/ potassium phosphate
D/L ABA injecion amount [mg]
Enzyme used for the reaction [µl] / 
stationary phase volume [ml]
CCC temperature [°C]
Flow rate [ml/min]
300
Injection volume [ml]
Enzyme activity by the colorymetric 
assay (dilution 1:100) [abs/min]
D-ABA conversion ratio [%]
Resolution between ABA and KBA
Rotational direction 
Rotational speed [rpm] 
D/L ABA in 10ml of ATPS [g]
enzyme used per mg of product 
produced [µl]
 
Table 41 Parameters for the three experiments where pure L-ABA was isolated: CCC-bioreactor 
performed in a Single Flow Mode, CCC-bioreactor performed at the Multiple Dual-Mode, the reaction 
mixture after completed deracemisation separated on the CCC.  
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5.5. Conclusion  
This chapter presents the first successfully created, optimised CCC-bioreactor 
using a model process of isolating enantiopure L-ABA from the racemic mixture of 
ABA.  
Although in the literature140,138,139,141,142 there are examples of applying 
countercurrent chromatography as a bioreactor/separator, none were discovered which 
would perform a total bioconversion of an injected substrate by the enzyme 
immobilised in the stationary phase, as well as a complete separation of the products 
created in the column.  
By selecting the conditions optimized in Chapter 5, L-ABA of 99% enantiomeric 
activity was achieved totally separated from KBA. To obtain a total separation of 
unaltered L-ABA from the KBA produced in the coil, Multiple Dual-Flow mode was 
applied.  
In spite of more effective mixing, the hydrostatic CCC (CPC) was found to be a 
less effective tool as a CCC-bioreactor (6.2.2.2.).  
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6. ENZYME IN WHOLE CELLS 
 
6.1. Introduction 
In spite of the successfully performed CCC-bioreactor, with L-ABA totally 
isolated from D-ABA (5.3.3.), the enzyme instability made using it in a continuous 
mode impossible. In fact, even performing a second injection of the substrate would 
result in a decline in purity (4.3.10.). 
It was considered that by using the enzyme in whole cells of E. coli, the enzyme’s 
stability during the bioconversion might be improved considerably. Therefore, it was 
investigated if the enzyme in whole cells can be applied to the CCC-bioreactor.  
E. coli cells were used to express the enzyme, DAAO. In the previous sections of 
this thesis, the free enzyme (2.4.2.1.) was isolated from cells by mechanical disruption 
and used for the CCC-bioreactor. Since the E. coli membrane is permeable to ABA 
and KBA, it is possible to perform a bioconversion using whole cells instead of the 
free, isolated enzyme. In this case, the substrate (D-ABA) migrates through the 
membrane to the cytoplasm to be converted there to KBA. Since the enzyme is 
encapsulated in whole cells, it is separated from the reaction medium. This reduces 
the inactivation of the enzyme and might improve its stability in the phase system 
used for the CCC-bioreactor.  
Moreover, that opens up the possibility of application of a wide rage of aqueous-
organic two-phase systems, which are the most widely used phase systems for CCC 
but known to inactivate a free enzyme (section 3.4). Therefore, in addition to DAAO, 
E. coli cells with another enzyme activity, mono amino acid oxidase, MAO (section 
1.5.4), suitable for catalysing the oxidation of nonpolar substrates such as α-
methylbenzylamine, amylamine and 2-phenylpyrrolidine, were tested. Being nonpolar 
those substrate molecules would distribute between the two phases of an organic two-
phase system.  
In the literature there are examples of using enzymes in whole cells of 
microorganisms for industrial production of such chemicals as L-sorbose, L-malic 
acid, D-aspartic acid and 2-keto-L-gulonic acid.168  
Sanchez and Demain 169 in their review published in 2011 reported the use of 
whole cells of various microorganisms with cloned genes encoding feruloyl-CoA 
synthetase and enoyl CoA hydratase for the production of vanillin from ferulic acid. 
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Microorganisms used were, E. coli, Bacillus pumilis, Bacillus fusiformis and 
Pseudomonans putida. In turn, Hua et al170 used Pseudomonans sp to convert ferulic 
acid to vanillin. Dhillon et al171 (1987) used E. coli with the activity of glucosamine 
synthase to convert fructose-6-phosphate into glucosamine-6-phosphate.  
Abad et al172, using D-methionine as the substrate, demonstrated a three-fold 
enhanced stability of Trigonopsis variabilis D-amino acid oxidase (TvDAAO) in 
whole cell of Pichia pastoris in comparison to the free form of this enzyme expressed 
in E. coli. 49% of the total intracellular oxidase activity was available after applying 
permeabilisation of P. partoris with 10% propanol.  
 
6.2. Whole cells of E. coli 
Two types of whole cells of E. coli were obtained from Ingenza. These differed in 
activity. One type had the enzymatic activity of DAAO (1.5.3), whereas the other had 
MAO activity (1.5.4).  
Cells of E. coli were obtained in frozen form, defrosted to dispense separate 
quantities into Eppendorf vials and then stored frozen at -80°C. Before analysis, the 
cells were thawed by placing an Eppendorf vial into cold water.  
 
6.3. Whole cells of E. coli with MAO activity 
Monoamine oxidase (MAO) catalyses the oxidative deamination of primary 
amines (section 1.5.4). The specific reaction examined was the oxidation of α-
methylbenzylamine to acetophenone. Since substrate and product, are nonpolar, a 
range of potential organic two-phase systems was tested for the CCC-bioreactor with 
this enzyme.  
The enzymatic activity of MAO was also tested against two substrates; 2-
phenylpyrrolidine and amylamine.  
 
6.3.1. Activity against α-methylbenzylamine 
The reaction was performed in the presence of 50mM sodium phosphate buffer, 
pH 7.6, which was optimal for the enzyme. 120mg of E. coli cells with MAO activity 
and 10µl of α-methylbenzylamine was placed into 2ml of the sodium phosphate 
buffer. The reaction was monitored by HPLC analysis of a sample with the gradient 
presented in Table 42.  
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Figure 76 shows a chromatogram of a sample analysed 21.5h after the reaction 
was initiated. In contrast to the impression obtained from analysing the 
chromatogram, the amount of produced acetophenone is very little. For comparison, 
Figure 77 shows a chromatogram obtained for equal amounts of α-methylbenzylamine 
and acetophenone injected onto HPLC. Due to the presence of a carbonyl group, at 
the same molar concentration, acetophenone gives a much stronger signal than α-
methylbenzylamine. This comparison shows that the reaction yield in Figure 76 was 
very poor. 
acetophenonea-methylbenzylamine
 
Figure 76 Conversion of α-methylbenzylamine and acetophenone after 21.5h, catalysed by 120mg of 
cells, analysed by HPLC on a C18 column (GraceSmart) using the method presented in Table 41. 
Detection at 257nm. 
acetophenonea-methylbenzylamine
 
Figure 77 Analysis of α-methylbenzylamine and acetophenone on HPLC, C18 column (GraceSmart). 
Concentration of both chemicals was 1µl/ml of water. Detection at 257nm (maximum for α-
methylbenzylamine) 
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Time 
[min]
Flow 
[ml/min] %A %B %C %D Gradient
1 1.00 95.0 5.0 0.0 0.0
2 7.00 1.00 5.0 95.0 0.0 0.0 Linear
3 7.10 1.00 95.0 5.0 0.0 0.0 Linear
 
Table 42. The HPLC method used for α-methylbenzylamine and acetophenone analysis. Line A: water, 
Line B: acetonitrile 
 
6.3.2. Activity of MAO in the whole cells in organic solvents 
Despite poor conversion of α-methylbenzylamine an in aqueous environment 
(6.3.1), the MAO activity of the whole cells of E. coli was tested in 12 systems (Table 
43) made of water and organic solvents such as heptane, ethyl acetate, methanol and 
butanol. Since all 12 phase systems exist as two-phase systems, they could be used as 
a phase system for CCC.  
Into 2ml of a phase system, 36.9mg of cells and 20µl of α-methylbenzylamine was 
placed.  
The results form the experiment showed that there was no acetophenone 
produced, even 20 hours after the incubation was started. 
 
Solvent [µl] System 
No. Heptane EtOAc MeOH Butanol Water 
1 0 0 0 1000 1000 
2 0 400 0 600 1000 
3 0 800 0 200 1000 
4 0 1000 0 0 1000 
5 145 855 145 0 855 
6 250 750 250 0 750 
7 400 600 400 0 600 
8 545 455 545 0 455 
9 715 285 715 0 285 
10 835 165 835 0 165 
11 950 50 950 0 50 
12 1000 0 1000 0 0 
 
Table 43. Composition of phase systems made by the liquid-handling robot (6.4.3.3), to test MAO 
activity in the whole cells of E. coli.  
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6.3.3. Activity of MAO in the whole cells against various 
substrates. 
Since the MAO activity in the whole cells against α-methylbenzylamine was very 
low, two other substrates were tested, amylamine and 2-phenylpyrrolidine. For the 
comparison α-methylbenzylamine was also used.  
The activity of MAO was determined by the modified colorimetric assay 
presented in section 2.5.2.1. Since the enzyme activity was compared against three 
different substrates, each set of three wells, as the analysis was preformed in triplicate, 
contained one of the three different substrates at the same molar concentration. Then, 
using a 12 channel automatic pipette, a mixture of enzyme assay solution with E. coli 
cells was added. The absorbance was measured at 490nm in 2min intervals.  
Results are presented in Figure 78. Among the three tested substrates, the activity 
of MAO was the lowest towards the initially tested (6.3.1) α-methylbenzylamine. In 
comparison to methylbenzylamine, 12 times more 2-phenylpyrrolidine was converted 
when DAO was used in the whole cells. The difference in activity might have resulted 
from substrate specificity of the enzyme as well as the selective permeability of the 
cell membrane towards the tested substrates. To eliminate the last possibility, the 
activity of the free, isolated enzyme towards the three substrates would need to be 
tested, which was done and presented in the next section.  
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Figure 78. Activity of MAO in the whole cells of E. coli against three substrates: 2-phenylpyrrolidine, 
amylamine and α-methylbenzylamine. To each well of a 96-well plate 20µl of a substrate solution 
(0.1M) was added. Then 180µl of the enzyme solution containing E. coli cells (930µg). An equivalent 
of 1ml OD600=5 cells was suspended in 322µl of water. 200µl of that suspension was mixed with 3.4ml 
of the enzyme assay solution.  
 
6.3.4. Activity of the free form of MAO against various substrates 
The activity of MAO in the whole cells (6.3.3) seemed to be too low to use in the 
CCC-bioreactor. Therefore, the activity of the free enzyme, isolated from E. coli was 
tested against the same three substrates. The experiment was done as the E. coli cell 
membrane was suspected to affect permeability of substrates and therefore affect the 
activity of MAO. 
 
In order to do a direct comparison between the activity of MAO in the whole cells 
and its free form, the same amount of cells, as used in the previous experiment (6.3.3) 
was lysed (section 2.4.2.2) and the supernatant containing the free enzyme protein 
used for the assay. Thus into each well of a 96-well plate was placed 20µl of a 
substrate solution (0.1M) and 180µl of the enzyme solution containing MAO isolated 
from 930µg of E. coli.  
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As presented in Figure 79, the free form of MAO is the most active against 2-
phenylpyrrolidine and amylamine and least towards α-methylbenzylamine, just as it 
was in the cells (Figure 78). The enzyme activity in the whole cells against these 
substrates were lower by only 15, 8 and 29%, respectively. Therefore, using the 
enzyme in the whole cells and in the isolated form did not seem to make a significant 
difference in the activity towards analysed substrates. Thus, the low activity of the 
enzyme did not result from the presence of the cell membrane.  
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Figure 79. Activity of the free form of MAO in isolated from E. coli cells, against three substrates; 2-
phenylpyrrolidine, amylamine and α-methylbenzylamine.  
 
6.3.5. Conclusion to MAO  
Due to a very low activity of MAO in the obtained whole cells of E. coli, no CCC 
experiment was performed. In comparison to the whole cells of E. coli with DAAO 
activity (section 6.4), the activity of MAO was 180 times lower. It meant that to 
convert the same amount of molecules as E. coli cells with DAAO activity, 180 times 
more cells with MAO activity needed to be used. E. coli cells were found to flocculate 
and block CCC (6.4.3.4). Therefore, using 180 times more concentrated cell 
suspension in CCC-bioreactor seemed to be a big limitation.  
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6.4. Whole cells of E. coli with DAAO activity 
 
6.4.1. Determining the D-ABA conversion ratio 
The chiral ABA derivatisation used in the HPLC analysis of ABA was previously 
discovered to stop the enzymatic conversion of D-ABA catalysed by the free form of 
D-amino acid oxidase (2.5.1.2d). For accurate analysis it had to be shown that the 
derivatisation step also stops the bioconversion catalysed by the enzyme in whole 
cells. Furthermore, the derivatised sample needs to be centrifuged before injecting on 
an HPLC column to avoid column blockage caused by cells. Therefore, it was also 
investigated how quickly the sample has to be centrifuged after a derivatisation, as it 
might happen that only removing cells from a reaction mixture stops the reaction.  
The reaction mixture was made by placing 10.6mg of whole cells into 2ml of 
50mM potassium phosphate buffer, pH 7.5, and adding 100µL solution of DL-ABA 
(3.1mg). 500µL of the reaction mixture was immediately derivatised with the 
derivatising reagent premixed with borate buffer, keeping all proportions as desctibed 
in section 2.5.1.2b. To investigate how time affects a derivatised sample before 
centrifugation, the derivatised sample was divided into 5 fractions and each of them 
was centrifuged under the same conditions after a different elapsed time. The first 
fraction was centrifuged immediately (5min, 10000 rpm) after the derivatisation and 
analysed on HPLC. Next fractions were centrifuged in sequence of 8 min intervals 
and analysed on HPLC. For the control, the rest of the reaction mixture was 
derivatised after 32min, immediately centrifuged and analysed on HPLC. Results are 
presented in Table 44. 
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Peak area [mVs] 
  
Time after 
which the 
derivatised 
sample was 
centrifuged 
[min] 
L-ABA D-ABA 
Ratio 
D/L 
0 1679 1640 0.98 
8 1692 1654 0.98 
16 1691 1665 0.98 
22 1686 1659 0.98 
Derivatised 
reaction 
mixture  
28 1689 1664 0.99 
     
Control  0 1938 230 0.12 
 
Table 44 Demonstration that the chiral derivatisation method stops the enzymatic action of DAAO in 
whole cells in D-ABA. HPLC peak area of D-ABA and L-ABA obtained for the derivatised enzymatic 
solution. 
 
The ratio D- to L-ABA was constant (0.98) in all analysed samples. The time after 
which the derivatised sample was centrifuged did not affect the D-ABA conversion 
ratio. This means that the bioconversion was stopped by adding the derivatisation 
reagent to the sample. The conversion ratio of 0.12 obtained for the control incubated 
for 32min before the derivatisation proves that the enzyme in whole cells was active. 
This experiment shows that the ABA derivatisation method, described in section 
2.5.1.2b, totally stops the enzymatic action of the enzyme in whole cells.  
 
 
6.4.2. Whole cells in organic solvents 
The activity of DAAO in whole cells was tested in 36 organic solvents systems 
developed by Dr Ian Garrard for the collaborative project on “Anti-angiogenic 
activities of the volatile oil of Angelica sinensis”160 used already in section 3.3. All 
the 36 solvent system were made by liquid-handling robot (Perkin Elmer), using 12 
organic solvents and water. 
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6.4.2.1. Activity in organic solvents 
To each 5 ml test tube containing 2ml of each phase system made by the robot, 
10µl DL-ABA (1.4mg/ml) solution was added. Next the enzymatic reaction was 
initiated by adding 20µl of suspension containing 10.0mg whole cells to every test 
tube at 30 sec interval. A rotating wheel provided continuous phase mixing during the 
reaction. The bioconversion was stopped after 30 min (timer) by derivatisation of the 
sample (2.5.1.2). Derivatised samples were analysed on HPLC.  
The enzyme activity was expressed as a percent of converted D-ABA after 30 min 
reaction (Table 45), using L-ABA as an internal standard. A higher value, showing 
greater D-ABA conversion, indicated higher enzymatic activity in a system. In the last 
column, enzyme activity is shown using different colours. A green colour shows very 
high enzyme activity, whereas red indicates very low. The highest conversion (over 
60% converted D-ABA) was obtained for systems No 3, 4, 5, 6 and 27. For those 
system and systems No 17 and 31, where the conversion was above 30%, the enzyme 
stability was determined (6.4.2.2).  
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Heptane EtOAc MeOH Butanol Water ACN Toluene Acetic Acid Acetone tBME DCM Ethanol Propanol L-ABA D-ABA
1 0 0 0 1000 1000 0 0 0 0 0 0 0 0 436 357 18
2 0 400 0 600 1000 0 0 0 0 0 0 0 0 559 417 25
3 0 800 0 200 1000 0 0 0 0 0 0 0 0 609 246 60
4 0 1000 0 0 1000 0 0 0 0 0 0 0 0 551 145 74
5 145 855 145 0 855 0 0 0 0 0 0 0 0 530 83 84
6 250 750 250 0 750 0 0 0 0 0 0 0 0 599 232 61
7 400 600 400 0 600 0 0 0 0 0 0 0 0 588 478 19
8 545 455 545 0 455 0 0 0 0 0 0 0 0 548 466 15
9 715 285 715 0 285 0 0 0 0 0 0 0 0 549 529 4
10 835 165 835 0 165 0 0 0 0 0 0 0 0 521 521 0
11 950 50 950 0 50 0 0 0 0 0 0 0 0 589 587 0
12 1000 0 1000 0 0 0 0 0 0 0 0 0 0 399 397 0
13 1000 0 900 0 0 100 0 0 0 0 0 0 0 475 473 0
14 1000 0 600 0 0 400 0 0 0 0 0 0 0 552 548 1
15 1000 0 0 0 0 1000 0 0 0 0 0 0 0 0 0
16 1000 0 0 0 0 900 100 0 0 0 0 0 0 143 128 10
17 1000 0 0 0 0 600 400 0 0 0 0 0 0 14 8 44
18 0 0 0 950 950 0 0 100 0 0 0 0 0 248 240 3
19 0 0 0 900 900 0 0 200 0 0 0 0 0 60 49 18
20 800 0 560 0 240 0 0 0 0 0 400 0 0 559 562 -1
21 0 0 0 400 1000 200 0 0 0 400 0 0 0 549 524 5
22 625 250 500 0 0 625 0 0 0 0 0 0 0 198 187 6
23 0 0 0 842 1052.5 0 0 0 105.5 0 0 0 0 530 510 4
24 333 333.5 0 0 333.5 0 0 0 1000 0 0 0 0 390 346 11
25 1000 0 800 0 0 0 0 0 200 0 0 0 0 392 389 1
26 0 0 0 400 1000 200 0 0 0 400 0 0 0 497 471 5
27 0 0 0 0 1000 0 0 0 0 1000 0 0 0 555 162 71
28 0 0 800 0 533.5 0 0 0 0 0 666.5 0 0 251 249 1
29 1000 0 0 0 0 800 0 0 0 0 200 0 0 20 16 20
30 750 0 0 0 625 0 0 0 0 0 0 625 0 595 467 22
31 513 513 0 0 307.5 0 0 0 0 0 0 666.5 0 580 370 36
32 0 800 0 0 800 0 0 0 0 0 0 400 0 552 409 26
33 0 500 0 800 600 0 0 0 0 0 0 100 0 619 459 26
34 0 0 0 889 889 0 0 0 0 0 0 222 0 574 518 10
35 1000 0 0 0 750 0 0 0 0 0 0 0 250 684 625 9
36 1143 0 457 0 114.5 0 0 0 0 0 0 0 285.5 518 495 4
0 0
Water 2000 607 62 90
Water 2000 617 56 91
<10
11-30
31-60
>50
D-ABA 
conversion [%]
System 
No.
Solvent [µl] Peak Area [mVs] D-ABA 
conversion 
[%]
 
Table 45. The enzyme activity 36 organic two-phase systems which are combinations of 12 different organic solvents and water. Peak areas of D- and L-ABA derivatised and 
analysed on the HPLC after 30 min bioconversion are shown. In the last column percent of unreacted D-ABA is given. The conversion ratio is marked with different colours. In 
green are marked systems with a very high conversion ratio - less than 50% D-ABA stayed unconverted. Whereas, in red colour are shown systems in which the conversion was 
very low, more than 90% D-ABA stayed unreacted.  
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6.4.2.2. Stability in organic solvents 
For the 7 solvents systems mentioned above, where the remaining D-ABA was 
lower than 70%, the stability was determined by analysing the enzyme activity after 2 
and 4 hours of whole cells incubation in the tested phase systems. The enzyme 
activity was expressed as % of converted D-ABA. The higher the value, the more D-
ABA was converted and therefore the more active the enzyme must have been. 
Results are presented in Table 46. 
For a better understanding of the effect of the tested phase systems on whole cell 
stability, the results from Table 46 are also presented in a graph (Figure 80). 
The enzyme was most active and stable in system No 27, made of water/ tert-
butyl methyl ether. 100% D-ABA was converted even if the whole cells had been 
incubated for 4 hours in that system. A high enzymatic activity was also noticed for 
system No 4 (ethyl acetate/water) where 78% D-ABA was converted. Even after 4 
hours, 46% of the initial enzymatic activity remained. 
It had previously been found that the free enzyme was also the most active in 
these two systems (see section 3.4). 100% D-ABA conversion was achieved when 
free enzyme was used in system No 27. However, it was found that these systems 
could not be used because of unfavourable ABA partitioning. Moreover, to provide a 
mixing between the two phases, a rotary wheel was used. By contrast, CCC provides 
considerably more efficient mixing between the phases. That would expose the 
enzyme in the aqueous phase to contact with the organic solvent to a higher extent and 
presumably inactivating it.  
Among the tested aqueous-organic phase systems, there is not any which would 
provide both whole cell enzyme stability and preferable ABA partitioning. Therefore, 
a phase systems based on organic solvents was not selected for use within this project 
for the CCC-bioreactor with the whole cells of E. coli. 
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Heptane EtOAc MeOH Butanol Water ACN Toluene tBME Ethanol L-ABA D-ABA
Stand. - 6731 6894 -2 -
0 610 221 64 100
2 639 591 8 12
4 563 540 4 6
0 587 129 78 100
2 550 263 52 67
4 573 367 36 46
0 507 52 90 100
2 645 479 26 29
4 532 502 6 6
0 448 197 56 100
2 1340 1337 0 0
4 614 611 0 1
0 257 242 6 100
2 35 27 0 0
4 508 508 0 2
0 370 0 100 100
2 524 0 100 100
4 346 0 100 100
0 407 284 30 100
2 550 543 1 4
4 569 572 -1 -2
0 598 0 100 100
2 613 0 100 100
4 558 0 100 100
307.50
000020000
666.5000
1000 0
0
0
0 1000 0 0
0
0
0
0
0 0
0
0
0
0400600
0
0
0
750
00
0855
1000
0
250
145
0
513
1000
855
750
0
0
0
513
0
1000
0800
0
0
0
0
250
145
0
0
001000200Syst. No 3
Incubation 
time [h]
% of the 
initial 
activity
System 
No.
Peak Area [mVs] D-ABA 
conv. ratio 
[%]
Solvent [µl]
0 00
Syst. 
No 6
Syst. 
No 5
Syst. 
No 4
Buffer
Syst. 
No 31
Syst. 
No 27
Syst. 
No 17
 
Table 46 Enzymatic stability in whole cells in aqueous organic phase systems determined by HPLC analysis of the D-ABA converted within a 30min reaction. Phase 
systems were made by the robot. 10.1mg of cells was incubated with 2ml of phase system, made by the robot, for 2 or 4 hours. After that time 10µL solution of DL-
ABA (1.33mg) was added to initiate the bioconversion, which was performed for 30min. To determine the initial activity DL-ABA solution was added first, then the 
cell suspension.  
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Whole cells stability in organic solvents
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Figure 80 Enzymatic stability of whole cells in aqueous organic phase systems based on Table 46.  
 
6.4.3. Whole cells in ATPS 
 
6.4.3.1. Enzymatic stability of whole cells in ATPS 
The main reason for using whole cells in the CCC-bioreactor was the possible 
higher stability of enzyme. The stability of the enzyme in whole cells was determined 
in the ATPS, 14/14% PEG1000/potassium phosphate, which was chosen for the CCC-
bioreactor. For a control the reaction was performed in 2ml of 50mM sodium 
phosphate buffer, pH 7.5. To plastic test tubes, 1ml of the upper phase, 1ml of the 
lower phase and 50µl of aqueous cell suspension (205mg/ml), were placed. The cells 
were then incubated at room temperature (23°C) in the phase system or in the buffer 
for 1, 2 or 4 hours on a rotating wheel, which provided a continuous phase mixing. 
After these times, each time using a new sample, 20µl of the D/L-ABA solution 
(83.2mg/ml) was added and the reaction was stopped after 15min by derivatising 50µl 
of a sample for ABA according to the procedure described in section 2.5.1.2d. Results 
are presented in Figure 81.  
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Figure 81 Stability of the enzyme in the whole cells in the ATPS 14/14% PEG1000/potassium 
phosphate (pH 7.6) and in 50mM sodium phosphate buffer (pH 7.5). The experiment was performed in 
triplicate. The activity was determined by incubating 10.2mg of E. coli with 2ml ATPS or buffer for 1, 
2 and 4h. After that time the bioconversion was initiated by adding 20µL solution of DL-ABA (1.6mg) 
and stopped 15min later by derivation of a sample for ABA. The activity was determined as % of D-
ABA converted within 15min reaction.  
 
The stability of the enzyme in whole cells was compared with the stability of the 
free DAAO (Figure 81). The enzyme in whole cells lost only 5% of its initial activity 
when incubated for 4h in the buffer and 9% when incubated in the ATPS. The enzyme 
in whole cells was very stable, both in the buffer and in the ATPS.  
Within that time, the free enzyme lost 92% of the initial activity in buffer and 59% 
in ATPS (Figure 82). That makes the enzyme in whole cells more favourable for the 
CCC-bioreactor compared to the free enzyme.  
In contrast to the experiment presented in section 4.3.7, this new batch of the 
enzyme was found to be more stable in ATPS than in buffer solution.  
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Figure 82 Comparison between the stability of the enzyme in whole cells and the free enzyme. The 
stability was determined by referring the activity (% converted D-ABA) measured after 2 and 4h to the 
initial activity which was set at 100%. The stability was determined in 50mM sodium phosphate buffer 
pH 7.5 (a) and in the ATPS 14/14% potassium phosphate pH 7.6 (b).  
To determine the stability of the free enzyme, 20µL was added to 1980µL of the ATPS or buffer. After 
2 and 4 hours, 20µL DL-ABA solution was added (3mg) and the reaction was continued for 5min and 
stopped by derivatising the sample for ABA.  
 
6.4.3.2. Whole cell partitioning in ATPS 
Partitioning of the whole cells of E. coli was determined in the ATPS based on the 
enzyme activity. It was assumed that the cells’ membrane is integral and enzymatic 
activity was proportional to the concentration of cells in a sample. Therefore, 
partitioning of the whole cells could be determined by analysing the enzymatic 
activity in both phases of the ATPS. 
First cell integrity had to be proved. If integral cells are spun down, there should 
not be any activity in the supernatant. The enzyme activity was determined for the cell 
suspension (0.202 abs/min, green bar Figure 83a). Next cells were spun down and the 
enzyme activity was determined for the supernatant (red bar Figure 83a). The activity 
was 0.024 [abs/min] which means nearly 90% reduction. The enzyme activity did not 
reduce when the solution of the free enzyme was spun down under the same 
conditions (Figure 83b), which demonstrates that centrifugation had not inactivated 
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the enzyme. Therefore the difference in enzymatic activity before and after 
centrifuging the cell suspension must have been caused by removing integral cells 
from a solution. This experiment demonstrated that at least 90% of the enzyme is in 
integral cells, therefore cell concentration can be determined based on the enzyme 
activity.  
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Figure 83 Integrity of E. coli with DAAO activity determined by measuring enzymatic activity in a 
suspension before and after centrifuging. a) Integrity of whole cells. 23.5mg E. coli was dissolved in 
5ml water. The activity was determined by the colorimetric assay (2.5.2.1). Cells were then spun down 
on the centrifuge. After this the enzyme activity was determined once again for the supernatant. b) The 
activity in a solution of the free enzyme, before and after centrifuging. 
 
E. coli was placed into the ATPS previously used with the free enzyme for the 
successful CCC-bioreactor, (14/14% PEG1000 potassium phosphate). The activity of 
the enzyme was determined for both phases. Results are presented in Figure 84.  
Based on the enzyme activity, the whole cells partition into the lower phase (D-
value 0.05), which is not preferable for the CCC-bioreactor. Therefore, another 
solvent system or a method which alters partitioning, such as cell PEGylation, would 
need to be found. Both aqueous-organic (section 6.4.2) and ATPS (section 6.4.3) 
systems were examined together with cell surface PEGylation (section 6.4.3.5).  
CHAPTER 6 – Enzymes in whole cells 
 
 195 
Partitioning of whole cells in ATPS
0.014
0.274
0.000
0.050
0.100
0.150
0.200
0.250
0.300
1
En
z
ym
e 
ac
tiv
ity
 
[ab
s/
m
in
]
Upper phase Lower phase
 
Figure 84 Partitioning of E. coli in ATPS (14/14% PEG1000/potassium phosphate) determined by 
DAAO activity. The experiment was done in triplicate. 14.3mg E. coli was placed into 5ml of ATPS, 
equal amount of the upper and the lower phase. Both phases were analysed for the enzyme activity 
(2.5.2.1).  
 
6.4.3.3. ATPS selection using a liquid-handling robot 
Partitioning of E. coli was tested in 98 ATPSs made by means of a liquid-handling 
robot which had the advantage of making a large number of ATPSs from stock 
solutions of PEG and various salts in relatively short period of time in comparison to 
a traditional making of ATPS which would involve an individual weighing of PEG 
and a salt for each sample.  
The distribution ratio of cells was determined by measuring their optical density in 
the upper and the lower phase of a phase system.  
 
a) Description of a liquid handling robot 
A liquid-handling robot (Perkin Elmer Multiprobe II), equipped with 4 tips, and 
both a syringe and a peristaltic pump was used. The robot transfers the desired 
volume of a liquid from the source using the syringes. The peristaltic pump is used for 
flushing the tubing with water, which eliminates any cross contamination. Figure 85 
shows the liquid-handling robot.  
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Figure 85 The liquid-handling robot, Perkin Elmer Multiprobe II 
 
b) Preparing solvents for the robot 
A liquid-handling robot is designed to transfer a desired volume of a liquid. It was 
generally used for making phase systems based on organic solvents and water.173 The 
concentration of solvents in those systems is expressed as % v/v, e.g. to make 50/50% 
butanol/water the same volume of both needs to be taken.  
ATPS is made of PEG, salt and water. PEG400 is a liquid at room temperature, 
PEG1000 is a solid, whereas PEG3350 and all salts selected are powders. Therefore 
to make them available for the robot, which can transfer only liquids, aqueous 
solutions of PEG and salts were prepared. Moreover the concentration of PEG and 
salt in ATPS was expressed as % w/w. For that reason, densities of all stock solutions 
had to be determined to know the exact weight of PEG and salt in a given volume of 
transferred stock solution. In Table 47, the results of measuring densities of PEG 
solutions are presented. The stock solutions of PEG400 and 1000 were 55% w/w 
concentration. In the case of PEG 3350 and 8000, due to the high viscosity of their 
aqueous solutions, concentrations of the stock solutions were reduced to 35% and 
30% (w/w), respectively.  
The density depends only on the PEG concentration, not on its molecular weight 
(Figure 86).  
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PEG 
mol. 
weight 
Concentr. 
w/w 
Empty 
glass 
[g] (me) 
Glass  with PEG 
solution [g] (ms) 
Glass filled with 
water [g] (mw) 
Specific 
gravity 
51.6752 49.3657 
51.6702 49.3549 400 55% 24.4723 
51.6568 
51.6674 
49.3703 
49.3636 1.093 
44.4743 42.0812 
44.4664 42.1080 1000 55% 17.2244 
44.4745 
44.4717 
42.1073 
42.0988 1.095 
51.4047 49.8947 
51.3742 49.8696 3350 35% 25.1108 
51.3547 
51.3779 
49.8597 
49.8747 1.061 
85.0487 82.4164 
85.0451 82.4160 8000 30% 32.6556 
85.0406 
85.0448 
82.4366 
82.4230 1.053 
 
Table 47 Density of PEG stock solutions used for the robotic ATPS making. The determined density 
(ρ) was related to the density of water and was calculated according to the equation: 
ew
es
mm
mm
−
−
=ρ ; 
ms – weight of a volumetric flask totally filled with an analysed solution; mw – weight of a volumetric 
flask totally filled with water; me – weight of an empty volumetric flask. Volumetric flasks used were 
of the volume of 25 and 50ml. All weights [g] were determined on an analytical balance (ρ =0.1mg). 
Solutions and water were brought to 20°C. 
 
Density of PEG aqueous solutions
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Figure 86 Density of aqueous solutions of PEG. The graph shows a linear relationship between the 
concentration of PEG solution (%) and the density (g/ml).  
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Also the density of salt solutions were determined. The concentration of sodium 
phosphate and sodium sulphate stock solutions were 29% (w/w) due to lower 
solubility of these salts. Stock solutions of all other salts were made at concentration 
40% w/w (Table 48). 
 
Concentr 
(w/w) Salt type 
Glass 
no 
Salt solution [g] 
(ms) 
Water 
[g] (me) 
Empty 
[g] 
(mw) 
Specific 
gravity 
24.3301 
24.3303 Potassium phosphate 1515 
24.3262 
24.3289 20.4985 10.6064 1.387 
22.8645 
22.8595 Ammonium phosphate 1522 
22.8610 
22.8617 20.5244 10.8226 1.241 
23.3283 
23.3241 Potassium citrate 1522 
23.3252 
23.3259 20.5244 10.8226 1.289 
23.2223 
23.2209 Sodium citrate 1522 
23.2267 
23.2233 20.5244 10.8226 1.278 
22.7746 
22.7724 
40% 
Ammonium 
sulphate 1515 
22.773 
22.7733 20.4985 10.6064 1.230 
23.1986 
23.1961 Sodium phosphate 1522 
23.1926 
23.1958 20.5244 10.8226 1.275 
23.3667 
23.3656 
29% 
Sodium 
sulphate 1522 
23.3634 
23.3652 20.5244 10.8226 1.293 
 
Table 48 Density of salts stock solutions used for the robotic ATPS making. The determined density 
(ρ) was related to the density of water and was calculated according to the equation: 
ew
es
mm
mm
−
−
=ρ ; 
ms – weight of a glass pycnometer with a stopper totally filled with an analysed solution,; mw – weight 
of a glass pycnometer with a stopper totally filled with water; me – weight of an empty a glass 
pycnometer with a stopper. All weights [g] were determined on an analytical balance (d=0.1mg). 
Solutions and water were brought to 20°C. 
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c) Preparing a solvent table for the robot 
All ATPSs were made of water and stock solutions of PEG and salts. The volume 
of added stock solutions of PEG and salts was calculated based on the density 
presented in Table 47 and Table 48. All calculations were done in Excel (Microsoft 
Office). The method used for calculating the volume of solutions that the robot used 
to make ATPS is explained below, based on the example of ATPS 16/16% 
PEG400/potassium citrate.  
In 100g of an ATPS 16/16% there is 16g PEG, 16g of salt and 68g of water. In 
columns 4-13 (Table 49) calculations are presented to make 4g of ATPS. 4g of ATPS 
16/16% PEG400/potassium citrate contains 640mg PEG. That amount of PEG is in 
1164mg 55% PEG stock solution (column 5). 1064µL of the stock solution (column 
7) needs to be transferred as the density of PEG400 solution (55%) is 1.094g/cm3 
(column 6). The same was calculated for a salt. 4g of the ATPS contains 640mg of 
potassium citrate which is in 1600mg 40% potassium citrate stock solution (column 
9). Therefore 1241µL of the stock solution (column 11) needs to be taken as the 
density of 40% potassium phosphate is 1.289g/cm3 (column 10). Column 12 shows a 
volume of water that needs to be added to make 4g of ATPS. It needs to be noted that 
the various ATPSs made of different salts and at different concentration would all 
have the same weight (4g, column 13), but different volumes (column 14), as the final 
volume of an ATPS depends on the PEG and salt concentration as well as on the salt 
type. The more concentrated the ATPS, the higher percent of PEG and salt which, 
being denser then water, affects the total volume (column 14). This complicates the 
situation. For instance if a fixed sample volume was added to a different volume of 
ATPS, % concentration of the sample would differ. Moreover the robot might work 
less effectively if the surfaces of the transferred liquids were at different levels. 
Therefore to standardise the system, the volume of PEG (column 15), salt (column 
16) and water (column 17) was proportionally increased to get a total volume of 4ml 
in all 98 ATPS. From the calculated volume of water, 100µL was subtracted (column 
18) to allow for the addition of a sample usually in an aqueous solution.  
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
% M [mg] Density V [µl] % M [mg] Density V [µl]
400 K citrate 16 55 1164 1.094 1064 40 1600 1.289 1241 1236 4000 3541 1201 1402 1297 100 4000
400 K citrate 18 55 1309 1.094 1197 40 1800 1.289 1396 891 4000 3484 1374 1603 923 100 4000
400 K citrate 20 55 1455 1.094 1330 40 2000 1.289 1552 545 4000 3427 1552 1811 537 100 4000
400 K citrate 22 55 1600 1.094 1463 40 2200 1.289 1707 200 4000 3369 1736 2026 137 100 4000
400 KPO4 16 55 1164 1.094 1064 40 1600 1.387 1154 1236 4000 3454 1232 1336 1332 100 4000
400 KPO4 18 55 1309 1.094 1197 40 1800 1.387 1298 891 4000 3385 1414 1533 953 100 4000
400 KPO4 20 55 1455 1.094 1330 40 2000 1.387 1442 545 4000 3317 1603 1739 558 100 4000
400 KPO4 22 55 1600 1.094 1463 40 2200 1.387 1586 200 4000 3249 1801 1953 146 100 4000
400 Na citrate 16 55 1164 1.094 1064 40 1600 1.278 1252 1236 4000 3552 1198 1410 1292 100 4000
400 Na citrate 18 55 1309 1.094 1197 40 1800 1.278 1408 891 4000 3496 1369 1612 919 100 4000
400 Na citrate 20 55 1455 1.094 1330 40 2000 1.278 1565 545 4000 3440 1546 1820 534 100 4000
400 Na citrate 22 55 1600 1.094 1463 40 2200 1.278 1721 200 4000 3384 1729 2035 136 100 4000
400 NaPO4 16 55 1164 1.094 1064 29 2207 1.275 1731 629 4000 3424 1243 2022 635 100 4000
400 NaPO4 18 55 1309 1.094 1197 29 2483 1.275 1947 208 4000 3352 1428 2324 148 100 4000
400 NaSO4 16 55 1164 1.094 1064 29 2207 1.293 1707 629 4000 3400 1251 2008 641 100 4000
400 NaSO4 18 55 1309 1.094 1197 29 2483 1.293 1920 208 4000 3325 1440 2310 150 100 4000
Total 
weight 
[mg]
Total 
volume 
[µl]
Total 
volume 
[µl]
Water 
volume 
[µl]
Salt 
volume 
[µl]
PEG 
volume 
[µl]
Sample 
volume 
[ul]
Water 
[g,µl]
PEG 
type
PEGConcen
tationSalt type
Salt
 
 
Table 49. Part of the calculations made to program the liquid-handling robot to make ATPS. The whole table is in the appendix on p217 to 219. Column 1) molecular weight of 
PEG used ; Column 2) salt type; column 3) concentration of both PEG and a salt in ATPS; column 4) concentration of PEG stock solution used [% w/w]; column 5) amount [mg] 
of stock solution of PEG to make 4g of ATPS; column 6) density of PEG stock solution [g/cm3]; column 7) volume [µl] of stock solution of PEG to make 4g ATPS; 8) 
concentration of salt stock solution used [% w/w]; column 9) amount [mg] of stock solution of salt to make 4g of ATPS; column 10) density of salt stock solution [g/cm3]; column 
11) volume [µl] of stock solution of salt to make 4g ATPS; 12) volume of water to make 4g ATPS; column 13) total weight [µg] of ATPS; column 14) total volume [µl] of 4g 
ATPS; column 15) volume [µl] of PEG stock solution to make 4ml ATPS; column 16) volume [µl] of salt stock solution to make 4ml ATPS; column 17) volume of water to make 
4ml ATPS; column 18) volume of a sample; column 19) total volume  
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d) Determining the distribution ratio of E. coli in ATPS 
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Figure 87 The correlation between the E. coli cell concentration and OD measured at 630nm on the 
plate reader. 300µl of E. coli suspension was placed into a well of 96-well plate. The OD was measured 
at 630nm. 
 
The robot made 98 ATPSs. To each of them, 100µl of cell solution (8.0mg cells) 
was added, so the cell concentration in each tube was 2.0mg/ml. The volume ratio of 
the two phases for most systems was close to 1. Therefore, if all cells were distributed 
in one phase their concentration (4mg/ml) would still be within the linear detection 
range (Figure 87). After manually shaking, the samples were left for 30min to allow 
the two phases to separate. 300µl of each phase was separately placed by the robot 
into the well of a 96-well plate. Then the optical density at 630nm (OD630) was 
determined. This was the closest available wavelength to 600nm, the standard 
wavelength used to determine the optical density of cells.  
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E. coli ATPS made 
by the robot OD at 630nm 
Each phase placed 
into a well
 
 
Figure 88. Determination of E. coli partitioning in ATPS made by the liquid-handling robot. 
Suspension of E. coli cells were added to ATPS made by the robot, which then transferred separately 
the upper and the lower phase of the phase system to 96-well plate. The OD630 was determined by the 
plate reader. 
 
The distribution ratio was determined for each ATPS by dividing OD630 obtained 
for the upper phase by OD630 obtained for the lower phase.  
The expected total OD630 was between 0.5 [abs], if cells were equally distributed 
between the two phases and 1.0 [abs] if cells totally partitioned into one phase. 
However, the cells frequently partitioned into the interface area and in that case the 
sum of OD630 for both phases was much lower than 0.5 [abs]. From the results it was 
possible to select 8 ATPSs where the distribution ratios were measurably over 10 
(Table 50). A high distribution ratio is desirable as it means the cells partition almost 
entirely to the stationary phase of the CCC-bioreactor. Where these samples show a 
very high SD, this indicates a heterogeneous distribution of cells in the phase systems 
as it was calculated from 5 OD630 readings of the same samples.  
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No 
PEG 
molecular 
weight 
Salt 
type 
Concentr 
[% w/w] 
D-value 
of whole 
cells 
SD 
1 400 NaSO4 18 60 48 
2 400 NaSO4 20 22 22 
3 1000 NaPO4 16 12 7 
4 1000 NaPO4 18 231 202 
5 1000 NaSO4 14 256 412 
6 1000 NaSO4 16 17 3 
7 1000 NH4SO4 16 114 13 
8 1000 NH4SO4 18 648 514 
 
Table 50 Selected phase systems where the whole cells partition mainly to the top, PEG-rich phase, 
giving a D-value over 10. The D-value was determined by dividing OD630 for an upper phase by OD630 
for a lower phase. OD630 for each phase was determined 5 times.  
 
The two ATPSs made of ammonium sulphate (NH4SO4) were rejected as this salt 
makes the ABA analysis difficult (2.5.1.2a). To achieve satisfactory cell partitioning, 
ATPS based on PEG 400 needs to be made at high concentration which make the 
ATPS expensive. Therefore the best phase systems seem to be an ATPS made of 
PEG1000 and either sodium sulphate or sodium phosphate.  
 
There was a slight inconsistency between the experiments presented in Table 50 
and Tables 50 and 51. By contrast to the experiment presented in Table 50, when all 
ATPS were made by the robot, this time ATPS were made by weighing and mixing 
all components (PEG, salt and water) separately, which is considered to be more 
accurate. In ATPSs made of PEG1000 and sodium sulphate, only at the concentration 
of 14/14% did the cells partition into the upper PEG-rich phase. At higher ATPS 
concentrations, the cells partitioned to the interface area (Table 51), which can 
indicate instability of cells in this phase system. Only a visual observation was done 
as most of the material was visible in the interface area.  
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PEG1000/sodium sulphate 
ATPS 
concentration 
[w/w%] 
Cells 
partitioning 
14 upper phase 
16 interface 
18 interface 
20 interface 
 
Table 51 Whole cell partitioning in ATPS made of PEG1000 and sodium sulphate. 9.2mg of cells were 
placed into 4ml of ATPS. Due to the cloudiness of the cell suspension, it was possible to observe where 
the majority of the cells lay.  
 
In case of the ATPS made of PEG 1000 and sodium phosphate, cell partitioning strongly depends 
on the ATPS concentration ( 
Table 52). The higher the ATPS concentration, the more cells partition to the 
upper, PEG-rich phase. The D-value was determined based on DAAO activity in 
whole cells.  
 
ATPS 
concentration 
[w/w%] 
D-value St. error 
12.5 0.1 0.01 
14 2.6 0.13 
16 8.3 0.24 
18 10.7 0.32 
 
Table 52 Partitioning of whole cells of E. coli in ATPS made of PEG1000 and sodium phosphate 
determined by comparing DAAO activity in the colorimetric enzyme assay. Standard error calculated 
for 3 replications. 
 
Based on the cell partitioning, the phase system for the CCC-bioreactor was 
chosen as 16/16% PEG1000/sodium phosphate. The concentration 14/14% did not 
provide a sufficiently high D-value of cells, whereas 18/18% was rejected because of 
the risk of salt precipitation. 
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6.4.3.4. Calculation of the whole cell concentration in SP 
required for the CCC-bioreactor 
The concentration of whole cells to be used in the stationary phase was calculated, 
based on the enzymatic activity of these cells compared to the activity of the free 
enzyme used for the CCC-bioreactor (5.2.2). According to the colorimetric enzyme 
assay (2.5.2.1), the enzymatic activity of the 2% free enzyme solution, obtained by 
dissolving 2ml of the enzyme in 100ml of stationary phase, was 0.6 abs/min. Based 
on the enzymatic activity of whole cells, to obtain this activity in 100ml of the 
stationary phase, 1.1g of whole cells needed to be used.  
 
Therefore, 1.17g of E. coli was suspended in 100ml of the upper phase of 16/16% 
PEG1000/sodium phosphate. First, cells were mixed with 2ml of water, then added to 
the upper phase and mixed by an electromagnetic stirrer for 10min. Surprisingly the 
pump blocked when the stationary phase containing the cells was pumped onto the 
CCC column. It was noticed that cells in the stationary phase were flocculating and 
then sedimenting. The flocculated cells also caused the CCC coil to block. For that 
reason the experiment was stopped and the CCC-bioreactor was not performed using 
whole cells.  
It needs to be mentioned that in any of the experiments presented in the previous 
section, no flocculation of cells in ATPS was observed. This might be explained by a 
different type of mixing applied to the partitioning studies. The suspension of cells 
was placed in ATPS and mixed by manually inversing the test tube several times. 
This mixing was effective enough to the distribute cells evenly in a phase system but 
not so vigorous as to initiate flocculation of cells, as accrued when more powerful 
electromagnetic stirring was applied.  
 
6.4.3.5. Effect of Polyethylene Glycol Monostearate on E. coli 
sedimentation in ATPS 
A method that prevents E. coli from flocculation in ATPS was required. 
Therefore, the use of Polyethylene Glycol Monostearate to prevent flocculation was 
investigated. Polyethylene Glycol Monostearate (n=10), palmitate and stearate 
mixture (PEG-MS, CAS number 9004-99-3), was purchased from TCI America. 
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E. coli cells premixed with PEG-MS were placed into the upper phase of ATPS. 
The OD600 was determined at time 0 and 4h using a spectrophotometer (Shimadzu 
Deutschland GmbH). The beam of the light passed through the side of a cuvete. 
Therefore, the difference in OD600 was assumed to be caused by cell sedimentation. In 
the experiment, four factors were analysed, namely salt type, ATPS concentration, 
cell concentration and PEG-MS concentration. To reduce the total number of 
conditions and experiments to be investigated, a design of experiment software 
(Design-Expert®, Stat-Ease, Inc) was used. 
Two types of ATPS were analysed, PEG1000/sodium sulphate and 
PEG1000/sodium phosphate at the concentration of 14/14, 16/16 and 18/18%. Cell 
concentration in ATPS varied from 2 to 20mg/ml and PEG-MS from 0 to 5mg/ml. For 
those conditions, the Design Expert program generated 18 variations. These were then 
tested experimentally as follows. To each plastic cuvete was placed the cell 
suspension (2.1g of cells mixed with 1ml water), PEG-MS solution (243mg/ml) and 
water in the amounts given in the last 3 columns in Table 53. 
 
 Std
ATPS 
concentr. 
[% w/w] 
Cells 
[mg/ml]
PEG-MS 
[mg/ml] Salt type
ATPS 
[ml] Cells [g]
PEG-MS 
[µL] Water [µL]
1 14 2 0 Sulphate 4.0 8 0 192
2 18 20 0 Sulphate 4.0 80 0 120
3 14 2 5 Sulphate 4.0 8 103 89
4 18 2 5 Sulphate 4.0 8 103 89
5 14 20 5 Sulphate 4.0 80 103 17
6 18 20 5 Sulphate 4.0 80 103 17
7 14 2 0 Phosphate 4.0 8 0 192
8 18 2 0 Phosphate 4.0 8 0 192
9 14 20 0 Phosphate 4.0 80 0 120
10 18 20 0 Phosphate 4.0 80 0 120
11 18 2 5 Phosphate 4.0 80 103 89
12 14 20 5 Phosphate 4.0 44 103 17
13 16 11 2.5 Sulphate 4.0 44 51 105
14 16 11 2.5 Phosphate 4.0 44 51 105
15 16 11 2.5 Sulphate 4.0 44 51 105
16 16 11 2.5 Phosphate 4.0 44 51 105
17 16 11 2.5 Sulphate 4.0 44 51 105
18 16 11 2.5 Phosphate 4.0 44 51 105
 
Table 53 Composition of samples used to determine effects of ATPS concentration, salt type, cells 
concentration and presence of PEG-MS on E. coli sedimentation in the upper phase of ATPS.  
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After 1 hour, 4ml of upper phase of ATPS was added to each cuvete and the 
absorbance measured at 600nm using a spectrophotometer. The samples were then 
left for 4 hours to allow the cells to settle down. After that time, the absorbance was 
measured again. The sedimentation rate (S) after 4h was calculated according to 
Equation 13.  
100100
0
4
⋅−=
=
=
t
t
OD
ODS ; [%] Equation 13 
where ODt=0 is the optical density measured at 600nm at the time 0, ODt=4 is the 
optical density measured at 600nm after 4 hours. Results are shown in Table 54.  
 
Absorbance Std 
ATPS 
concentr. 
[w/w %] 
Cells 
[mg/ml] 
PEG-
pal 
[mg/ml] 
Salt type 
t=0h t=4h 
Sedimentation 
after 4h [%] 
1 14 2 0 Sulphate 0.625 0.690 -10 
2 18 20 0 Sulphate 2.686 0.900 66 
3 14 2 5 Sulphate 2.159 0.628 71 
4 18 2 5 Sulphate 1.406 0.260 82 
5 14 20 5 Sulphate 3.163 1.250 60 
6 18 20 5 Sulphate 2.950 1.624 45 
7 14 2 0 Phosphate 0.656 0.401 39 
8 18 2 0 Phosphate 0.580 0.479 17 
9 14 20 0 Phosphate 2.804 0.823 71 
10 18 20 0 Phosphate 2.640 0.567 79 
11 18 2 5 Phosphate 2.057 0.628 69 
12 14 20 5 Phosphate 3.096 1.670 46 
13 16 11 2.5 Sulphate 2.700 1.273 53 
14 16 11 2.5 Phosphate 2.600 1.043 60 
15 16 11 2.5 Sulphate 2.421 1.578 35 
16 16 11 2.5 Phosphate 2.486 1.084 56 
17 16 11 2.5 Sulphate 2.342 1.302 44 
18 16 11 2.5 Phosphate 2.520 1.070 58 
     
  
 
19 0 2 0 Water 1.100 1.107 -1 
20 0 20 0 Water 3.015 3.003 0 
 
Table 54. Sedimentation calculated for tested samples by comparing OD600 measured immediately 
after placing cells treated with PEG-MS to ATPS and after 4hours.  
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Calculated values of sedimentation (S) shown in Table 54, as well as analysed 
parameters (ATPS concentration, cell concentration, PEG-MS concentration and salt 
type), were typed to the Design Expert table to perform statistical analysis.  
Table 55 shows analysis of variance (ANOVA) generated by the Design Expert. 
Values of “Prob > F” less than 0.0500 indicate model terms are significant. In this 
case B, C, D, BC, CD, ABC are significant model terms. Based on this information 
cell sedimentation depends on cell concentration, PEG-MS concentration and the type 
of salt used for ATPS and is independent of ATPS concentration.  
In needs to be noted that based on Table 51 (section 6.4.3.3d), concentrated ATPS 
caused the flocculation of E. coli as they partitioned to the interface area. However, 
that experiment was performed in the absence of polyethylene glycol monostearate. 
 
Sum of Mean F
Source Squares DF Square Value Prob > F
Model 7121.429 9 791.2698 14.17567 0.0010
A 3.375 1 3.375 0.060463 0.8128
B 570.375 1 570.375 10.21832 0.0151
C 979.4579 1 979.4579 17.54707 0.0041
D 320.6429 1 320.6429 5.744344 0.0477
AB 15.85786 1 15.85786 0.284095 0.6105
AC 1.041667 1 1.041667 0.018662 0.8952
BC 4030.042 1 4030.042 72.19854 < 0.0001
CD 780.125 1 780.125 13.97601 0.0073
ABC 392 1 392 7.022714 0.0329
        ANOVA for Selected Factorial Model
Analysis of variance table [Partial sum of squares]
 
Table 55 ANOVA test for the analysed samples generated by Design Expert.  
 
Figure 89, generated by Design Expert, presents a correlation between PEG-MS 
concentration [mg/ml] and cell sedimentation after 4h [%] at the cell concentration of 
11mg/ml for two ATPS, PEG1000/sodium phosphate and PEG1000/sodium sulphate, 
both at the concentration of 16/16% (w/w).  
The simulation was performed for a cell concentration of 11mg/ml as that 
concentration had previously been chosen for the CCC-bioreactor based on the 
enzyme activity (7.3.5.). The ATPS concentration was 16/16%. As mentioned above, 
cell sedimentation is independent of that factor, therefore the simulation could be 
performed for any ATPS concentration within the range of 14-18%.  
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Figure 89 Effect of cells and PEG-MS (PEG-pal) concentration in the upper phase of 16/16% 
PEG1000/sodium sulphate and 16/16% PEG1000/sodium phosphate on cell sedimentation determined 
by Design Expert program.  
 
In Figure 89 there are two lines showing the sedimentation of E. coli cells in 
PEG1000/sodium sulphate (black line) and PEG1000/sodium phosphate (red line). At 
the cell concentration of 11mg/ml, the sedimentation is independent of the presence of 
PEG-MS in the upper phase of PEG1000/sodium phosphate (red line). After 4 hours 
about 50% cells sedimented regardless of PEG-MS concentration. The presence of 
PEG-MS in PEG1000/sodium sulphate increase cell sedimentation from 25% where 
no PEG-MS was used to over 60% at the PEG-MS concentration of 5mg/ml.  
Since the presence of PEG-MS does not prevent E. coli from sedimentation when 
used at the concentration of 11mg/ml, this method is not adequate for the project.  
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6.5. Conclusion 
As expected, the enzyme DAAO is much more stable when used in whole cells, 
rather than as a free, isolated form. Incubation for 4h in ATPS lost only 5% of its 
initial activity (6.4.3.). An unexpected challenge was the partitioning of the E. coli 
cells to the desired phase of a phase system. Using a robotic phase system selection 
approach the ATPS, 16/16% (w/w) PEG1000/sodium phosphate, was selected due to 
a preferable partitioning of the cells to the top, PEG-rich phase. Nevertheless under 
these conditions, cells of E. coli have a tendency to flocculate and precipitate out of 
the phase system, which greatly reduces their effectiveness in the CCC-bioreactor. A 
PEG-derivative, polyethylene glycol monostearate did not stop the cells from 
flocculation in ATPS. 
None of the tested organic solvent systems (6.4.2.) could provide both enzyme 
stability and preferable partitioning of ABA. Therefore this type of a solvent system 
was rejected as a phase system for the CCC-bioreactor with whole cells of E. coli.  
MAO in the whole cells of E. coli was not investigated due to a very low 
enzymatic activity (6.3) of the obtained cells as confirmed by applying the isolated 
form of the enzyme (6.3.4). Moreover, as the enzyme was in the whole cells of E. 
coli, the problem with flocculation would be likely to arise as in the previous 
example. 
Despite the high enzymatic stability in whole cells, they were not used for the 
CCC-bioreactor because of their flocculation in the most favourable phase systems.  
Further work is required to identify an agent that would stop cells from 
flocculation in ATPS. Another possibility is either finding a suitable phase system or 
a different type of cell which would not have a tendency to flocculating. 
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7. CONCLUSION 
The presented work shows the first successfully created CCC-bioreactor which, at 
the same time, can provide both a total conversion of the injected substrate and a 
complete separation of products of the reaction.  
In the literature there are a few examples of the use of countercurrent 
chromatography for a combined bioconversion and separation. However, a 
successfully created CCC-bioreactor capable of both a total conversion of an injected 
substrate and a complete separation of the reaction products, has not been described. 
For instance, Bousquet et al138 achieved only 80% of enantiomeric purity when 
countercurrent chromatography was applied for the enantioselective hydrolysis of 2-
cyano cyclopropyl-1,1 dicarboxylic acid dimethylesters with a bacterial esterase 
present in the aqueous stationary phase. The whole process took 8 hours. In turn, 
Hollander and co-workers141,142 investigating a bioreactor based on CPC for the 
enantioseparation of amino acids did not resolve peaks completely. Moreover, the 
authors reported a small amount of unconverted substrate eluting from the column, 
which would indicate incomplete deracemisation of the injected substrate. Also 
Armstrong et al140 did not achieve a total conversion of the substrate in CPC used as a 
combined bioreactor/separator. The enzyme α-chymotrypsin, used to perform the 
enantioseparation of DL-tryptophan methyl ester, was found to be unstable in the 
aqueous - organic phase system applied in the project. 
 
In contrast to the works of other research groups who tried to apply CCC as a 
combined bioreactor and separator, in this research project not only the total 
bioconversion of the injected substrate and resolution of the peaks were achieved, but 
comprehensive optimisations of the process as well as the phase system selection 
were presented.  
The use of a countercurrent centrifuge bioreactor/separator for manufacture of 
enantiopure small molecules was demonstrated on a model reaction of deracemisation 
of DL-amino butyric acid using a Brunel-made Milli CCC machine. The technique 
allowed isolation of L-ABA of an enantiomeric purity >99% ee, free of KBA, the 
product of the enzymatic conversion, as well as the enzyme which catalysed the 
reaction.  
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All the aims and objectives listed in Chapter 1 have been met. Analytical 
procedures which allowed ABA, KBA and enzyme activity to be analysed were either 
developed or adopted to the presence to ATPS. A significant challenge was the 
development of analytical methods which were not affected by the presence of the 
phase systems. Since both ABA and KBA are small molecules, HPLC was selected as 
an analytical method. GC was not used due to incompatibility of this technique with 
samples containing salts at high concentration, such as ATPS.  
Four HPLC methods were investigated to analyse ABA and KBA. Only a HILIC 
column enabled simultaneous analysis of the two compounds. Despite this great 
advantage and the fact that there was no requirement for a sample to be derivatised, 
this method had the downside of low sensitivity, lack of differentiation between the 
two chiral forms of ABA and incompatibility with some phase systems. Therefore, 
whenever a concentration of both ABA and KBA had to be determined, each sample 
was analysed twice, using separate methods for ABA and KBA. Due to a higher 
sensitivity, samples were usually analysed for KBA on a C18 column, rather than on 
an anion exchange column. Moreover, the C18 HPLC columns lasted much longer 
than the anion exchange type, which reduced the cost of analyses. The drawback of 
this method was the necessity of derivatisation of each sample. To analyse ABA, 
derivatisation with ortho-phthalaldehyde was used. Replacing the reducing agent, 2-
mercaptoethanol, by N-isobutyryl-L-cysteine allowed the two chiral forms of ABA to 
be separated on a standard C18 column. Due to the presence of ammonium cations, 
the procedure of ABA derivatisation was not compatible with phase systems made of 
ammonium sulphate, the salt which was initially selected for the reason of 
requirement for KBA reduction in the next step. This was overcome by extracting 
ABA with methanol, which does not solubilise ammonium sulphate.  
An analytical method was also needed to analyse partitioning of the enzyme in a 
phase system. This could be done either by measuring enzyme activity or 
concentration of protein. Most of the available protein concentration assays were 
either not sensitive enough (Biuret assay, absorbance measurement at 280nm) or not 
compatible with ATPS. This was mainly a result of either a high concentration of 
phosphate salts, which having a very strong buffering effect would interfere with such 
assays as Lowry, Bradford and BCA, or the presence of ammonium cations, which 
would react with ortho-phthalaldehyde. Therefore partitioning of the enzyme was 
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determined by measuring its enzymatic activity. Moreover, it was more important to 
know how much enzymatic activity was in each phase, rather then enzyme molecules, 
which could be inactivated.  
 
Phase system selection is a big part of each CCC separation. This can take hours, 
days or even months. In this project, selection of an appropriate phase system was even 
more challenging due to additional necessary criteria. For effective bioreactor/separator 
action, a high partitioning of the biocatalyst to the stationary phase was required in 
order to retain the biocatalyst in the coil, with differing partitions of substrates and 
products between the stationary phase (SP) and mobile phase (MP) so that these could 
be separated. Selecting an appropriate phase system was proceeded by testing the whole 
range of two-phase systems such as aqueous two-phase systems (ATPS), aqueous–ionic 
liquid phase systems and aqueous organic phase systems. ATPS is used for a 
preparative extraction of such enzymes as α-amylase, β-xylosidase, endoglucanase, 
glucoamylase, α-1-antytripsin, α-galactosidase. Unexpectedly, the enzyme used in this 
project turned out to be unstable in most of the tested phase systems, including ATPS 
which was well reported to be effective in preserving enzyme activity. Therefore, one 
of the most important parameters in the selecting a phase system was enzyme stability. 
Due to promising initial results as well the recommendations found in the literature, the 
research concentrated on ATPS. The enzyme stability, as well as the distribution ratios 
of DL-ABA, KBA and DAAO were measured in a range of phases with polyethylene 
glycols (PEGs) of different molecular weights, different salts, and different 
compositions of PEG and salt. There are many different approaches for phase system 
selection for CCC. This can involve, for instance, trial and error methods, testing a 
range of solvent systems, or testing phase systems reported in the literature for 
separation of similar compounds. In this research a systematic approach was applied 
and the effect of only one factor at a time was tested on enzyme activity. Later in the 
project, when the partitioning of cells in ATPS was tested, more sophisticated methods 
involving the liquid-handling robot and DoE software were used. The enzyme was 
found to be most stable in phase systems made of high molecular weight PEG, such as 
3350 at a relatively low concentration. However, under such conditions the enzyme did 
not partition into the preferred top, PEG-rich phase. It was discovered that this could be 
overcome by applying the reaction of PEGylation to the enzyme. However, due to the 
extra cost and inconvenience, this approach was not taken further. Instead ATPS made 
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of PEG1000 at the concentration of 14/14% was applied, which did not require the use 
of PEGylated enzyme. A system of 14% w/w PEG 1000 and 14% w/w potassium 
phosphate, pH 7.6, gave the best combination of distributions ratios (CPEG phase/Csalt phase 
= CSP/CMP) for ABA, KBA and biocatalyst (DAAO) of 0.6, 2.4 and 19.6 respectively.  
Compared to aqueous-aqueous phase systems, aqueous-organic phase systems are 
known to give more efficient mixing between phases and better stationary phase 
retention in CCC. This results in much higher resolution between separated compounds. 
Since in the literature there are reported examples of successfully performed 
bioconversions in the presence of organic solvents, even under totally anhydrous 
conditions, a short study was done where a number of aqueous-organic phase systems 
were examined. Initially, some aqueous-organic phase systems showed promise, with 
high enzyme activity. However, it was discovered that in these systems the enzyme 
remained in the aqueous phase. Due to a large polarity difference between the phases, 
ABA and KBA also partitioned totally into the aqueous phase and would therefore 
never elute from CCC if this phase was used as the stationary phase. In all phase 
systems where the enzyme contacted organic solvents, a loss of activity was observed.  
Also ionic liquid (IL) two-phase systems were also reviewed, due to their potential 
as a phase system reported in the literature,. For instance it has been reported that four 
different proteins: cytochrome C, myoglobin, ovoalbumin and haemoglobin all 
partitioned totally into the IL phase in [BMIM][Cl]/K2PO4 phase system. This was 
desired as the enzyme would be retained in IL-phase, the stationary phase in the CCC-
bioreactor. Furthermore, DAAO was reported to be relatively stable in two water 
immiscible IL, [BMIM][Tf2N] and [BMIM][PF6], where it maintained over 80% of the 
initial activity after 24h incubation at 30°C. Moreover, a very low vapour pressure, 
makes ILs nonvolatile solvents. Therefore, the composition of phase systems consisting 
of IL does not change. This allows reusing of a phase system, which would reduce the 
overall cost of the process. Unfortunately, this enzyme did not maintain activity in most 
of the tested ILs. Therefore, these phase systems were not used as a phase system in the 
CCC-bioreactor.  
 
To achieve a complete deracemisation of ABA, unwanted D-ABA had to be totally 
converted to its keto analog, KBA, otherwise it would contaminate the product L-ABA 
by coeluting with it. Therefore, CCC operating conditions, such as substrate 
concentration, biocatalyst concentration, the mobile phase flow rate (residence time in 
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the CCC coil), temperature and rotational speed, were optimised. Effects of these 
conditions on D-ABA conversion were predicted and measured. Some surprises were 
encountered. For example, in contrast to most enzymatic reactions, a higher 
bioconversion was achieved at a lower temperature. Operational modes (single flow 
and Multiple Dual-Mode) and types of mixing (cascade and wave-like) were also 
optimised. Between the two types of mixing, wave-like mixing turned out to be more 
efficient, as being less vigorous it broadened the ABA plug, extending the contact with 
the enzyme and giving better conversion.  
For the optimum run conditions of the CCC-bioreactor, a plug of the racemate of 
ABA in the amount of 8mg was injected with the mobile phase pumped at the flow rate 
of 0.5ml/min with the CCC column (45ml) rotated at the rotational speed 1800rpm. The 
concentration of the enzyme D-amino acid oxidase in the stationary phase was 0.4g·l-1 
and the temperature of the CCC coil 20°C. Multiple Dual-Mode was applied to achieve 
a complete separation of L-ABA from KBA. The process took 300min, however L-
ABA finished eluting 160 min after the injection, so if the intention was to collect only 
the pure, single enantiomer, the run could be stopped after this time. L-ABA of an 
enantiomeric purity >99% ee was free of KBA, the product of the enzymatic 
conversion.  
The biggest advantage of applying the CCC-bioreactor is the isolation of 
enantiomerically pure L-ABA in a single step, as both the bioconversion of unwanted 
D-ABA and the separation of the produced KBA occurred at the same time. 
Moreover, not only did the isolated L-ABA elute free of KBA, but also free of the 
enzyme, which offers the potential to use the CCC-bioreactor in a continuous mode. 
However, a subsequent substrate injection was not possible due to the unpredicted 
instability of the enzyme in the phase system.  
Despite the advantages of the CCC-bioreactor over current commercial 
technology, such as reduced equipment footprint, faster purification and possible 
continuous operation mode, its drawbacks arising from the enzyme instability and 
excessive optimisation time, as well as a low throughput, reduces its commercial 
appeal. However, this technique may have a commercial potential in the isolation of 
high valuable enantiomers such as L-amino acids. In order to decrease enzyme 
consumption, which is the factor that most affects the cost of the whole process, 
multiple injections should be applied. This would allow the same portion of enzyme 
to catalyse many batches of substrate loaded into t
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would require use of a much more stable enzyme. Engineering the enzyme to achieve 
extended stability in phase systems might be the key to make the process more 
economical. As mentioned, a further limitation of the process comes from the low 
substrate loading, which makes the ratio of obtained product to enzyme used in the 
process unprofitable. However, this can be overcome by improving the enzyme 
activity, or perhaps applying other reactions such as enantioselective deamination.  
Future work should include investigation into improving the enzyme stability and 
enhancing the substrate loading. Investigations into the use of the biocatalyst in the 
whole cells of E. coli showed the potential to overcome the problem with the enzyme 
instability. Eventually, due to flocculation in ATPS, E. coli cells were not used in the 
CCC-bioreactor. However, there are other types of host cells, such as Pichia pastoris, 
available with the activity of D-amino acid oxidase, and these should be considered. 
In addition, other phase systems can be examined to find ones that give little 
flocculation. For example PEG-dextran phase systems prepared in isotonic buffers 
have been widely used for cell separations. This would require optimisation of the 
distribution ratios of all components, and then optimisation of the operating 
conditions. However, further complications such as a difficulty of product extraction 
from the dextran-phase, may arise from applying this kind of a phase system.  
A very low substrate loading is a factor which, at this time, makes the process 
uneconomical. This might have been caused by the saturation of the FAD-dependent 
enzyme, which in the absence on oxygen could not regenerate, or the elution of FAD 
together with the mobile phase. Additional research should be performed to 
investigate these possibilities and develop ways of overcoming the limitations, if 
necessary. Alternatively, enzymes catalysing other reaction types, such as 
enantioselective, cofactor-independent hydrolase should be investigated.  
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
% M [mg] Density V [µl] % M [mg] Density V [µl]
1 400 K citrate 16 55 1164 1.094 1064 40 1600 1.289 1241 1236 4000 3541 1201 1402 1297 100 4000
2 400 K citrate 18 55 1309 1.094 1197 40 1800 1.289 1396 891 4000 3484 1374 1603 923 100 4000
3 400 K citrate 20 55 1455 1.094 1330 40 2000 1.289 1552 545 4000 3427 1552 1811 537 100 4000
4 400 K citrate 22 55 1600 1.094 1463 40 2200 1.289 1707 200 4000 3369 1736 2026 137 100 4000
5 400 KPO4 16 55 1164 1.094 1064 40 1600 1.387 1154 1236 4000 3454 1232 1336 1332 100 4000
6 400 KPO4 18 55 1309 1.094 1197 40 1800 1.387 1298 891 4000 3385 1414 1533 953 100 4000
7 400 KPO4 20 55 1455 1.094 1330 40 2000 1.387 1442 545 4000 3317 1603 1739 558 100 4000
8 400 KPO4 22 55 1600 1.094 1463 40 2200 1.387 1586 200 4000 3249 1801 1953 146 100 4000
9 400 Na citrate 16 55 1164 1.094 1064 40 1600 1.278 1252 1236 4000 3552 1198 1410 1292 100 4000
10 400 Na citrate 18 55 1309 1.094 1197 40 1800 1.278 1408 891 4000 3496 1369 1612 919 100 4000
11 400 Na citrate 20 55 1455 1.094 1330 40 2000 1.278 1565 545 4000 3440 1546 1820 534 100 4000
12 400 Na citrate 22 55 1600 1.094 1463 40 2200 1.278 1721 200 4000 3384 1729 2035 136 100 4000
13 400 NaPO4 16 55 1164 1.094 1064 29 2207 1.275 1731 629 4000 3424 1243 2022 635 100 4000
14 400 NaPO4 18 55 1309 1.094 1197 29 2483 1.275 1947 208 4000 3352 1428 2324 148 100 4000
15 400 NaSO4 16 55 1164 1.094 1064 29 2207 1.293 1707 629 4000 3400 1251 2008 641 100 4000
16 400 NaSO4 18 55 1309 1.094 1197 29 2483 1.293 1920 208 4000 3325 1440 2310 150 100 4000
17 400 NH4PO4 16 55 1164 1.094 1064 40 1600 1.241 1289 1236 4000 3589 1185 1437 1278 100 4000
18 400 NH4PO4 18 55 1309 1.094 1197 40 1800 1.241 1450 891 4000 3538 1353 1640 907 100 4000
19 400 NH4PO4 20 55 1455 1.094 1330 40 2000 1.241 1612 545 4000 3487 1525 1849 526 100 4000
20 400 NH4PO4 22 55 1600 1.094 1463 40 2200 1.241 1773 200 4000 3435 1703 2064 133 100 4000
21 400 NH4SO4 16 55 1164 1.094 1064 40 1600 1.230 1301 1236 4000 3601 1182 1445 1273 100 4000
22 400 NH4SO4 18 55 1309 1.094 1197 40 1800 1.230 1463 891 4000 3551 1348 1648 904 100 4000
23 400 NH4SO4 20 55 1455 1.094 1330 40 2000 1.230 1626 545 4000 3501 1519 1858 523 100 4000
24 400 NH4SO4 22 55 1600 1.094 1463 40 2200 1.230 1789 200 4000 3451 1695 2073 132 100 4000
25 1000 K citrate 14 55 1018 1.094 931 40 1400 1.289 1086 1582 4000 3599 1035 1207 1658 100 4000
26 1000 K citrate 16 55 1164 1.094 1064 40 1600 1.289 1241 1236 4000 3541 1201 1402 1297 100 4000
27 1000 K citrate 18 55 1309 1.094 1197 40 1800 1.289 1396 891 4000 3484 1374 1603 923 100 4000
28 1000 K citrate 20 55 1455 1.094 1330 40 2000 1.289 1552 545 4000 3427 1552 1811 537 100 4000
29 1000 K citrate 22 55 1600 1.094 1463 40 2200 1.289 1707 200 4000 3369 1736 2026 137 100 4000
30 1000 KPO4 14 55 1018 1.094 931 40 1400 1.387 1009 1582 4000 3522 1057 1146 1697 100 4000
31 1000 KPO4 16 55 1164 1.094 1064 40 1600 1.387 1154 1236 4000 3454 1232 1336 1332 100 4000
32 1000 KPO4 18 55 1309 1.094 1197 40 1800 1.387 1298 891 4000 3385 1414 1533 953 100 4000
Total 
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volume 
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volume 
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Table 56. Aqueous two-phase systems made using the liquid-handling robot. Columns 2-4 show characteristic of ATPS: PEG molecular weight, salt type, concentrations. In 
columns 5-8 parameters of PEG stock solutions and in columns 9-12 the parameters of salt stock solution to make 4g of ATPS, are presented. In columns 16-19 volumes of PEG 
stock solutions, salt stock solution, water and a substrate stock solution to make 4ml of ATPS. These volumes were used to make ATPS by the robot. Page 1 of 3.  
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
% M [mg] Density V [µl] % M [mg] Density V [µl]
33 1000 KPO4 20 55 1455 1.094 1330 40 2000 1.387 1442 545 4000 3317 1603 1739 558 100 4000
34 1000 KPO4 22 55 1600 1.094 1463 40 2200 1.387 1586 200 4000 3249 1801 1953 146 100 4000
35 1000 Na citrate 14 55 1018 1.094 931 40 1400 1.278 1095 1582 4000 3608 1032 1214 1654 100 4000
36 1000 Na citrate 16 55 1164 1.094 1064 40 1600 1.278 1252 1236 4000 3552 1198 1410 1292 100 4000
37 1000 Na citrate 18 55 1309 1.094 1197 40 1800 1.278 1408 891 4000 3496 1369 1612 919 100 4000
38 1000 Na citrate 20 55 1455 1.094 1330 40 2000 1.278 1565 545 4000 3440 1546 1820 534 100 4000
39 1000 Na citrate 22 55 1600 1.094 1463 40 2200 1.278 1721 200 4000 3384 1729 2035 136 100 4000
40 1000 NaPO4 14 55 1018 1.094 931 29 1931 1.275 1515 1051 4000 3496 1065 1733 1102 100 4000
41 1000 NaPO4 16 55 1164 1.094 1064 29 2207 1.275 1731 629 4000 3424 1243 2022 635 100 4000
42 1000 NaPO4 18 55 1309 1.094 1197 29 2483 1.275 1947 208 4000 3352 1428 2324 148 100 4000
43 1000 NaSO4 14 55 1018 1.094 931 29 1931 1.293 1493 1051 4000 3475 1071 1719 1110 100 4000
44 1000 NaSO4 16 55 1164 1.094 1064 29 2207 1.293 1707 629 4000 3400 1251 2008 641 100 4000
45 1000 NaSO4 18 55 1309 1.094 1197 29 2483 1.293 1920 208 4000 3325 1440 2310 150 100 4000
46 1000 NH4PO4 14 55 1018 1.094 931 40 1400 1.241 1128 1582 4000 3641 1023 1239 1638 100 4000
47 1000 NH4PO4 16 55 1164 1.094 1064 40 1600 1.241 1289 1236 4000 3589 1185 1437 1278 100 4000
48 1000 NH4PO4 18 55 1309 1.094 1197 40 1800 1.241 1450 891 4000 3538 1353 1640 907 100 4000
49 1000 NH4PO4 20 55 1455 1.094 1330 40 2000 1.241 1612 545 4000 3487 1525 1849 526 100 4000
50 1000 NH4PO4 22 55 1600 1.094 1463 40 2200 1.241 1773 200 4000 3435 1703 2064 133 100 4000
51 1000 NH4SO4 14 55 1018 1.094 931 40 1400 1.230 1138 1582 4000 3651 1020 1247 1633 100 4000
52 1000 NH4SO4 16 55 1164 1.094 1064 40 1600 1.230 1301 1236 4000 3601 1182 1445 1273 100 4000
53 1000 NH4SO4 18 55 1309 1.094 1197 40 1800 1.230 1463 891 4000 3551 1348 1648 904 100 4000
54 1000 NH4SO4 20 55 1455 1.094 1330 40 2000 1.230 1626 545 4000 3501 1519 1858 523 100 4000
55 1000 NH4SO4 22 55 1600 1.094 1463 40 2200 1.230 1789 200 4000 3451 1695 2073 132 100 4000
56 3350 K citrate 12 35 1371 1.060 1294 40 1200 1.289 931 1429 4000 3653 1417 1019 1464 100 4000
57 3350 K citrate 14 35 1600 1.060 1509 40 1400 1.289 1086 1000 4000 3596 1679 1208 1012 100 4000
58 3350 K citrate 16 35 1829 1.060 1725 40 1600 1.289 1241 571 4000 3538 1950 1403 546 100 4000
59 3350 K citrate 18 35 2057 1.060 1941 40 1800 1.289 1396 143 4000 3480 2231 1605 64 100 4000
60 3350 KPO4 12 35 1371 1.060 1294 40 1200 1.387 865 1429 4000 3588 1443 965 1493 100 4000
61 3350 KPO4 14 35 1600 1.060 1509 40 1400 1.387 1009 1000 4000 3519 1716 1147 1037 100 4000
62 3350 KPO4 16 35 1829 1.060 1725 40 1600 1.387 1154 571 4000 3450 2000 1337 563 100 4000
63 3350 KPO4 18 35 2057 1.060 1941 40 1800 1.387 1298 143 4000 3381 2296 1535 69 100 4000
64 3350 Na citrate 12 35 1371 1.060 1294 40 1200 1.278 939 1429 4000 3661 1413 1026 1461 100 4000
65 3350 Na citrate 14 35 1600 1.060 1509 40 1400 1.278 1095 1000 4000 3605 1675 1216 1010 100 4000
66 3350 Na citrate 16 35 1829 1.060 1725 40 1600 1.278 1252 571 4000 3548 1945 1411 544 100 4000
67 3350 Na citrate 18 35 2057 1.060 1941 40 1800 1.278 1408 143 4000 3492 2223 1613 64 100 4000
Sample 
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Table 57. Page 2 of 3. 
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
% M [mg] Density V [µl] % M [mg] Density V [µl]
68 3350 NaPO4 12 35 1371 1.060 1294 29 1655 1.275 1298 973 4000 3565 1452 1456 992 100 4000
69 3350 NaPO4 14 35 1600 1.060 1509 29 1931 1.275 1515 469 4000 3493 1729 1734 437 100 4000
70 3350 NaSO4 12 35 1371 1.060 1294 29 1655 1.293 1280 973 4000 3547 1459 1443 998 100 4000
71 3350 NaSO4 14 35 1600 1.060 1509 29 1931 1.293 1493 469 4000 3472 1739 1721 440 100 4000
72 3350 NH4PO4 12 35 1371 1.060 1294 40 1200 1.241 967 1429 4000 3689 1403 1048 1449 100 4000
73 3350 NH4PO4 14 35 1600 1.060 1509 40 1400 1.241 1128 1000 4000 3638 1660 1241 1000 100 4000
74 3350 NH4PO4 16 35 1829 1.060 1725 40 1600 1.241 1289 571 4000 3586 1924 1438 537 100 4000
75 3350 NH4PO4 18 35 2057 1.060 1941 40 1800 1.241 1450 143 4000 3534 2197 1642 62 100 4000
76 3350 NH4SO4 12 35 1371 1.060 1294 40 1200 1.230 976 1429 4000 3698 1399 1055 1445 100 4000
77 3350 NH4SO4 14 35 1600 1.060 1509 40 1400 1.230 1138 1000 4000 3648 1655 1248 997 100 4000
78 3350 NH4SO4 16 35 1829 1.060 1725 40 1600 1.230 1301 571 4000 3597 1918 1446 535 100 4000
79 3350 NH4SO4 18 35 2057 1.060 1941 40 1800 1.230 1463 143 4000 3547 2189 1650 61 100 4000
80 8000 K citrate 12 30 1600 1.052 1521 40 1200 1.289 931 1200 4000 3652 1666 1020 1214 100 4000
81 8000 K citrate 14 30 1867 1.052 1774 40 1400 1.289 1086 733 4000 3594 1975 1209 716 100 4000
82 8000 K citrate 16 30 2133 1.052 2028 40 1600 1.289 1241 267 4000 3536 2294 1404 202 100 4000
83 8000 KPO4 12 30 1600 1.052 1521 40 1200 1.387 865 1200 4000 3586 1696 965 1239 100 4000
84 8000 KPO4 14 30 1867 1.052 1774 40 1400 1.387 1009 733 4000 3517 2018 1148 734 100 4000
85 8000 KPO4 16 30 2133 1.052 2028 40 1600 1.387 1154 267 4000 3448 2352 1338 209 100 4000
86 8000 Na citrate 12 30 1600 1.052 1521 40 1200 1.278 939 1200 4000 3660 1662 1026 1212 100 4000
87 8000 Na citrate 14 30 1867 1.052 1774 40 1400 1.278 1095 733 4000 3603 1970 1216 714 100 4000
88 8000 Na citrate 16 30 2133 1.052 2028 40 1600 1.278 1252 267 4000 3547 2287 1412 201 100 4000
89 8000 NaPO4 12 30 1600 1.052 1521 29 1655 1.275 1298 745 4000 3564 1707 1457 736 100 4000
90 8000 NaPO4 14 30 1867 1.052 1774 29 1931 1.275 1515 202 4000 3491 2033 1735 132 100 4000
91 8000 NaSO4 12 30 1600 1.052 1521 29 1655 1.293 1280 745 4000 3546 1716 1444 740 100 4000
92 8000 NaSO4 14 30 1867 1.052 1774 29 1931 1.293 1493 202 4000 3470 2045 1721 133 100 4000
93 8000 NH4PO4 12 30 1600 1.052 1521 40 1200 1.241 967 1200 4000 3688 1650 1049 1202 100 4000
94 8000 NH4PO4 14 30 1867 1.052 1774 40 1400 1.241 1128 733 4000 3636 1952 1241 707 100 4000
95 8000 NH4PO4 16 30 2133 1.052 2028 40 1600 1.241 1289 267 4000 3584 2263 1439 198 100 4000
96 8000 NH4SO4 12 30 1600 1.052 1521 40 1200 1.230 976 1200 4000 3697 1646 1056 1199 100 4000
97 8000 NH4SO4 14 30 1867 1.052 1774 40 1400 1.230 1138 733 4000 3646 1947 1249 705 100 4000
98 8000 NH4SO4 16 30 2133 1.052 2028 40 1600 1.230 1301 267 4000 3595 2256 1447 197 100 4000
Sample 
volume 
[ul]
Total 
volume 
[µl]
Total 
volume 
[µl]
PEG 
volume 
[µl]
Salt 
volume 
[µl]
Water 
volume 
[µl]
No PEG type Salt type
Concent
ration
PEG Salt Water 
[g,µl]
Total 
weight 
[mg]
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